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 The human genome contains ~1.5% coding sequence, with the remaining 98.5% 
being non-coding [1].  The functional potential of the majority of this non-coding 
sequence remains unknown.  Much of this non-coding sequence is derived from 
transposable element (TE) sequences.  These TE sequences contain their own regulatory 
information, e.g. promoter and transcription factor binding sites.  Given the large number 
of these sequences, over 4 million in the human genom , it would be expected that the 
regulatory information that they contain would affect the expression of nearby genes.  
This dissertation describes research that characterizes that alternation of and contribution 
to the human transcriptome by non-coding elements, i cluding TE sequences.   
 Research advance 1: Chapter 2 evaluates the abundance of cis-natural antisense 
transcript (cis-NAT) promoters derived from TE insertions within human genic loci.  TE 
sequences require their own promoters for transcription, and previous examples of TE-
derived promoters are known.  Here it is shown that TE sequences provide cis-NAT 
promoters inside of human genes and that these TE-derive  cis-NAT promoters are more 
common toward the 3’-end of genic loci. 
Research advance 2: In chapter 3, the presence of alternative promoters for 
human genes derived from endogenous retrovirus (ERV) insertions is investigated 
genome-wide.  Paired-end diTag (PET) and Cap Analysis of Gene Expression (CAGE) 
data from mammary epithelial cell lines are used to i entify transcripts of human genes 
that are initiated from ERV sequences.  The work shown here demonstrates that ERV 




Research advance 3:  In chapter 4, we review techniques for characterizing 
transcription factor binding sites derived TE sequences using ChIP-seq data.  TE 
sequences contain transcription factor binding sites (TFBS) that they use for their own 
transcription, as well as potentially harboring sequences similar to other TFBS.  The 
spread of TE sequences in a host genome could thus create additional TFBS [2].  Such 
novel TFBS could greatly affect the expression of nearby host genes.  However, the short 
read length of ChIP-seq data necessitates special care when characterizing DNA-protein 
interactions involving TE sequences.  The methods shown here are generally applicable 
for characterizing TFBS derived from TE sequences.     
Research advance 4: In Chapter 5, the regulation of cis-NAT promoter activity 
via chromatin modification is characterized.  The activity of cis-NAT promoters is shown 
to be correlated with the local presence of activating histone modifications, e.g. H3K9Ac, 
and anti-correlated with the presence of the repressiv  H3K27Me3 modification [3, 4].  It 
is also shown that the distribution of histone modifications near promoters is very similar 
to that of canonical promoters for protein coding genes.  Finally, the cis-NAT promoters 
characterized are shown to be active in fewer cell types on average than promoters of 
protein coding genes.  The regulation of cis-NAT promoters via chromatin modification 
is indicative of the function of cis-NAT promoters in the human genome. 
Research advance 5: Chapter 6 reviews instances in which ERV sequences have
been shown to have an effect on the host transcription via epigenetic modification of the 
ERV sequence.  The control of ERV sequences via repressive epigenetic modifications 
has the potential to lower the expression of host genes near the ERV sequences.  Several 




genes.  Studies showing the converse, examples of ERVs bearing activating epigenetic 
marks positively affecting gene expression, are also reviewed.  The studies reviewed here 
demonstrate that the epigenetic modification of ERV sequences has the potential to effect 
host gene expression.    
Research advance 6: In chapter 7, the extent to which TE sequences within gene 
loci terminate the transcription of human genes, and the cell type-specificity of such 
termination, are explored.  TE sequences within gene loci are more often than not found 
in the antisense orientation, likely resulting from selection against sense insertions that 
could terminate gene transcription.  Utilizing high-throughput PET data, many thousands 
of alternative transcription termination sites (TTS) derived from TE sequences (TE-TTS) 
are characterized across eight human cell types.  The relative strengths of TTS derived 
from sense and antisense sequences as well as different TE families are evaluated; TE-
TTS in the sense orientation are generally much stronger, and the different TE families 
show substantial differences in the strength of TE-TTS derived from them.  We further 
show that TE-TTS provide many highly cell type specific TTS.  These results 
demonstrate that TE sequences have had a major effect on the expression of human genes 





INTRODUCTION AND LITERATURE REVIEW 
 
 
Eukaryotic genomes contain abundant non-coding DNA 
Transposable elements (TE) are DNA sequences which have the ability to ‘transpose’ or 
move about in the genome.  There are four main types of TEs: SINEs, LINEs, LTR 
elements and DNA transposons.  The first three types move through in the genome via 
retrotransposition where the element is first transcribed into mRNA then reverse 
transcribed and into the genome.  The fourth type moves by a ‘cut-and-paste’ mechanism 
where the actual DNA sequence of the element is excis d from the genome and inserted 
elsewhere.  SINEs (short interspersed nuclear elements) are small TE sequences, 
typically derived from non-coding RNAs, e.g. tunas, 7SL RNAs, etc.  SINEs do not 
encode any of the enzymes required for retrotransposition and instead rely on enzymes 
encoded from other classes of TEs.  LINEs (long interspersed nuclear elements) are a 
family of TEs which do encode enzymes necessary for retrotransposition; it is thought 
that SINEs typically rely on LINE-encoded enzymes for retrotransposition.  LTR 
elements are a class of TEs which have, on either end of their internal sequences, long 
terminal repeats, for which LTR elements are named.  These LTRs are direct repeats, i.e.
the 5’ LTR and 3’ LTR are identical.  Like LINEs, these TEs encode the enzymes and 
other proteins required for their retrotransposition, though the process is substantially 
different from LINEs.   
Transposable elements (TEs) often make up a substantial fraction of non-coding 




sequences [5].  However, a recent study suggests that much of the of remainder of the 
human genome is composed of highly diverged TE sequences,  and that the human 
genome may be as much as 69% TE sequence [6].  An example of the abundance of TE-
derived sequence in the human genome is shown in Figure 1.1.  Three human protein 
coding genes (black) are present in this short region, however they are dwarfed by the 
number of TE sequences (grey).  This region is fairly representative of the human 
genome as a whole; the amount of sequence coding for human genes is vastly exceeded 




Figure 1.1.  The human genome is dense with TE sequences.  Three human genes 
(black) are present in the region.  Various TE sequences within the region from the four 
TE classes are shown in grey.   
 
 
In contrast to other species, there are relatively few actively transposing TE 
families in the human genome [1, 7, 8].  Indeed, only a few specific subfamilies of the 
Alu, L1 and SVA families are currently active in the uman genome [1].  Alu elements 
are an active family of SINEs specific to the primate lineage, originating from the 




has been extremely successful, expanding to ~1.2 million copies in the human genome [5, 
9, 10].  L1 elements are an active family of LINEs found throughout mammals, and 
contribute 17% of the human genome [1, 5].  SVAs are a elatively recent family of non-
coding TEs derived from a fusion of other TE families.  SVAs are active, but rare; only 
~4,500 copies are present in the human genome [11]. In addition to these families, there 
are many thousands of sequences derived from functionally dead TE families in the 
human genome.  Mammalian Interspersed Repeats (MIRs) and L2s are tRNA derived 
SINEs and LINEs, respectively.  Though both families stopped spreading some time ago, 
many more of these sequences than expected have been conserved over evolutionary 
time, suggesting that they have exapted to play some r le for the host genome [12].  
Importantly, these sequences contain regulatory sequences to promote their own 
transcription and spread.  L1 elements contain, for example, their own internal promoter 
and terminator sequences [13, 14].  When inserted within or near to a host gene, these 
regulatory sequences could drastically alter the transcription of the host gene. 
Active TE Sequences can generate many additional copies in a relatively short 
evolutionary time. There are, for example, many TE sequences which inserted after the 
divergence between human and chimpanzee.  Between th  human and chimpanzee 
genomes, there are over 9,000 TE insertions lacking in one genome or the other, and an 
additional ~4,000 L1 insertions.  Interestingly, while ERVs appear to be dead or near 
dead in the human genome, several families have multiplied in the chimpanzee genome 
yielding several hundred new insertions [1, 8].   
The human-chimpanzee divergence was very recent in evolutionary terms.  The 




and mouse have very different sets of active TEs.  While the human genome contains 
~1.2 million Alu sequences, the Alu family is not present in the rodent lineage [1, 7].  
While LTR elements are functionally dead in humans, they are the most active TEs in 
mouse, particularly the intracisternal-A particle (IAP) family of ERVs.  An example of 
the dramatic differences in TE content between human and mouse is shown for the 
CHRNA2 locus (Figure 1.2).  It can be seen that the coding exons of the CHRNA2 gene 
(thick black blocks) are present in both species, i. . the coding exons are located within 
aligned regions (blue blocks).  It is worth noting that the annotated promoters from 
human and mouse do not arise from homologous loci (see below).   For both the human 
and mouse genomes, there are many large gaps in the alignment representing sequences 
not present in the other species; many of these gaps are due solely to the presence of 
lineage-specific TE sequences.  For example, the highlighted TE sequence (red) resulted 
from the insertion of a B2 element, a rodent-specific family of SINEs, and it leads to a 
gap in the alignment as there is no homologous sequence in the human genome.  Being 
lineage-specific, these TE sequences and whatever effect they have on the transcription 
of host genes are also lineage-specific.  The vast number of differences in the TE 
sequence content between human and mouse, much of it within coding loci, virtually 
guarantees that TE sequences have altered gene expression via non-coding means.  
Indeed, many such examples are known, and five of the works in this dissertation add to 







Figure 1.2.  Many TE sequences at the CHRNA2 locus are lineage-specific.  
Homologous annotated CHRNA2 transcripts (black) from human and mouse are shown 
above regions which align between the two genomes (blue blocks) and annotated TE 
sequences within each genome (grey).   A B2 insertion (red) in the rodent lineage 
generated a rodent-specific genomic sequence resulting in a gap in the alignment with the 
human genome.  There are many other lineage-specific TE sequences (grey) that 
correspond to gaps in the human-mouse genome sequence alignment. 
 
 
The human genome contains many functional non-coding elements 
There exists in the human genome a wide variety and a very large number of non-coding 
elements that influence gene transcription.  The mechanisms by which these non-coding 
elements influence transcription are equally varied.  This dissertation is concerned with 
three of the most prominent varieties of non-coding regulatory elements: promoters, 
transcription termination sites (TTS), and transcription factor binding sites (TFBS).   Of 
interest, it has been show that various TE sequences have been exapted to function as all 
of these non-coding elements.   
Every gene has some non-coding elements which influe ce its transcription: at 
least one promoter and at least one terminator.  Promoters are where the transcription of 




allow for a condition and cell type-specific expression of genes and isoforms [15-17].  It 
is worth noting that alternative promoters derived from TE sequences have been 
previously described [18]. Promoters, however, are not exclusive to protein-coding 
genes; there are many known, long non-coding transcipt  in the human genome, many of 
which show cell type-specific expression as protein coding genes do [19].  At the 
opposite end of the transcript is the polyadenylation signal and transcription termination 
site.  As with promoters, human transcription terminators derived from TE sequences 
have been known for some time [20, 21].  Promoters can substantially alter the amount of 
mRNA produced, while both alternative promoters andterminators can alter the coding 
sequence, potentially changing both the quality and quantity of the mRNA.   
The third category of concern here, transcription factor binding sites, including 
enhancers, alter the expression of genes not via initi tion or termination of transcription, 
but by recruiting proteins required for transcription to the promoter proper.  As with 
promoters and terminators, transcription factor binding sites and enhancers derived from 
TE sequences have been described.  For example, a very old SINE insertion was shown 
to act as an important enhancer in neural development [22, 23].  Recently, it was shown 
that a family of LTR elements, MER41, has greatly expanded number of functional 
STAT1 binding sites in the human genome [24].  
 
High-throughput techniques and massively-parallel sequencing and have drastically 
altered the study of genome function 
Previous methods of characterizing genomic function fell short in a number of ways, 




sequences.  EST sequencing using Sanger sequencing is far too low throughput to capture 
the breadth and variation in human gene expression or to accurately characterized DNA-
protein interactions genome wide.  The large size of the human genome means also that 
genome-wide (tiling) microarrays are unfeasible.  Further, microarray based techniques 
cannot detect TE-derived sites due to their repetitiv  nature.  Thus TE sequences and any 
functional elements they may provide cannot be detect d via such methods, e.g. the pilot 
phase of the ENCODE project [25].  Current technologies using massively-parallel 
sequencing allow for the genome-wide, unbiased characte ization of RNA transcripts 
(RNA-seq) and DNA-protein interactions (Chromatin Immunoprecipitation followed by 
high-throughput sequencing, ChIP-seq).  For example, an early large-scale study using 
RNA-seq and the Illumina platform showed that nearly ll multi-exon human genes are 
alternatively spliced in some tissue, far more than previously appreciated [26].  Another 
early study used the Illumina platform to characterize NRSF binding genome wide via 
ChIP-seq [27].  Several of the works shown here make use of ChIP-seq data and/or RNA-
seq data from the production phase of the ENCODE project to characterize non-coding 
functional elements in the human genome [28, 29].   
 Along with massively parallel sequencing technologies, several molecular 
techniques have greatly aided the characterization of promoters and terminators.  The 
first, cap analysis of gene expression (CAGE), generates short tags from the 5’ end of 
mature mRNA transcripts, which, when sequenced and mapped to the genome, can 
identify TSS and promoters [30, 31].  A second technique, paired-end diTag (PET) 
generates similar data, but allows for the characteization of both the 5’ and 3’ ends of a 




in-depth interrogation of promoter and terminator activity.  Importantly, as these 
techniques are not array based, they allow for the functional characterization of TE-
derived sequences.  Indeed, CAGE has been previously been combined with massively-
parallel sequencing to characterize the transcription of TE sequences across a large 
number of human and mouse cell types [32].  Data generated using the CAGE and PET 
technique are used in the majority of the studies shown here to characterize the 
contribution of non-coding sequences to human transcription.   
 
Antisense transcription is pervasive in the human genome 
One of the more interesting observations in recent y ars is that the large majority of the 
human genome, including both strands, is transcribed at some point in time.   
A substantial fraction of this transcription is in the form of non-coding cis-natural 
antisense transcripts (cis-NATs) [33, 34].  These transcripts are transcribed from the 
opposite strand of a gene coding locus, and would thus be antisense and complementary 
to the sense product.  Several examples of cis-NAT transcription negatively affecting 
sense product abundance are known [35, 36].  Whether or not general cis-NAT 
transcription is functional, or simply noise, remains to be seen.  The sources of cis-NAT 
transcription and regulation are characterized in two of the studies presented here. 
Alternative transcription termination has attracted recently attracted great interest 
It has previously been estimated that at least 50% of human genes contain alternative 
termination sites; utilization of these sites by an elongating RNA polymerase results in 
different transcript isoforms [37, 38].  The effect of such alternative termination on gene 




translated protein product.  Utilizing intronic termination sites, genes encoding receptor 
tyrosine kinases have been found to produce shorter transcripts encoding truncated 
receptors missing transmembrane domains.  Proteins produced from these truncated 
transcripts may act as molecular decoys, sequestering other proteins that would otherwise 
interact with the full-length products.  Recent studies have shown that cancer cells and 
other proliferating cells broadly express transcripts with shortened 3’UTRs compared to 
differentiated cells [39, 40].  Conversely, it was shown that cells going through 
differentiation progressively express transcripts with longer 3’UTRs [41].  These studies 
strongly suggest that the use of the use of alternative termination sites to generate shorter 
or longer transcripts is an important part of gene regulation.  In this dissertation, the cell 






HUMAN CIS-NATURAL ANTISENSE TRANSCRIPTS INITIATED 
BY TRANSPOSABLE ELEMENTS  
 
Abstract 
The capacity of human transposable elements (TEs) to promote cis natural antisense 
transcripts (cis-NATs) is revealed by the discovery of 48,718 human gene antisense 
transcriptional start sites (TSSs) within TE sequences.  TSSs that yield cis-NATs are 
overrepresented among TE sequences, and TE initiated cis-NATs are more abundant 
close to the 3’ ends of genes.  The TE sequences that promote antisense transcription 
within human genes are relatively ancient suggesting that selection has acted to conserve 
their function.   
Introduction 
Cis natural antisense transcripts (cis-NATs) are RNAs that are transcribed from the 
antisense strand of a gene locus, which are thus complementary to the RNA transcribed 
from the sense strand.  It is becoming increasingly apparent that cis-NATs are used to 
regulate the expression of human genes [33, 42, 43].  Cis-NATs may regulate expression 
at the transcriptional level, via the avoidance of transcriptional collisions [44], or post-
transcriptionally through any one of the number of d uble stranded RNA (dsRNA) 
induced regulatory pathways collectively known as RNA interference [45].   
Transposable elements (TEs) have been shown to contribute a variety of non-




species including human.  Indeed, TEs encode a number of distinct classes of regulatory 
RNAs including short interfering RNAs [46-48], microRNAs [49, 50], repeat-associated 
small interfering RNAs [51] and piwi-interacting RNAs [52].  It appears that multiple 
distinct RNA interference mechanisms have evolved independently as genome defense 
mechanisms against TEs only to be later coopted to regulate host genes [49].  There are 
three reasons to believe that TEs may represent a potentially rich source of cis-NATs that 
can regulate human gene expression: i-the abundance of TEs in the human genome [1], 
ii-the ability of TE sequences to promote transcription [53] and iii-the relationship 
between TEs and RNA interference.  To explore this possibility, we have conducted a 
genome-scale survey of the ability of TE sequences to contribute cis-NATs to human 
genes. 
Methods 
Identification of TE-TSSs from CAGE data 
A library of 1,551,672 human CAGE sequence tags [31, 54] was download from 
the Japanese National Institute of Genetics website 
(http://genomenetwork.nig.ac.jp/public/download/cage_Database_e.html).  The data used 
in the manuscript correspond to the 2007.3.28 releas .  Human CAGE sequence tags 
were mapped to the hg18 version, i.e. the National Center for Biotechnology Information 
release 36, of the reference human genome sequence as pr viously described [30].  A 
browser extensible data (BED) format custom track with all CAGE tag-to-genome 
mapping coordinates, available on request, was generated in order to integrate the CAGE 
data with the human genome reference sequence annotatio s available from the UCSC 




a series of custom developed Perl scripts, available on request, to identify the intersection 
between human transcriptional start sites (TSSs) ident fied by CAGE tags with human 
transposable elements (TEs).  To identify TE-derived TSSs, the human CAGE custom 
track was intersected with the Repeat Masker [5] (rmsk track) annotation track using 
100% overlap and non TE-classes of repetitive DNA were subsequently eliminated from 
consideration.  Specific TE family/class identities of the resulting TE-TSSs were 
determined by mapping these results back to the rmsk track and parsing the annotation 
therein.  The observed percentages of 1) all, 2) sense and 3) antisense TE-TSS were 
determined for seven individual classes/families of TEs.  The observed values were 
compared to the expected values that were determined by calculating their relative 
frequencies in the RepeatMasker annotation for the w ole genome.  Observed and 
expected values sum to 100% over all TE categories.    
Human genes and TSSs from CAGE data 
 The UCSC Genome Browser ‘Old Known Genes’ track annotations 
(http://www.genome.ucsc.edu/cgi-
bin/hgTrackUi?hgsid=99200641&c=chr7&g=knownGeneOld2) were used to define the 
coordinates of human protein-coding genes on the hg18 reference sequence.  These 
human gene annotations were chosen because they repr sent a conservative set of gene 
definitions that are supported by multiple lines of evidence from the SWISS-PROT, 
TrEMBL and Genbank databases [56, 57].  A custom Perl script was used to divide all 
human genes, from their 5’ to 3’ ends, into twenty equal sized bins, and the TSSs 
identified from CAGE data were mapped into gene-specific bins.  Where the Old Known 




genomic locus in the same direction, the resulting TSSs locations were only counted 
once.  The antisense-versus-sense orientations (ratios) of TSSs were then considered with 
respect to their location in each bin along the gene l gths.  This procedure was repeated 
for 1) non TE-TSS, 2) all TE-TSS and 3) individual families/classes of TE-TSS.   
Relative ages of TE-TSSs 
 The relative ages of different families/classes of TEs were taken from the 
RepeatMasker analysis of the human genome reference sequence [1].  Since TE 
sequences in the human genome are derived from, and related to, copies of once active 
elements, and have subsequently accumulated mutations after insertion in the genome, 
the elements can be clustered into phylogenetic trees and grouped into related 
families/classes.  The ensemble of sequences in any given class can be used to compute a 
consensus sequence, which is taken to represent the ancient (active) copy of the TE [58].  
Such consensus sequences have been extensively constru ted from human genome TEs 
and are available in the Repbase database [59, 60].  Ages of TEs can be then be inferred 
by comparing the sequence divergence between the exant element sequence identified in 
the genome and its most closely related consensus sequence [61].  This information is 
made available as the ‘millidiv’ output, i.e. number of substitutions per 1,000 sites, from 
the RepeatMasker program.  Percent substitution of extant TEs from consensus sequences 
was used to show that the human genome has experienc d successive waves of expansion 
of different families/classes.  Consequently, some families/classes are substantially older 
(or younger) than others.  The most ancient families n the human genome are the L2 and 
MIR families, while the youngest are L1 and Alu [1].  These are the specific findings that 




 Divergence (d) of extant TE sequences identified in the human genome from their 
consensus sequences were also used to evaluate the relative ages of TEs within the Alu 
family of elements.  To do this, individual Alu insertion millidiv values were converted to 
Jukes-Cantor DNA sequence distances [62] using the following formula: 
d = −3/4 * ln[1− 4 /3(millidiv /1,000) 
Then, the average and standard deviation d-values were computed and compared for Alu 
elements that donate TSSs versus those that do not using the Student’s t-test.  
Human-Mouse conservation of TSS 
 To evaluate the relative human-to-mouse evolutionary conservation, i.e. 
presence/absence of orthologous insertions, of 1) non TE-TSS, 2) all TEs and 3) all TE-
TSS, the UCSC Genome Browser ‘liftOver’ utility was run locally.  This program allows 
for annotation coordinates from one genome, or build, to be directly transferred to a 
second genome based on where they correspond.  In the case of the human-mouse 
comparison, the coordinate correspondence is based on whole genome sequence 
alignments [63] represented in the Mouse Chain track (http://www.genome.ucsc.edu/cgi-
bin/hgTrackUi?hgsid=99200641&c=chr7&g=chainMm9).  To count the number of base 
pairs conserved between human and mouse for the different categories mentioned above, 
the ‘Base Coverage’ utility of the Galaxy Server [64] was used.  Relative conservation 




Results and Discussion 
Genome-scale identification of cis-NATs 
In order to evaluate the capacity of TEs to contribu e cis-NATs to the human 
genome, we took advantage of a relatively new technology – cap analysis of gene 
expression (CAGE) [30] – to define the location of transcriptional start sites (TSSs) in the 
human genome.  CAGE relies on the isolation of full length cDNAs using biotinylated 
mRNA caps.  Linkers are ligated to the 5’ ends of the full length cDNAs, and the first 
20bp of the cDNAs are cleaved with restriction enzymes.  The resulting fragments are 
then amplified, concatamerized and sequenced allowing for the high-throughput 
characterization of the 5’ ends of mRNAs.  Mapping of the 5’ mRNA end CAGE 
sequence tags to the genome unambiguously identifies TSSs.  Then, the location and 
orientation of human TSSs can be compared to gene and TE annotations to assess the 
relationship between cis antisense transcription and TEs.   
A library of >1.5x106 human CAGE sequence tags are available for download 
from the Japanese National Institute of Genetics websit .  We mapped these CAGE 
sequence tags to transcriptional units (TUs) in the human genome, and compared their 
locations to those of TEs, to assess whether TEs provide cis-NATs.  A TU is defined here 
as a single protein-coding locus, with a characteristic strand orientation, bounded by the 
most 5’ and 3’ transcription start and termination sites respectively.  The UCSC Genome 
Browser database [55] KnownGenes annotations were used to locate TUs on the human 
genome sequence.  KnownGenes annotations were chosen because they are supported by 




mRNAs.  A single TU may cover alternative transcript variants in the same orientation, 
and more than one TU may overlap at a single genomic locus.   
A total of 869,085 CAGE sequence tags were mapped to 39,288 human genome 
TUs.  The majority (639,490 or ~74%) of human TU-TSSs defined in this way 
correspond to sense transcripts, i.e. in the same orientation of the protein-coding mRNA.  
On average, each human TU has 16.3 sense TSSs.  The prevalence of sense oriented 
TSSs in the human genome is consistent with previous results and reflects the initiation 
of mRNA transcripts from multiple alternative promoters [54, 65].  The relative excess of 
sense oriented TSSs is also thought to be due to selection against initiation of antisense 
transcription based on avoidance of collisions betwe n the RNA transcription machinery 
tracking along the DNA [44].  Human TUs also have numerous anti-sense oriented TSSs 
(229,595 or ~26%), which correspond to cis-NATs.  The abundance of human cis-NATs 
is underscored by the fact that the average human TU has 5.8 antisense TSSs. 
TEs initiate antisense transcription 
The location of TEs in human TUs were taken from the RepeatMasker [5] 
annotation of the genome, and these data were used to discover transcripts that are 
initiated within TEs inserted into human TUs.  176,578 (~20%) of human TU-TSSs were 
found to be initiated from within TE sequences.  These data underscore the substantial 
capacity of TEs to promote transcription in human ge e regions.  TSSs that are initiated 
from within TEs are more likely to be found in the antisense orientation than non-TE-
TSSs.  48,718 of TE-TSS are found in the antisense orientation, yielding a TE 
antisense/sense ratio of 0.38 compared to 0.35 for non-TE-TSSs.  This difference, while 




(48,718/127.860 non-TE-TSS antisense/sense=180,877/511,630 χ2=156.6 P=6e-36).  In 
other words, the TSSs that originate from within TE sequences are significantly enriched 
for cis-NATs, and this observation can not be explained by random sampling alone.  The 
vast majority of TEs that encode TSSs are found in introns (98.2%), which is consistent 
with the transcriptional collision model [44] for their mechanism of regulatory action 
since these cis-NATs may not necessarily form dsRNA with mature sense transcripts. 
The enrichment of cis-NATs initiated from within TE sequences is even more 
marked when the distribution of TSSs across TUs, from the 5’ to the 3’ ends, is observed.  
Human TUs were divided into 20 equal sized bins and antisense/sense TSS ratios were 
calculated for each bin.  When bin-specific averages across all human TUs are plotted, 
the ratio of antisense/sense TE-TSSs increases progressively from the 5’ to the 3’ ends of 
human TUs (Figure 2.1).  The slope of this trend is po itive, and the correlation is 
statistically significant.  This enrichment suggests the possibility that antisense TE-TSSs 
near the 3' ends of genes are more efficacious regulators and thus favored by selection.  
Under the transcriptional collision model [44], the preponderance of cis-NATs initiated 
near the 3’ ends of genes would provide for more opportunities for collisions between 
RNA polymerase complexes tracking along opposite strands of the DNA and less chance 
for sense transcription complexes to get through to t e ends of the genes.  The opposite 
5’-to-3’ trend in antisense/sense TSS ratios is seen for non-TE-TSSs.  There is a slight 
decrease in the antisense/sense ratio along human TUs; although, this trend is far less 





Figure 2.1.  Ratio of antisense/sense TSSs along human genes. Human TUs were 
divided into twenty equal size bins, and ratios of the numbers of antisense/sense TSSs 
were calculated for each bin.  Average bin-specific ratios are shown for TSSs initiated 
within TEs (TE-+ in grey) and TSSs not initiated from TEs (Non-TE TSSs in black).  
Linear regression was used to plot the slope of the antisense/sense ratio trend along bins 
from 5’-to-3’ gene ends and the Spearman rank correlation coefficient (R) was used to 
evaluate the significance of the trends.  For TE-TSSs y=10e-2, R=0.87, t=7.62, P=5e-7.  
For non TE-TSSs y=-3e-2, R=-0.34, t=1.54, P=0.14. 
 
 
The relative excess of antisense transcripts initiated from TEs and their 
enrichment closer to the 3’ ends of TUs suggests the possibility that they may yield cis-
NATs with biologically significant regulatory activities.  If this is indeed the case, then 
one may expect natural selection to preserve these functionally active TE-derived cis-
NATs.  Accordingly, TEs that initiate cis-NATs are predicted to be older than those that 
do not initiate transcription owing to the fact that they have been preserved in the genome 
by selection.  The age distribution of the TEs thatdonate cis-NATs was analyzed to 
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classes/families that donate cis-NATs were compared to the expected proportions based 
on their relative frequencies in the genome.  Consistent with the expectation, relatively 
ancient elements are significantly overrepresented (Figure 2.2).  For instance, there are 
more TU-TSSs derived from the ancient L2 and MIR families than expected by their 
genome frequencies.  Members of younger element families, such as L1 and Alu, initiate 
significantly fewer TU-TSSs than expected based on their genome frequencies. 
 
 
Figure 2.2. Relative proportions of TE-derived cis-NATs.  Human genome TEs are 
broken down into seven classes/families and the relativ  percentages of TE-derived cis-
NATs are shown in gray for each family.  The expected percentages of TE-derived cis-
NATs, based on the genome proportions of each class/family, are shown in black.  A χ2 
test for goodness of fit was used to compare the obs rved versus expected proportions of 
TE-derived cis-NATs.  The differences between the observed and expected distributions 




The relative ages of TEs within families can be measured by taking the 
divergence of the TE sequences from their family consensus sequence, since older TEs 





















younger TE families, relative divergence values indicate that the TEs that donate 
antisense TSSs are older than TEs from the same family that do not donate TU-TSSs.  
For instance, Alu elements that initiate antisense transcription with human TUs have 
significantly greater sequence divergence from their consensus sequences than Alus that 
do not co-locate with TSSs (average±standard deviation Jukes-Cantor distance for Alu-
antisense-TSS=0.15±0.05, Alu-non-TSS=0.14±0.05, t=19.42, P=6e-84).  This suggests 
that many antisense TE-TSSs are in fact conserved by selection and also helps to resolve 
a standing question as to why older elements of some classes of TEs, such as Alus, are 
enriched in gene regions.  Alus insert more frequently i to AT-rich DNA but are 
preferentially retained in GC-rich gene regions; this has been taken to suggest that they 
are conserved in gene regions by virtue of some unknown functional role that they play 
for those genes [1].  Our data indicate that, in the case of some Alu sequences, their 
functional role is related to the initiation of regulatory cis-NATs. 
Another way to evaluate the relative ages of TEs is to compare their evolutionary 
conservation based on presence/absence patterns of orth logous insertions between 
related species.  Using this approach, we compared the human-to-mouse conservation of 
TEs that encode TSSs versus those that do not.  15.3% percent of TE-TSSs are conserved 
between human and mouse versus 2.8% percent of TEs that do not encode TSSs; this 
difference is statistically significant (χ2=4x106 P=0).  The greater between species 
conservation of TE-TSSs is further evidence consistent with the action of purifying 





The ability of TEs to contribute regulatory sequences to eukaryotic genomes was 
discovered through a number of case-by-case studies on individual genes [66, 67].  Later, 
genome-scale approaches began to uncover just how widespread this phenomenon is, 
particularly in mammalian genomes with high TE copy numbers [68-70].  Relying on a 
genome-scale approach for the identification of TSSs, we have shown that TEs contribute 
tens-of-thousands of cis-NATs to human genes.  The pot ntial regulatory effects of these 









RETROVIRAL PROMOTERS IN THE HUMAN GENOME 
 
Abstract 
Endogenous retrovirus (ERV) elements have been shown t  contribute promoter 
sequences that can initiate transcription of adjacent human genes.  However, the extent to 
which retroviral sequences initiate transcription within the human genome is currently 
unknown.  We analyzed genome sequence and high-throug put expression data to 
systematically evaluate the presence of retroviral p omoters in the human genome. We 
report the existence of 51,197 ERV-derived promoter sequences that initiate transcription 
within the human genome, including 1,743 cases where transcription is initiated from 
ERV sequences that are located in gene proximal promoter or 5’ untranslated regions 
(UTRs).  114 of the ERV-derived transcription start sites can be demonstrated to drive 
transcription of 97 human genes, producing chimeric transcripts that are initiated within 
ERV long terminal repeat (LTR) sequences and read-through into known gene sequences.  
ERV promoters drive tissue-specific and lineage-specific patterns of gene expression and 
contribute to expression divergence between paralogs.  These data illustrate the potential 
of retroviral sequences to regulate human transcription on a large scale consistent with a 
substantial effect of ERVs on the function and evoluti n of the human genome. 
Introduction 
Approximately 5% of the human genome sequence is der ved from retroviruses [1].  




integration of provirus genomes into the DNA of germline cells [71, 72].  The abundance 
of these so-called endogenous retrovirus sequences (ERVs) testifies to the extent that 
human evolution has been shaped by successive waves of iral invasion [73]. 
One way that ERVs have affected the function and evolution of the human genome is 
by donating regulatory sequences that control the expression of nearby genes.  The gene 
regulatory effects of ERVs were first uncovered in a umber of anecdotal studies on 
specific genes [74].  For instance, the long terminal repeat (LTR) of a human ERV 
(HERV-E) was shown to serve as an enhancer element that confers parotid-specific 
expression on the amylase gene [75].  Later, more syst matic computational analyses of 
the human genome sequence revealed that many human genes contained ERV-derived 
regulatory regions, suggesting an even greater contibution of retroviruses to human gene 
regulation [68, 70].  Continued efforts to characterize ERV-derived promoters have 
turned up several new cases in recent years [76-78].  Nevertheless, the full extent of the 
contribution of ERV sequences to the initiation of transcription in the human genome has 
yet to be appreciated.  
Initiation of transcription by ERV promoters often results in the production of 
alternative transcripts that are both tissue-specific and lineage-specific.  For instance, 
testis-specific expression of the human gene encodig the neuronal apoptosis inhibitory 
protein (NAIP) is driven by an LTR promoter sequence, whereas a distinct LTR promoter 
in rodents confers constitutive expression of the orthologous gene [78].  An ERV LTR 
sequence also serves as an alternative promoter tha drives expression of the beta1,3-




The lineage-specific regulatory effects of ERV promoters can be attributed the fact that 
ERV sequences result from past germline infections, many of which occurred relatively 
recently along specific evolutionary lineages.  In fact, most of the ERV sequences in the 
human genome are primate-specific [73], while most human genes are far more ancient 
and share orthologs with distantly related species [1].  This means that regulatory effects 
exerted by ERV promoters will often lead to expression differences between primate and 
non-primate orthologs or between deeper evolutionary lineages for more ancient ERVs.  
In other words, ERV promoters are likely to drive evolutionary changes in gene 
expression, long thought to be an important determinant of species divergence [79]. 
 The application of novel high-throughput techniques for the analysis of gene 
expression has revolutionized the study of the human transcriptome and revealed far 
more regulatory complexity than previously imagined.  Two techniques in particular, Cap 
analysis of gene expression (CAGE) and Paired-end ditag (PET) sequencing, enable the 
precise genome mapping of many thousands of promoter sequences that initiate 
transcription.  CAGE is a technique that allows for the characterization of short sequence 
tags from the 5’-most ends of full-length cDNAs [30].  Accordingly, mapping CAGE 
tags to the human genome unambiguously identifies transcription start sites (TSS) and 
their corresponding promoters.  PET sequencing involves the determination of sequences 
for tags from both the 5’ and 3’ ends of full-length cDNAs [80].  Thus, when PETs are 
mapped to the genome, paired transcriptional initiation and termination sites are 
identified along with the intervening genomic sequences that are transcribed as pre-
mRNAs.  We used human CAGE and PET data to more thooughly evaluate the 





CAGE tags (n=1,551,672) were downloaded from the Japanese National Institute of 
Genetics website 
(http://genomenetwork.nig.ac.jp/public/download/cage_Database_e.html) and mapped to 
the human genome as previously described [30].  Thehuman genome locations of PETs 
(n=669,840) were taken from the UCSC Genome Browser [55] annotations 
(http://www.genome.ucsc.edu/cgi-
bin/hgTrackUi?hgsid=100351785&c=chr9&g=wgEncodeGisRnaPet).  The PETs were 
generated from several cell lines: log phase of MCF7 cells (113,858), MCF7 cells treated 
with estrogen (4,911), HCT116 cells treated with 5-fluorocil (124,770) and log phase of 
embryonic stem cell hES3 (426,301).  Overlapping CAGE tags and overlapping PETs 
were clustered to identify individual TSS on the human genome.  The UCSC Table 
Browser [81] and the program Galaxy [64] were used to compare the locations of CAGE 
tags and PETs to the locations of human ERVs annotated with the RepeatMasker 
program [5].  Only ERVs ensu strictu, as opposed to more ancient mammalian apparent 
LTR-retrotransposons (MaLR), were analyzed here.  The National Center for 
Biotechnology (NCBI) Refseq [82] gene model annotati ns were used to evaluate the 
production of chimeric transcripts that are initiated by ERVs and read-through into 
human genes.  Transcriptional units (TUs) are defined as genomic regions spanning the 
5’ to the 3’ ends of individual Refseq gene models.  TUs and 1 kilobase (kb) flanking 
regions upstream and downstream of TUs were evaluated for the presence of ERV-
derived promoters.  A series of custom Perl scripts were used to post-process the genome 




analysis with the UCSC Genome Browser.  All scripts and mapping data are available 
upon request. 
The genomic presence/absence of ERV insertions acros species was evaluated using 
whole genome sequence alignments of complete mammalian sequences built with the 
Multiz tool [83].  Human genome sequence conservation levels are based on the 
phastCons tool [84].  The species distribution of human gene orthologs was assessed 
using BLASTP [85] results from the NCBI Blink utiliy along with homology annotations 
from the GeneCards webserver [86].  Gene expression analysis was based on the Novartis 
Gene Expression Atlas version 2 (GNF2) [87]. 
Detailed information on all methods including PET and CAGE analysis along with gene 
expression and Gene Ontology analyses can be found in the Supplementary Information. 
Results and Discussion 
 
A total of 49,814 mapped CAGE tag clusters, each corresponding to an individual TSS, 
were found to map to the ERV LTR sequences (Table 3.1).  The high number of ERV-
derived TSS in the human genome identified with CAGE tag mapping underscores the 
potential of retroviral promoters to drive transcription.  However, it is not possible to 
directly assess whether retroviral promoters identifi d using CAGE tag mapping actually 
drive the expression of known human genes.  In fact, most of the ERV promoters 
identified with CAGE map to intergenic regions.  This intergenic ERV promoter activity 
is likely to be a relic of the ERVs’ ability to drive transcription of their own genome 
sequences from LTR promoters and may not necessarily be related to the transcription of 




human genome demonstrates that ERV sequences can maintain the ability to promote 
transcription for millions of years after their initial insertion into the genome. 
 







CAGE 49,814 9,292 
PET 1,513 114 
 
a Total number of tag clusters representing individual ERV-derived TSS. 
b For CAGE data, ERV-TSS that map within 1kb upstream or downstream of Refseq gene 
annotated 5’ UTR sequences.  For PET data, ERV-ditag sequence clusters that start 
within 1kb of Refseq gene annotated 5’ UTR sequences, or within 5’ UTRs, and end 




In addition to the intergenic ERV promoters, there a  9,292 CAGE identified 
ERV promoters that initiate transcription within 1kb upstream or downstream of the 
previously characterized TSS of known human genes (Table 3.2).  PET sequence 
mapping data were also used to search for transcript  that are initiated from ERV 
promoters, and there are 1,513 cases of PET identified ERV promoters in the human 
genome (Table 3.1).  Because PET sequence tags include both the 5’ and 3’ ends of full-
length transcripts, they can be used to identify transcripts that are initiated within ERV 
sequences and read-through into human gene regions.  These cases correspond to 
chimeric transcripts, composed partially of both ERV and human gene sequences, and 
demonstrate ERV promoted expression of human genes.  Thi  approach identified 114 
distinct retroviral TSS that promote transcription of human genes (Table 3.2 and Table 
A.1).  21 of these retroviral promoters have co-located ESTs, which independently 




Refseq transcripts over 97 distinct gene loci.  Thepositions of TSS for ERV-derived 
human gene promoters were analyzed to evaluate whether ERVs provide canonical 
promoters or promote alternative transcripts.  While there are a number of ERV TSS that 
map to 5’ UTRs (Table A.2 and Figure A.1), and are thus taken to promote transcription 
at (or near) previously characterized TSS, the majority f ERV promoters promote 
alternative transcription of human genes from upstream regions or from within the TU 
(Table A.2).  This further underscores the fact thaERVs promote alternative 
transcription of human genes. The ability of ERVs to promote alternative transcripts of 
human genes is illustrated (Figure 3.1) by the caseof an alternative promoter of the 
glutathione-S-transferase omega 1 encoding gene (GSTO1 Refseq accession 
NM_004832) found on chromosome 10q25.1.  The GSTO1 protein is a member of the 
theta class glutathione S-transferase-like family, and it has been shown to act as a stress 
response protein through cellular redox homeostasis [88].  GSTO1 nucleotide 
polymorphisms have been implicated in a number of cerebrovascular diseases including 




Table 3.2.  Numbers of ERV-human gene associated orchimeric transcripts. 
 
a Counts for ERV-derived CAGE sequence tag clusters that map within human Refseq 
gene 5’ UTRs or 1kb upstream or downstream (i.e. within the TU) of the 5’ UTR. 
b Counts for ERV-derived PET sequence clusters associated with human genes are 
shown.  ERV-PETs with 5’ ends that are 1kb upstream of human Refseq gene 5’ UTRs, 
within 5’ UTRs or within TUs are shown in columns.  ERV-PETs with 3’ ends that are 
within TUs, in 3’ UTRs or 1kb downstream of 3’ UTRs are shown in rows 
1,550 of these ERV CAGE tag clusters map to 5’ UTRs, consistent with transcription 
from previously characterized promoters, but the majority (7,742) map just upstream of 
the 5’ UTR, in the proximal promoter region, or downstream within genes’ TUs.  
Therefore, these ERV-derived promoters are likely to be responsible for generating 




There is an ERV LTR sequence from the MER4A subfamily of sequences less 
than 500bp upstream of the Refseq annotated 5’ UTR of GSTO1 (Figure 3.1A).  There 
are 15 individual PET sequences, forming 3 distinct TSS clusters, that have 5’ ends inside 
of the MER4A sequence and 3’ ends in the 3’ UTR of GSTO1 (Figure 3.1A and 3.1B).  
All of the MER4A PET sequences were derived from only o e of the four PET libraries 
(χ2=8.6 P=0.04), log phase of embryonic stem cell hES3, indicating that this promoter is 
tissue- or condition-specific.  In addition to the PET sequence based evidence, there are a 
number of spliced ESTs that also indicate the MER4A sequence as an alternative 
promoter for GSTO1 (Figure 3.1B).         
 
CAGEa    
Total Upstream 5’ UTR TU 
9,292 193 1,550 7,549 
PETb    
PET 3’ ends PET 5’ ends   
 Upstream 5’ UTR TU 
TU 5 6 34 
3’ UTR 
 
12 13 21 





Figure 3.1. MER4A alternative promoter of the GSTO1 gene.  A) TheMER4A (red) 
ERV sequence is located in the proximal promoter region <500bp from the GSTO1 5’ 
UTR.  The locations of PET sequences (green) and spliced ESTs (black) are shown.  B) 
The MER4A (red) sequence region is enlarged and the individual PET sequences (green) 
and spliced ESTs (black) that support the existence of this promoter are shown.  C) 
Evolutionary conservation of MER4A versus GSTO1.  MER4A is only found in chimp 
and rhesus and no other mammals (green bars), i.e. it is not conserved, whereas the 




Inspection of multiple sequence alignments of complete mammalian genomes 
reveals that the GSTO1 adjacent MER4A insertion is present in the human, chimp (Pan 
troglodytes) and rhesus (Macaca mulatta) genome sequences but absent in the bushbaby 
(Otolemur garnetti), mouse (Mus musculus), rat (Rattus norvegicus) and all other 
placental mammal sequences (Figure 3.1C).  In other words, that particular MER4A 
sequence inserted after the primate radiation began, and it is specific to the Haplorrhini 
suborder, which includes both new world and old world monkeys.  On the other hand, the 
adjacent exonic sequences of GSTO1 show marked conservation compared to MER4A 




more ancient than the MER4A insertion, having well conserved orthologs among 
mammals and other vertebrates along with Drosophila melanogaster, Caenorhabditis 
elegans and a number of other more distantly related species.   
The comparative sequence analysis suggests the possibility that the MER4A 
insertion may confer lineage-specific expression pattern on GSTO1.  Furthermore, there 
are two human paralogs of GSTO1, GSTO2 and the pseudogene GSTO3P1, neither or 
which has the upstream MER4A insertion.  So the specific regulatory effects of the ERV 
may not only be tissue- and lineage-specific but cold also be involved in driving 
functional differentiation of paralogs via expression differences. 
In order to test for potential diversifying regulatory effects of the MER4A 
insertion on GSTO1, we compared tissue-specific expression patterns between human 
and mouse GSTO1 and GSTO2 orthologs as well as between human GSTO1-GSTO2 
paralogs using microarray data from the Novartis Gene Expression Atlas version 2 
(GNF2) [87].  The human-mouse GSTO1 orthologous pair has a low (r=-0.06), and not 
significantly different from 0 (P=0.77), correlation of expression levels across tissue  as 
does the human GSTO1-GSTO2 paralogous pair (r=0.006 P=0.98) (Figure A.2).  On the 
other hand, the human and mouse GSTO2 orthologous genes, which lack the alternative 
MER4A promoter, have significantly correlated expression patterns (r=0.76 P=2.2e-6).  
These patterns of expression divergence and conservation are consistent with variation in 
expression introduced by the MER4A-TSS.  In all, 37 out of 40 evaluated cases of human 
genes with ERV-TSS have expression patterns that are not significantly correlated with 




We further evaluated the potential regulatory effects of human ERV-derived 
promoters by comparing the expression patterns of all human genes with ERV-promoters 
versus genes without ERV promoters using the GNF2 data.  Human genes with ERV-
TSS have greater tissue-specificity than genes lacking ERV promoters, consistent with a 
diversifying regulatory effect of ERV-TSS (Table A.2).  In particular, ERV-TSS 
containing genes have anomalously high levels of expression, on average, in brain and 
testis (Figures A.4 and A.5).  A similar pattern of significantly elevated expression in 
brain and testis was found for ERV CAGE tags (Figure A.6).  Consistent with the brain-
specific expression pattern of ERV-TSS genes, Gene Ontology (GO) functional analysis 
indicated that these genes are enriched for metabolic and signaling processes active in the 
brain (Table A.3 and Figure A.7).    
Our analysis revealed that retroviral sequences in the human genome encode tens-
of-thousands of active promoters; transcribed ERV sequences correspond to 1.16% of the 
human genome sequence and PET tags that capture transcripts initiated from ERVs cover 
22.4% of the genome.  These data suggest that ERVs may regulate human transcription 
on a large scale.  However, it is a formal possibility that many of the ERV derived 
promoters identified here represent leaky transcription, i.e. noise, which is not 
functionally significant.  Definitive proof of biolgical activity for individual ERV-TSS 
may have to await experimental confirmation via knock- ut data or promoter swapping.  
However, it will soon be possible to validate ERV-TSS on a genome-scale owing to the 
accumulation of high-throughput data from tiling array experiments based on ChIP-chip 
and/or chromatin structure assays.  Such data, which are being generated by the 




across genomic sequence.  The presence and density of regulatory signals, such as 
transcription factor binding sites and open or specifically modified chromatin, have been 
shown to discriminate between biologically active and rtifactual TSS and thus could be 
used to validate ERV-TSS.      
Our analysis uncovered more than 100 cases of novel ERV-derived promoters 
that initiate chimeric ERV-human gene transcripts and several thousand more that are 
likely to do so.  ERV-derived promoters are characterized by their ability to promote 
alternative transcripts that are expressed in a way th t is tissue-specific, lineage-specific 
and distinct from related paralogous genes.  These data underscore the extent to which 








IDENTIFICATION OF TRANSCRIPTION FACTOR BINDING 
SITES DERIVED FROM TRANSPOSABLE ELEMENT 
SEQUENCES USING CHIP-SEQ 
 
Abstract 
Transposable elements (TEs) form a substantial fraction of the non-coding DNA of many 
eukaryotic genomes.  There are numerous examples of TEs being exapted for regulatory 
function by the host, many of which were identified through their high conservation.  
However, given that TEs are often the youngest part of a genome and typically exhibit a 
high turnover, conservation based methods will fail to dentify lineage- or species-
specific exaptations.  ChIP-seq has become a very popular and effective method for 
identifying in vivo DNA-protein interactions, such as those seen at transcription factor 
binding sites (TFBS), and has been used to show that there are a large number of TE-
derived TFBS.  Many of these TE-derived TFBS show por conservation and would go 
unnoticed using conservation screens.  Here, we describ  a simple pipeline method for 
using data generated through ChIP-seq to identify TE-derived TFBS. 
Introduction 
Transposable elements (TEs) are segments of DNA that possess the ability to ‘transpose,’ 
meaning that they can move themselves to distant loca ions of the host genome and 
replicate when they do so.  TEs are present in all domains of life, and abundant in the 




DNA and the genomes as a whole (nearly 50%, ~1.4Gb of the human genome) [1].  
Broadly speaking, there are two types of TEs.  Type I TEs, or retroelements, transpose by 
a copy and paste mechanism via an RNA intermediate, generating a new insertion.  Type 
II TEs, or DNA transposons, move by a 'cut and paste' mechanism where the actual 
insertion is moved [91].  Most TEs harbor their own promoters and regulatory sequences, 
and many active elements encode genes for their own transposition.  Active elements are 
a small minority, however, and most TE insertions are unable to transpose.   
Exaptation of Transposable Elements 
TEs exist solely to continue their own existence; th y do not, simply by their 
replication, contribute anything to the host [92, 93].  It is likely that many, if not the large 
majority of TE insertions, have little or no functional role for the host and are effectively 
under neutral or nearly neutral selection.  However, given the very large number of TE 
insertions in eukaryotic genomes and the opportunistic nature of evolution, it is only 
reasonable to expect that some would be ‘exapted’ [94] over time to take on a functional 
role that benefits the host, a process that could have a wide variety of results [95, 96].  A 
key factor in TE exaptation events is their ability to promote their own transcription; 
without this ability, they could not replicate themselves.  Given this ability, it stands to 
reason that TEs could be exapted to provide alternative promoters for host genes; this has 
been seen a number of times [97, 98].  Of most importance to this chapter, however, is 
the ability of TEs to provide new TFBS to the host.  If there existed an active TE that 
contained a TFBS, then each new insertion that the TE generated would also contain the 
TFBS.  If the TE were highly active, it could quickly spread the TFBS around the 




still spread this 'progenitor sequence' around the genome.  Over time, point mutations in 
individual insertions could alter the progenitor sequ nce so that it would now be bound 
by the TF [99].  Either way, the TE could spread the TFBS around the genome over timer 
and create a network of TFBS, and in doing so alterth  expression patterns of host genes.  
For example, it was recently shown that a large number of human c-myc binding sites are 
located in TE insertions, possibly creating a sub-network for c-myc control [100].  For a 
comprehensive review of TE-derived regulatory networks, see [2].  
Transposable Elements Evolve Rapidly 
Transposable elements are generally the most rapidly evolving part of a genome; 
so long as their insertions are not too deleterious t  the host, TEs can quickly increase in 
copy number and then are generally free to accumulate point mutations.  The rapid 
activity of TEs relative to the host genome means that lineage-specific insertions can be 
accumulated in a very short time frame.  In the 6 MY since the human-chimpanzee 
divergence, for example, there have been several thousand new TE insertions in each 
genome .  There also appears to be very little selective pressure on the deletion of most 
insertions, which can result in their chance deletion from one lineage, while they are 
retained in others.  Between human and mouse, thereis generally very little conservation 
of non-coding regions in the genome, including TEs.  Many insertions that appear to 
predate the human-mouse divergence are present in oe genome, but have been lost in the 
other (Figure 4.1.) [12].  The rapid insertion of TEs combined with their rapid loss means 
that two lineages can develop distinct TE complements in a relatively short time after 
divergence.  Given that two lineages can have very different TE complements, it could be 




4.1).  If the exaptation events were the creation of ew TFBS or promoters, then the 






Figure. 4.1.  Evolutionary scenarios related to TE exaptation events.  A) An ancient 
insertion is exapted and the resulting regulatory sequences are shared across multiple 
derived evolutionary lineages.  B) An ancient insertion is exapted but only selectively 
conserved in some of the derived evolutionary lineages. This could result in regulatory 
divergence between lineages.  C) A recent lineage-specific insertion is exapted resulting 
in regulatory differences between lineages. TEs are p ticularly prone to this scenario 




Detection of Functional TE-derived Non-coding sequences 
There are three widely used methods to find TFBS in ge omes.  It should be 
noted that these approaches are not mutually exclusive; indeed, the methods are often 
combined to more rigorously predict and locate TFBS. The first approach, phylogenetic 
footprinting, [102] can be done solely computationally via comparative sequence 
analysis.  A phylogenetic screen attempts to find regions of different genomes that have 
been conserved over time, and in the case of TFBS, looking for conserved non-coding 
elements (CNEs).  Screens looking for conserved non-coding elements (CNEs) represent 
a very successful technique for identifying the oldest, and due to their conservation most 
likely to be essential, non-coding parts of the genome.  Shortly after the sequencing of the 
human and mouse genomes, it was shown that a larger than expected number of mouse 
MIR and L2 elements had human orthologs [12].  Subsequently, several thousand 
insertions or insertion fragments near human genes were shown to be under purifying 
selection, suggesting their exaptation and possible involvement in transcriptional control 
[103].  In recent years, a number of insertions have been shown to be enhancers for 
human and vertebrate genes, many identified with phylogenetic screens.  An insertion 
from the CORE-SINE family was shown to be conserved across the mammalian lineage, 
and to be an enhancer of the POMC gene in mice [104].  The amniote SINE 1, 
AmnSINE1, family of TEs is a very old family that spread early in the amniote lineage.  
However, a number of conserved AmnSINE1 insertions exi t in the human genome, two 
of which were shown to be enhancers involved in brain development [22, 23, 105].  A 
mammalian interspersed repeat (MIR) was shown to have enhancer 'boosting' activity, in 




not on its own be an enhancer [106].  The problem with an approach based on 
conservation is that, while it will find many important regions, the screen will miss other 
regions that are also important, but also lineage-specific.  Lineage-specific TFBS, such as 
those that could be provided by lineage specific TE insertions, could generate lineage-
specific expression, and would this be missed by CNE screens [101].  Another case in 
which older elements may be overlooked in CNE screens is one in where an old insertion 
has been lost, as many are, in several lineages, but exapted in one (Figure 4.1).  Such an 
insertion may well play some role in the lineage that kept it, but it will be completely 
missed in CNE screens.  CNE screens will not only miss new TE exaptations, but also 
other non-coding functional elements.  It has been shown previously that sequences with 
low conservation can play important functional roles, such as rapidly evolving, long non-
coding RNAs [107]. 
 The second of the three methods to identify TFBS is also computational and 
involves scanning a genome for the sequence motif that the TF in question recognizes.  
REST, the RE1 Silencing Transcription factor, is know  to repress neuronal genes in 
non-neuronal cells.  Using experimentally identified REST binding sites, which contain 
the RE1 motif, Johnson et al. [108] created a Position-Specific Scoring Matrix, PSSM, 
for the motif, and used it to screen for possible REST binding sites in the human 
genome.  Johnson et al. were able to show that there are a number of TE-derived REST 
binding sites that had the ability to bind REST in vitro, suggesting that TEs have helped 
to spread the REST network.  When a PSSM is used to search for new TFBS in a 
genome, false positives are controlled by shuffling the sequence in the PSSM, re-




identified with the original PSSM to those found with the shuffled PSSM [53].  This 
approach will not work, however, for TFs that recognize motifs smaller than the RE1 
motif as there will likely be many false positives.  In addition, the presence of a TFBS 
sequence motif does not guarantee that the sequence that bears it is actually bound by its 
corresponding TF, while sequences that lack similarity to the motif may in fact be bound 
by that factor.  These challenges to the sequence-bas d computational approach 
necessitate an approach to identifying TFBS on a genom  wide scale that does not 
depend on the sequence of the TFBS, only the binding of the TF to the region. 
 The third major approach to finding TFBS is identifying in vivo protein-DNA 
interactions via chromatin immunoprecipitation (ChIP) followed by microarray analysis 
(ChIP-chip) or sequencing of the captured DNA.  Of the three approaches, this one offers 
the greatest sensitivity and potential specificity.  ChIP is able to find genomic DNA that 
is bound by a transcription factor, not just those regions that are conserved or for which 
there exists a well-defined TFBS motif.  ChIP is alo distinguished from the other 
approaches in the sense that it identifies sequences that are experimentally characterized 
to be bound by transcription factors, i.e., not just computational predictions.  Genome-
wide ChIP assays, such as ChIP-PET or ChIP-chip have been used successfully in the 
past; however, a newer and relatively inexpensive method, ChIP-seq has quickly become 
the dominant method of experimentally identifying TFBS, and it is on ChIP-seq that we 
focus the rest of our discussion.  The ChIP-seq method combines ChIP with massively 
parallel sequencing of the bound DNA [27].  The sequencing is usually carried out on one 
of the currently available short-read sequencers: Illumina Genome Analyzer, ABI 




ChIP-PET.  There is no cross-hybridization, as can occur in ChIP-chip, and the ChIP-seq 
signal is a digital count of reads mapping to the TFBS, rather than a fluorescence signal.  
ChIP-seq is also far less costly than ChIP-PET, which typically relied on capillary 
sequencing.   Using several ChIP-based data sets, includ ng one derived with ChIP-seq, 
Bourque et al. [109] identified a large number of TE-derived TFBS.  The majority of 
TFBS they observed were not well conserved, with many being lineage-specific.  This 
strongly suggests that expansion of TEs within a genome can lead to the concurrent 
expansion of transcription regulatory networks.  Below, we provide a specific example 
detailing how analysis of ChIP-seq data can be usedto identify TE-derived TFBS. 
Software 
All the software we describe and recommend here is publicly available. 
Bowtie [110] http://bowtie-bio.sourceforge.net/ 
MuMRescueLite [111] http://genome.gsc.riken.jp/osc/english/dataresource/ 
UCSC Genome Browser [112] http://genome.ucsc.edu 
UCSC Table Browser [81] http://genome.ucsc.edu 
Methods 
This section describes our choice of tools for the identification of TFBS derived 
from TE insertions using ChIP-seq data, and we show  these tools can be assembled 
into an analytical pipeline.  The tools presented were chosen for their speed, utility for 
analysis of TE-derived TFBS, ease of use and good dcumentation.  To illuminate the use 
of these tools, we first provide an overview of ouranalytical pipeline for the detection of 
TE-derived TFBS (Figure. 4.2), and then we give a specific example of how ChIP-seq 





Figure. 4.2. Schematic of the analytical pipeline presented here for finding TE-
derived TFBS with ChIP-seq. Each individual step is described in detail in the text 





The first step in finding TE-derived TFBS is to map reads generated by ChIP-seq 
back to the genome used.  Massively parallel sequencers generate millions of reads in run 
of a ChIP-seq experiment.  Mapping these reads in a genome as large as the human or 
mouse genomes with traditional techniques like BLAST [85] or BLAT [113] quickly 
becomes computationally overly expensive.  Fortunately, a number of programs have 
been developed explicitly for the mapping of short-read data.  The fastest of these are 
those that employ the Burroughs-Wheeler transform [114] to build a very dense index of 




mapping because of its speed and useful options (see Note 1).  Bowtie is generally the 
fastest of these aligners, and it can utilize read quality information in the FASTQ format 
data generated from Illumina sequencing. However, it cannot currently use colorspace 
reads generated from SOLiD sequencing (see Note 2). 
Read Rescue 
Were genomes fully random sequences of the four bases, then almost any ChIP-
seq read would be mappable to a unique region of the genome.  However, due in large 
part to the vast number of TE insertions, this is not the case.  There are numerous 
repeated sequences in eukaryotic genomes and sequenc  tags derived from these regions 
may not map unambiguously back to the genome – i. ., they may map to multiple 
genomic regions with equal probability.  The problem of such multiple-mapping ChIP-
seq reads arises in part due to their short length.  ChIP-seq reads must necessarily be 
short in order to provide good resolution protein bi ding locations in the genome; a 
500bp read from ChIP-seq would be easy to unequivocal map to the genome, but would 
give very little information about the exact location of the DNA-protein interaction.  A 
shorter read, on the order of <50bp, as most ChIP-seq data sets contain,  gives good 
resolution regarding the location of the DNA-binding, but will have a much greater 
probability of mapping to multiple locations in the g nome.  If a TE insertion provides a 
TFBS, the insertion is very young, and there are many similar TEs in the genome, then it 
may not be possible to map the ChIP-seq reads from that insertion.  For slightly older 
elements, there will be far fewer possible places to map the reads.  Many studies have 
simply discarded multi-mapping reads for both simplcity of analysis, and a desire to be 




studying TEs, as this will result in the loss of many of the reads coming from TE 
insertions.  To appropriately analyze ChIP-seq datain regards to TEs, some ‘rescue’ 
method must be used to resolve reads the map to multiple locations. 
Different Methods of Rescue 
There are currently several different schools of thught regarding 'rescuing' reads 
that map to multiple genomic locations.  MAQ [115] is a very commonly used mapping 
utility for short read data.  When it encounters reads that map to multiple locations with 
equal probability, it randomly chooses one of the locations to map the tag.  This poses 
problems for TE-derived sequences, as it will dilute the signal from legitimate TFBS, 
potentially resulting in both false positives and false negatives.  This method also ignores 
information on the local context of potential map positions given by uniquely mapping 
reads. MuMRescueLite [111, 116] takes this information into account and assumes that 
multi-mapping reads are more likely to come from regions which already have more 
uniquely mapping reads, and probabilistically determines where a read most likely came 
from.  We recommend that MuMRescueLite be used after the initial mapping to resolve 
multi-mapping reads. 
Peak Calling 
 Quality mapping is critically important for downstream analysis, and once this has 
been achieved, the first step is often finding 'peaks' or, more generally speaking, regions, 
that have a density of mapped ChIP-seq reads significa tly higher than the background 
(see Note 3).  These peaks are the regions bound by the TF that is being looked at in the 
ChIP-assay, and should contain the TFBS.  Methods fr peak calling, and indeed the area 




quality software choices available for identifying peaks in ChIP-seq data.  PeakSeq [117] 
and SISSRs [118] are two widely used utilities, andin this review, we recommend 
SISSRs due to its good documentation.  
Finding TE-derived TFBS 
SISSRs attempts, and in general is highly successful at, finding the TFBS to 
within a few tens of base pairs based on the strand orientations of reads forming the peak, 
as well as the density of reads in the region.  Ideally, the TFBS would always be at the 
point of highest read density.  In reality, it is very often co-located with the highest 
density, or if not that then very near by and SISSRs is correct in its predictions the large 
majority of the time.  What this means, practically, is that finding those regions identified 
by SISSRs that are contained within TEs will tell us which TFBS are TE-derived (see 
Note 4).  This can be accomplished in a number of ways, the simplest being the creation 
of two BED-formatted custom tracks for the UCSC Genome Browser [112], one from the 
predicted TFBS and one from the TEs, and uploading them to the browser.  Then, the 
table browser can be used to intersect the tracks (see Note 5).  Below, we provide a 
specific step-by-step example of how this can be done using the software cited in Section 
2. Software. 
Example 
Here we provide an example using ChIP-seq data for the CCCTC-binding factor 
(CTCF) from the human ENCODE (ENCyclopedia of DNA Elements) project [25].  
CTCF is zinc finger binding protein with multiple rgulatory functions including both 
transcriptional activation and repression as well as insulator and enhancer blocking 





For this example, we will be using the first repetition of CTCF and the control.  The 
majority of the steps in this procedure are done from the command line in the Unix/Linux 
operating system environment.   
Mapping 
The program Bowtie requires an index for the genome that the user wishes to map the 
tags to.  This is accomplished with the ‘bowtie-build’ utility.  It takes as input a FASTA 
file that contains the genome in question, the human genome in our example:  
 
$bowtie-build <human genome FASTA> <index name> 
 
Building the index typically takes several hours depending on the machine, though once 
built there is no need to build it again for different samples.  Bowtie takes as input a 
FASTQ file and the parameters to control the mapping (see Note 1), as well as the index 
to use for the mapping: 
 
$bowtie –q –v 4 –k 10 –m 10 --best --strata <index name> <FASTQ> <bowtie 
output> 
 
The mapping should be done for both the CTCF ChIP-seq set and the control set.  Bowtie 
is capable of mapping several thousand reads per second, or far more, depending on how 




Multi-mapping Read Rescue 
MuMRescueLite takes all of the information that theBowtie output has, but the 
information needs to be rearranged to meet the requirements of MuMRescueLite: 
 
$awk '/./ {print $1"\t"$7 + 1"\t"$3"\t"$2"\t"$4"\t" $4 + length($5)"\t1"}3333
 ' < <bowtie output> > <MuM Input> 
 
While the above command may appear daunting, it is s mply using awk to rearrange the 
columns of the Bowtie output and put tabs between th m.  MuMRescueLite is invoked 
with a much simpler command: 
 
$MuMRescueLite.py <MuM Input> <MuM Output> <Window Size> 
 
Keeping the window size small will prevent distant reads from rescuing reads that do not 
really come from the location.  We suggest keeping the window size under 100.  
MuMRescueLite produces output that is the same as the input, with an additional column 
that represents the calculated probability that the read in question is from that site.  Using 
the desired probability cutoff for multi-mapping read, use awk to create a BED track 
from the MuMRescueLite output for analysis with SISRs: 
 
$awk ‘$8 > <cut off> {print $3”\t”$5”\t”$6”\t”$4}’ <  <MuM Output> >  <Mapping 
BED> 
 
The output should then be sorted by chromosome, then start, then stop: 
 
$sort –k 1,1 –k 2n,2n –k 3n,3n –o <Mapping BED> <Ma pping BED> 
 





SISSRs takes as input the two BED files created in the previous step, and creates 
another file with peak calls: 
 
$sissrs.pl –i <CTCF File> -b <Control File> -o <Out put File> 
 
Use of the -i  option to specifies the ChIP set as the input, and the -b option to specify 
the control set as the background.  The -o  option tells SISSRs where to write the output.  
Formatting the output into a BED file will allow overlap of the identified TFBS with TEs 
in the UCSC genome browser: 
 
$awk ‘/^chr/ {print $1,$2,$3}’ < <Output File> > <T FBS BED> 
Identification of TE-derived TFBS      
The final step is to upload the SISSRs-identified TFBS, BED-formatted track to 
the UCSC genome browser as a custom track.  The namof the track should be changed 
so as not to be overwritten by later tracks.  Once that is done, create another custom track 
that will contain only TEs using the table browser.  This can be done by filtering the 
RepeatMasker track for only those repeats which have a ‘repClass’ of ‘LINE’, ‘SINE’, 
‘LTR’, or ‘DNA.’  Intersecting the track of CTCF TFBS with this TE-only track will give 
those TFBS that reside in TE insertions.   If everything has gone right, then there should 
be examples like that shown in Figure 4.3.  Here, two distinct CTCF binding sites are 
shown for a solo long terminal repeat sequence fromthe endogenous retrovirus family K 
(ERVK).  Although these particular binding sites were identified solely based on ChIP-




the bound genomic intervals.  Thus, a computational survey of TE sequences that possess 




Figure 4.3.  An example of two TE-derived CTCF binding sites found using ChIP-
seq data.  A) Two CTCF TFBS (red) identified by the SISSRs program are found within 
the long terminal repeat sequence of an endogenous retrovirus TE (ERVK in green).  The 
ChIP-seq read density (blue) shows two peaks in the ERVK that correspond to the CTCF 
bound regions.  Analysis of the bound regions with a CTCF position weight matrix 
(PWM) [120] using the program CLOVER [121] confirms the presence of two conserved 
CTCF binding site sequence motifs in the regions identified with the ChIP-seq data.  The 
sequences of the binding sites are shown compared to the sequence logo representing 
position-specific variation in the CTCF PWM.  B) Regions orthologous to the ERVK 
insertion site from completely sequenced mammalian genomes were compared using the 
vertebrate Multiz alignment.  Sequence regions conserved between species are shown in 
green.  Regions flanking the ERVK element are conserved in other mammalian genomes, 






Genome-wide there are 326 CTCF bound sites located within ERVK sequences, 
and ERVK elements show more than an order of magnitude greater likelihood to be 
bound by CTCF than members of other ERV families.  The number of CTCF bound 
ERVK sequences suggests that these TE-derived TFBS may play some role in regulating 
human genes, and in fact many ERVs are located in close proximity to genes.  For 
instance, the CTCF bound ERVK shown in Figure 4.3 is located in the 5’ regulatory 
region ~6kb upstream of the ATAD3A gene.    
ERV sequences in general, and members of the ERVK family in particular, are 
young lineage-specific elements that are poorly conserved across species.  Phylogenetic 
analyses revealed that the ERVK family invaded the primate lineage subsequent to the 
diversification between New World and Old World monkeys [73].  Consistent with their 
recent evolutionary origin in the human genome, ERVK sequences have a mean PhyloP 
(http://www.genome.ucsc.edu/cgi-
bin/hgTrackUi?hgsid=147315896&c=chr1&g=phyloPCons28way) base-wise 
conservation score of 0.22, while the genome as a whole has a mean score of 0.47.  
Therefore, phylogenetic footprinting approaches, which identify regulatory sequences in 
non-coding DNA by virtue of their sequence conservation, would be exceedingly 
unlikely to turn up any cases of ERVK-derived TFBS.  Indeed, comparison of the CTCF 
bound ERVK sequence shown in Figure 4.3 with ortholog us mammalian genome 
sequence regions indicates that this particular elem nt copy human-specific and missing 
in all other mammals.  Such lineage-specific TE-derived regulatory sequences may be of 
particular interest in the sense that they could be responsible for driving regulatory 





1.  Bowtie is currently the fastest short-read aligner available and our preference for 
mapping short-read data, such as that generated by ChIP-seq or RNA-seq.  It has many of 
the same advantages of MAQ, such as taking quality information into account, but also 
has other features useful for looking at TE-derived s quences that MAQ currently lacks.  
Bowtie is also quite memory-efficient and it scales well with genome size.  Bowtie can be 
run with the human genome on a computer with 4GB of RAM, though on such a 
computer nothing else should be started in the meantime, as when Bowtie is forced out of 
memory it tends not to recover.  Bowtie has a large number of options for controlling 
mapping and output, which can be listed by executing bowtie with no arguments.  The 
more important options are listed and explained here 
  -v <integer>  This specifies that there can be only a certain number of 
mismatches in the whole length of the alignment betwe n the read and genome, and not 
just in the seed as the default behavior allows.  This is also important for resolving multi-
mapping reads.  We suggest setting it fairly high in case some bases in the read have 
wrong calls and low quality scores. 
  -k <integer>  This option is critically important among those available.  This 
option tells bowtie that it should report more than one mapping, as by default it reports 
only the first.  At the current time, MAQ will not report more than one mapping.  
Currently, MAQ will use the quality scores to choose a location and assign the mapping a 
quality of 0.  Output of multi-mapping reads and their possible location is essential the 




  --best  Giving this option will cause bowtie to report only those mappings which 
have the highest quality, and is recommended if you have the FASTQ data and not just 
the FASTA data of base calls.  This can greatly reduc  the number of multi-mapping 
reads. 
  --strata  This option is used along with the --best option, a d will cause bowtie to 
return only the highest quality mappings . 
    -m <integer>  will eliminate reads that map more than m times.  We suggest 
making it the same as k.  This will remove reads that map to so many places in the 
genome that they could likely never be placed with confidence. 
    One major advantage of Bowtie is that it allows for the easy use of multiple cores, 
which every desktop shipped in the last ~3 years has.  Speed will become increasingly 
important as the number of reads generated per run increases.  On a dual-core machine, 
such as a machine with an Intel Core Duo, only 1 core is advisable.  However, on a quad-
core machine, it is generally advisable to use 2 or 3 cores.  On an eight-core machine 6 
cores are recommended.  The number of cores (process rs) is set with the -p option.  In 
some unfortunate cases, FASTQ files from a ChIP-seq experiment are not available, and 
only the base calls are supplied.  In this case, you w uld not supply the '-q' flag to 
indicate FASTQ format.  It is in these cases that te rescue is especially important. 
 
2.  The ABI SOLiD sequencing platform does not produce base calls like the Illumina 
platform, but rather 'color' calls that represent transitions between two bases.  Bowtie 




purpose [122].  Like Bowtie, it has generally low memory requirem nts and is also 
capable of using multiple cores when available. 
 
3.  Though many peaks from ChIP-seq data will be quite large and obvious, others may 
be closer to the background noise.  Complicating this is that the background in ChIP-seq 
is non-random, and tends to form peaks of its own.  Most peak-finding utilities will look 
for peaks with just the ChIP-seq data alone, but many also allow the use of both the 
ChIP-seq data and a control set.  By comparing the control set and the experimental set, 
false positives that result from peaks not related to the ChIP can be removed.  
 
4.  While SISSRs and other peak finders do a very good job of finding the actual TFBS 
from ChIP-seq data, they may still be off on occasion.  A more accurate way to find the 
exact TFBS is to scan the identified TFBS, along with their flanks, with a PSSM for the 
TFBS motif with a program such as MAST [123].  This will give the exact location of the 
TFBS if it exists in the peak region.   
 
5.  In this Chapter, we suggest using the UCSC Genom  Browser and table browser for 
the overlap of the identified TFBS and transposable elements.  This is very simple to do, 
but requires loading BED-formatted tracks to the browser and (relatively) lots of manual 
work.   'Kent Source Tree' is a large series of utilities, many of which form the back end 
of the browser.  One such utility, 'bedOverlap' will overlap two sets of tracks without 
having to upload them to the browser.  Numerous other useful utilities include the 




genome browser, which visualize the density of ChIP-seq reads, and hence protein 
binding intensity, along the genome.  Compilation and installation of the Kent Source 
Tree is not always easy, but is recommended if possible.  
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EPIGENETIC REGULATION OF HUMAN CIS-NATURAL 
ANTISENSE TRANSCRIPTS 
   
Abstract 
Mammalian genomes encode numerous cis-natural antisense transcripts (cis-NATs).  The 
extent to which these cis-NATs are actively regulated and ultimately functionally 
relevant, as opposed to transcriptional noise, remains a matter of debate.  To address this 
issue, we analyzed the chromatin environment and RNA Pol II binding properties of 
human cis-NAT promoters genome-wide.  Cap analysis of gene expression (CAGE) data 
were used to identify thousands of cis-NAT promoters, and profiles of nine histone 
modifications and RNA Pol II binding for these promters in ENCODE cell types were 
analyzed using chromatin immunoprecipitation followed by  sequencing (ChIP-seq) data.  
Active cis-NAT promoters are enriched with activating histone modifications and 
occupied by RNA Pol II, whereas weak cis-NAT promoters are depleted for both 
activating modifications and RNA Pol II.  The enrichment levels of activating histone 
modifications and RNA Pol II binding show peaks centered around cis-NAT 
transcriptional start sites, and the levels of activ ting histone modifications at cis-NAT 
promoters are positively correlated with cis-NAT expression levels.  Cis-NAT promoters 
also show highly tissue-specific patterns of expression.  These results suggest that human 
cis-NATs are actively transcribed by RNA Pol II and that their expression is 






In recent years it has become evident that substantial portions of mammalian genomes are 
actively transcribed as non-coding RNA, including thousands of cis-natural antisense 
transcripts (cis-NATs) [33, 34, 42, 43, 124].  Cis-NATs are transcripts produced from 
within protein coding loci, but from the opposite srand, and are thus complementary to 
the sense mRNA transcript (Figure 5.1A).  Cis-NATs may play important regulatory 
roles via transcriptional interference caused by collisi ns of RNA polymerase complexes 
moving in opposite directions across the same locus [34, 44] or through the formation of 
double stranded RNA leading to post-transcriptional silencing through RNA interference 
[125, 126].  However, the extent to which non-coding RNAs in general, and cis-NATs in 
particular, are biologically functional remains a mtter of debate.  Some studies have 
suggested that the majority of non-coding RNA transcripts are non-functional and simply 
represent transcriptional noise [127, 128], while others have found evidence in support of 





Figure 5.1.  Delineation and analysis of cis-NAT promoters.  Cis-NATs are initiated 
from within protein coding gene loci and transcribed in the opposite (antisense) direction.  
(a) Example of a protein coding gene locus with a genic promoter that drives 
transcription in the 5’-to-3’ direction along with a cis-NAT promoter that initiates 3’-to-
5’ transcription within the locus.  (b) cis-NAT transcription start sites (TSS) were defined 
using clusters of overlapping antisense CAGE tags.  Specific cis-NAT TSS locations 
were taken as the base with the highest density of mapped CAGE tags within the cluster.  
(c) cis-NAT promoter sequences were taken as genomic reg ons immediately flanking 
cis-NAT TSS, and the chromatin environment of cis-NAT promoters was analyzed using 
ChIP-seq data for histone modification and RNA Pol II binding.    
 
 
Previously, investigators have interrogated the functio al potential of novel non-
coding RNA transcripts by evaluating the chromatin environment in-and-around their 
promoters [19, 25, 131].  These studies were motivated by the fact that the promoters of 
well-characterized human genes have characteristic chromatin properties, including 
distinct protein binding and histone modification profiles, and these particular chromatin 




epigenetic, by which the genes are regulated [19, 25, 131].  For example, chromatin 
immunoprecipitation (ChIP-seq) studies have revealed that the promoters of actively 
transcribed genes are occupied by RNA Pol II and marked with a suite of specific histone 
tail modifications, such as acetylation of the lysine at position 9 of histone H3 (H3K9Ac) 
[3, 4, 132], whereas silent gene promoters are deplet d for RNA Pol II and enriched for 
known repressive modifications such as trimethylation of lysine 27 of histone H3 
(H3K27Me3).  On the other hand, it has been shown that the promoters of many novel 
non-coding transcripts that have been characterized by high-throughput sequencing 
methods, but for which there is no additional supporting information, do not show 
enrichment for histone modifications or an active chromatin environment [19, 25, 131].  
Thus, chromatin can be used to discriminate between th  promoters of actively regulated 
genes versus putative TSS that probably represent transcriptional noise. 
In this study, we evaluated the chromatin environmet surrounding hundreds of 
thousands of human cis-NATs across six different ENCODE cell types for ten RNA 
isolation conditions.  We sought to establish whether or not cis-NAT promoters show 
patterns of activity and chromatin modifications that are consistent with epigenetic 
regulation.  We found that active cis-NAT promoters a e enriched with active histone 
modifications and occupied by RNA Pol II, whereas silent cis-NAT promoters are 
depleted for both active modifications and RNA Pol II and enriched for the repressive 
modification H3K27Me3.  These data provide evidence for the epigenetic regulation of 






CAGE data analysis 
Human cis-NAT promoters were delineated using CAGE data from the ENCODE 
repository on the UCSC genome browser [28].  CAGE data from six cell types and across 
ten RNA isolation conditions were used for this study.  The cell types are: GM12878, 
H1HESC, HepG2, HUVEC, K562 and NHEK.  The RNA isolati n conditions consist of 
polyadenylated and non-polyadenylated RNA fractions from whole cells, cytoplasm, 
nucleus, nucleolus and nucleoplasm.  Altogether, a total of 16 different CAGE data sets 
were analyzed here (Table 5.1 and Table B.1).  CAGE tags from each data set mapped to 
the reference sequence of the human genome (NCBI build 36.1; UCSC version hg18) 
[133] were clustered by their genomic locations to identify promoters.  CAGE clusters 
with two or more co-located tags have previously been shown to represent validated 
transcription start sites (TSS) [32, 54]; accordingly, CAGE clusters containing two or 
more overlapping tags were used for the promoter analyses reported here.  For each 
CAGE cluster, the actual TSS was characterized by finding the base with the highest 
density of mapped CAGE 5’-ends (Figure 5.1B).  CAGE clusters that were anti-sense to a 
protein-coding locus from the UCSC known genes set were taken to be cis-NAT 
promoters as previously described [124] (Table B.2).  To reduce contamination of the cis-
NAT TSS by the possible degradation products of mRNAs, all CAGE clusters that 
overlapped an exon of the UCSC gene set were removed from the set of cis-NATs.  
CAGE clusters within 250bp of an annotated TSS of a protein coding loci were taken to 
be genic promoters and the TSS taken as the base with peak CAGE tag density.  As a 
control, CAGE clusters that overlapped an exon of the UCSC gene set and were in the 




ChIP-seq data analysis 
Histone modification and RNA Pol II occupancy for cis-NAT promoters were 
evaluated using ChIP-seq data from the ENCODE repository on the UCSC genome 
browser [133].  Where available, FASTQ ChIP-seq data for the H3K4Me1, H3K4Me2, 
H3K4Me3, H3K9Ac, H3K9Me1 H3K27Me3, H3K27Ac, H3K36Me3 and H4K20Me1 
modifications in the GM12878, H1HESC, HepG2, HUVEC, K562 and NHEK cell types, 
were taken from the ENCODE repository.  A non-specific input ChIP-seq control data set 
was also analyzed for each of the ENCODE cell types.  All ChIP-seq data were mapped 
to the May 2006 build of the human genome reference sequence (NCBI 36.1; UCSC 
hg18) using BowTie [110], keeping the best alignments with ties broken by quality 
scores.  Any reads with more than 20 possible mappings were discarded.   Remaining 
reads with multiple, high quality mappings were resolved using GibbsAM [134] (Table 
B.3).  Tag counts for a given modification were normalized by dividing by the total 
number of mapped tags for that modification, then multiplying by ten million.  ChIP-seq 
data were used to characterize the chromatin environment proximal to CAGE-
characterized cis-NAT promoters (Figure 5.1C). 
Association mining analysis 
For each cell type we used only the CAGE data from the nucleus (GM12878, 
HEPG2, K562 and NHEK), cytosol (HUVEC) or whole cell (H1HESC) isolate to classify 
the activity of sense genic promoters in relation t the sum cis-NAT activity for the genic 
promoter, i.e. the sum of downstream cis-NAT promoter activity.  For each cell type, 
genic promoters which had CAGE tags associated wereranked by their CAGE tag 




promoters that had no CAGE data or were in the bottom 25% were classified as ‘low 
activity’ in the cell type.  The same was done for the cumulative downstream cis-NAT 
activity of the genic promoters.  This resulted in four possible classification combinations 
for cis-NAT and genic activity levels: 1) high cis-NAT & high gene, 2) high cis-NAT & 
low gene, 3) low cis-NAT & high gene, 4) low cis-NAT & low gene.  We then used 
association mining to calculate the value of the Int rest (I) parameter, as previously 
described [135], which is the ratio of the observed fr quency of co-occurrence of any two 
classifications divided by their expected co-occurrence based on random association.  
Statistical analysis 
Student’s t-tests were used to compare differences in the average number of 
normalized ChIP-seq tags +/-5kb of cis-NAT promoters for different cis-NAT activity 
levels (Figure 5.2).  We used the statistical software R for calculating the Spearman’s 
rank correlation coefficients for all correlation aalyses (Figures B.3-B.4).  The statistical 
significance of Spearman’s rank correlation coefficients r was determined using the 
Student’s t distribution with d.f .= n-2 with the formula )1/()2( 2rnrt −−=   [136]. 
Results and Discussion 
Large-scale identification of cis-NAT TSS 
CAGE (cap analysis of gene expression) is a method for characterizing the 5’-end 
of RNA transcripts; genomic mapping of CAGE sequence tags identifies transcription 
start sites (TSS) and promoters [30, 31].  CAGE combined with high-throughput 
sequencing can identify many thousands of TSS, while at the same time quantifying their 




analyzed as described in the Methods to identify cis-NAT promoters in the human 
genome for the 16 different combinations of ENCODE cell type and RNA isolation 
conditions analyzed here.  The number of cis-NAT promoters identified in this way 
ranges from 11,650 to 313,003 across the ENCODE cell types (Table 5.1 & Table B.2).  
We evaluated whether the large differences in cis-NAT promoters identified across cell 
types were due to differences in the numbers of CAGE tags per library or differences in 
sequencing quality across libraries.  Library-specific read count values and read quality 
scores are not significantly correlated with the numbers of cis-NAT promoters identified 
across cell types, suggesting that the differences observed do not result from the CAGE 





 Table 5.1.  Numbers of cis-NAT promoters identified by CAGE clusters in each cell 




Poly-A- Poly-A+ Total 
GM12878 
Cytosol 24,107 --- --- 
Nucleoplasm --- --- 165,430 
Nucleus 62,704 --- --- 
H1HESC Whole Cell 67,216 --- --- 
HEPG2 
Cytosol 33,862 --- --- 
Nucleoplasm --- --- 214,364 
Nucleus 265,896 --- --- 
HUVEC Cytosol 25,309 --- --- 
K562 
Cytosol 164,399 30,867 --- 
Nucleoplasm --- --- 79,677 
Nucleolus --- --- 112,308 
Nucleus 313,003 148,461 --- 
NHEK 
Cytosol 11,650 --- --- 





Enrichment of chromatin modifications and RNA Pol II at cis-NAT promoters 
To characterize the relationship between local chromatin modifications and cis-
NAT promoter activity, we analyzed the number of ChIP-seq tags from each histone 
modification, and RNA Pol II, proximal (+/- 5kb) toeach cis-NAT TSS.  The analysis of 
cis-NAT chromatin modifications was conducted for 16 combinations of six ENCODE 
cell types over ten RNA isolation conditions.  Here, w  present an example of these 
results for one cell type and condition (NHEK cis-NATs characterized from nuclear non-
polyadenylated RNA); results for all other cell types and conditions are detailed in the 
Supplement.  Cis-NAT promoters were binned into 4 equal sized bins based on their 
promoter activity, from lowest to highest activity, as measured by CAGE tag counts.  
Histone modifications and RNA Pol II occupancy were th n compared for cis-NAT 
promoters with different levels of activity.  Cis-NAT promoters showed significant 
increases in ChIP-seq tag counts for the activating h stone modifications H3K4Me1, 
H3K4Me2, H3K4Me3, H3K9Ac, H3K27Ac with increasing levels of cis-NAT promoter 






Figure 5.2.  Enrichment of chromatin modifications and RNA Pol II at cis-NAT 
promoters.  Cis-NAT promoters identified in the NHEK cell type were divided into 4 
bins based on their activity (lowest to highest activity), and the normalized average 
numbers of ChIP-seq reads from each histone modification +/-5kb of the cis-NAT TSS 
were calculated for each bin.  A ‘+’ or ‘-‘ above a b r indicates that the number of ChIP-
seq reads for that bin and modification is significantly higher or lower, respectively, than 
the control for that bin (P < 0.001).   A ‘+’ or ‘-‘ within the bar indicates that a bin is 
significantly enriched or depleted, respectively, for the histone modification compared to 





Furthermore, each of these modifications shows significa tly greater average cis-NAT 
tag counts than seen for the ChIP-seq control (Figure 5.2).  These histone modifications 
have previously been characterized as activating modifications by virtue of their 
association with the promoters of actively transcribed genes [3, 4, 132].  H3K27Me3, on 
the other hand, is known as a repressive modification that is associated with silent genes, 
and ChIP-seq tag counts for H3K27Me3 are lower thanseen for the control in all cis-
NAT promoter activity bins (Figure 5.2).  Similar qualitative patterns are seen for 
H3K9Me1, H3K36Me3 and H4K20Me1, but the tag counts do not vary as much with cis-
NAT promoter activity.  This is may be due to the fact that these modifications are 
associated with transcribed regions, where the cis-NAT promoters are located, as 




promoter activity for these marks may be obscured by the fact that they are enriched 
within gene bodies where the cis-NATs are located.  Overall, the patterns of enrichment 
seen for histone modifications at cis-NAT promoters suggest that the cis-NATs identified 
here are epigenetically modified in accordance with their relative expression levels and 
are thus likely to be specifically regulated, which s a pre-condition for their functional 
relevance, as opposed to non-specific artefacts such as RNA degradation products.  For 
all activity levels, the level of Pol II binding ishigher than seen for the non-specific input 
control, suggesting that regions near cis-NAT promoters are bound by Pol II.  
Qualitatively similar patterns of histone modification and Pol II occupancy across 
different cis-NAT promoter activity levels were seen for 14 out of the 15 remaining 
CAGE data sets analyzed here; the only exception was the NHEK cytosol CAGE data set 
(Figures B.1 and B.2). 
To further evaluate whether histone modifications were correlated with cis-NAT 
promoter activity, cis-NAT promoters were divided into 200 bins based on activity as 
measured by CAGE tag counts.  Cis-NAT TSS CAGE tag counts were then compared to 
ChIP-seq proximal promoter histone modification andRNA Pol II tag counts using the 
Spearman rank correlation (Figures B.3 and B.4).  Cis-NAT promoter activity and 
histone modifications generally showed positive correlations for the activating H3K4 
methylations and H3K9 and H3K27 acetylations and weaker, though still positive 
correlations for the H3K9Me1, H3K36Me3 and H4K20Me1 modifications.  A weaker 
negative correlation was seen for the repressive H3K27Me3 modification.  As would be 




correlation between cis-NAT promoter activity and RNA Pol II presence and RNA-seq 
read density. 
Histone modification, RNA Pol II occupancy and transcription near cis-NAT 
promoters 
The enrichment of activating histone modifications a d RNA Pol II occupancy 
near active cis-NAT promoters suggests that cis-NAT expression is epigenetically 
regulated; however, this enrichment could result from cis-NATs being located in open 
chromatin regions inside gene bodies, and not from the promoters being specifically 
modified to regulate their activity.  To evaluate this possibility, we analyzed the 
distribution of histone modifications and RNA Pol II occupancy around cis-NAT TSS.  If 
the enrichment of chromatin modifications observed for cis-NATs is due solely to their 
location in open chromatin, then we do not expect to see any variability in enrichment 
along chromosomal regions surrounding cis-NATs.  On other hand, actively regulated 
cis-NATs would be expected to show modification peaks centered around the TSS as has 





Figure 5.3.  Chromatin modification and RNA Pol II environment around cis-NAT 
promoters.  Cis-NAT promoters identified in the NHEK cell type were divided into 4 
bins based on their activity (lowest to highest), and the normalized average numbers of 
ChIP-seq reads in 10 base-pair windows +/-5kb of the cis-NAT TSS (at position 0) were 






Cis-NAT promoters were broken down by activity level, as described above, and 
the average numbers of ChIP-seq tags were calculated for 10 base-pair windows +/-5kb 
from cis-NAT TSS (Figure 5.3).  Methylations of H3K4 (H3K4me1, H3K4me2 & 
H3K4me3) are known activating marks of promoters [3], and were all found to be 
enriched near cis-NAT promoters for the NHEK nuclear non-polyadenylated RNA data 
set (Figure 5.2).  In further accordance with their epigenetic regulation, peaks of ChIP-
seq read density from the H3K4Me1, H3K4Me2 and H3K4Me3 modifications were 
observed on either side of the cis-NAT TSS in this same data set, with more active 
promoters being more highly modified on average (Figure 5.3b,c,d).  A notable dip can 
be seen near the cis-NAT TSS for these three modifications, suggesting nucleosome 
absence, similar to what has been seen at canonical TSS in CD4+ T-cells [4].  Similar 
patterns were seen for the activating acetylations of H3K9 and H3K27 (Figure 5.3e,g).  
No discernable difference between bins was seen for the repressive mark H3K27Me3 
(Figure 5.3j).  The similarities seen for the genomic distributions of cis-NAT promoter 
modifications to those of protein-coding loci promoters [3, 4, 25, 132] provides evidence 
that cis-NAT expression is not simply transcription resulting from open chromatin, but is 
specifically regulated.  The nucleosome absence seen ev n at the TSS with the lowest 
activity suggests that these TSS, which are identifi d by only a small number of CAGE 
tags, are bona fide TSS that have been epigenetically silenced by histone deacetylation.  
Pol II occupancy is seen at the TSS for all activity b ns, with the higher activity bins 
showing a much higher occupancy, in accordance with the activity of the bins (Figure 




enrichment similar to the control with no observable enrichment on either side of the TSS 
(Figure  5.3g,h,i).  This is likely to be due to the fact that these modifications are 
associated with actively transcribed regions, such as gene bodies, where the cis-NAT TSS 
in this study are located [3, 132].  RNA-seq data also peaks near the cis-NAT promoters, 
and increases with cis-NAT promoter activity (Figure 5.3l).  Patterns of modification near 
cis-NAT TSS using CAGE and ChIP-seq data were qualitatively similar for 10 out of the 
15 remaining CAGE data sets analyzed here; the HepG2 nucleus, K562 nucleoplasm, and 
both K562 nucleus CAGE sets have greatly distorted patterns of modification (Figures 
B.5 and B.6).  Taken together, these data indicated that cis-NAT promoters show 
genomic distributions of histone modifications and RNA Pol II binding around TSS that 
are consistent with specific activation of transcription at the TSS as opposed to a simple 
accumulation of activating marks inside actively transcribed protein coding gene regions.   
For comparison, the same chromatin enrichment analyses were done for CAGE 
clusters associated with genic promoters in the 6 ENCODE cell types.  The patterns of 
local histone modifications for these promoters were la gely qualitatively similar to those 
seen for the cis-NAT promoters (Figures B.7 and B.8) [3, 4, 25, 132].  However, histone 
modification levels and RNA Pol II binding are substantially more enriched around genic 
promoters.  In addition, genic promoters show distinct enrichment patterns for 
H3K9Me1, H3K36Me3and H4K20Me1; these differences are likely due to the location 
of cis-NATs in gene bodies, which differ with respect to the distribution of these 
particular modifications.  Overall, these results further support the functional and 
regulatory potential of cis-NAT promoters that are ctively transcribed, albeit at lower 




It is formally possible that the cis-NAT chromatin e richment patterns observed 
here can be attributed the fact that the cis-NATs were identified using CAGE, and any 
CAGE cluster would show such a pattern.  To control for this possibility, we performed a 
similar analysis using CAGE clusters overlapping exons in the sense orientation, which 
may not be expected to show the same pattern of modification as CAGE clusters 
associated with genuine promoters.  Indeed, sense exonic CAGE clusters have previously 
been suggested to represent transcriptional degradation products, as opposed to 
promoters, and were not found show promoter characteristic chromatin profiles [137].  
Here, we performed the same set of chromatin enrichment analyses done for cis-NATs on 
exonic CAGE clusters.  The patterns of histone modificat ons near exonic CAGE clusters 
are markedly different from those seen for cis-NAT promoters and genic promoters 
(Figures B.5 and B.6).  These results indicate that the cis-NAT chromatin enrichment 
profiles observed here are not simply a generic marker for the presence of CAGE 
clusters.    
Differential expression of cis-NAT promoters 
Differential expression of cis-NATs was measured by counting the fraction of the 
6 ENCODE cell types in which each cis-NAT promoter was expressed.  In order to 
remove cis-NATs whose expression falls below the limit of CAGE detection, only those 
cis-NAT promoters that show activity higher than the 90th percentile in some cell type 
were used.  On average, these cis-NAT promoters are expressed in 33% of the ENCODE 
cell types studied here compared to 43% seen for genic promoters (Figure 5.4a), this 
difference is statistically significant (P≈0, Wilcoxon rank sum) indicating that cis-NAT 




Rarefaction curve analysis was used to evaluate the xtent to which each 
individual CAGE data set uncovers novel cis-NAT promoters compared to novel genic 
promoters.  For this analysis, the average numbers of ci -NAT or genic promoters 
detected across all possible CAGE data set combinations, ranging from 1-16 data sets, 
were calculated.  Compared to genic promoters, a significantly smaller fraction of cis-
NAT promoters is detected when one or only fewer than 8 CAGE data sets are 
considered (P < 0.001, Wilcoxon rank sum) (Figure 5.4b).    For both genic and cis-NAT 
promoters, the number of new promoters detected decreases rapidly as more CAGE sets 
are considered, suggesting that most cis-NAT and geic promoters have been captured.   
The differences seen for the cis-NAT versus genic curves further underscore the extent to 
which cis-NATs are specifically regulated. 
Association between cis-NAT and genic promoter activity 
Previous studies have suggested that the presence of cis-NATs leads to the down-
regulation of gene expression[44].  If cis-NATs areindeed repressive regulatory 
elements, then one may expect to observe a negative corr lation between cis-NAT 
expression levels and the expression levels of the gen s in which they are found.  To 
evaluate this prediction, we regressed the activity levels of genic promoters with those of 
the corresponding cis-NAT promoters, however no correlation was apparent (Figures B.9 
and B.10).  Therefore, we used a more sensitive data mining approach to search for 
possible associations between genic promoter activity and cis-NAT promoter activity.  To 
do this, genic promoters were classified as having h gh or low activity, and the 
corresponding genes were classified as having high or low cis-NAT activity in each of 




levels of co-occurrence of the four possible gene and cis-NAT activity category 
combinations:  1) high cis-NAT & high gene, 2) high cis-NAT & low gene, 3) low cis-
NAT & high gene, 4) low cis-NAT & low gene.  We found that co-occurrence of high 
cis-NAT and high genic promoter activity occurs approximately twice as frequently as 
would be expected by chance (Figure 5.5 and Table B.4).  Similarly, the frequency of 
high/low associations is much lower than would be expected and the frequency of 
low/low associations is higher than expected.  This association remains when only those 
cis-NAT promoters distal (> 2.5kb downstream) to the genic promoter or proximal (< 
2.5kb downstream) to the genic promoter are considered (Figures B11 and B12 and Table 
B.5 & B.6). These results raise the possibility that t e majority of cis-NATs are activating 
rather than repressive regulatory elements. 
Conclusions  
It has been known for some time that there is active antisense transcription in the human 
genome, though it has only recently become appreciated how pervasive it is.  However, 
the functional significance of human cis-NATs is a m tter of debate; it is possible that 
many of the apparent cis-NATs actually represent transcriptional noise or degraded 
fragments of sequence processed from larger transcripts.  Here, we have attempted to 
address the potential functional significance of human cis-NATs genome-wide by 
evaluating the chromatin environment and regulatory properties of their promoters.  This 
approach is based on the rationale that specifically regulated promoters will have distinct 
chromatin profiles and protein binding properties.  Accordingly, the presence and 




transcripts, when considered together with their relative activity levels, can be used to 
provide support for their regulation and potential functional significance.   
Taking advantage of methods for characterizing protein binding and histone 
modifications genome-wide, we demonstrate that active human cis-NAT promoters are in 
fact enriched for histone modifications and RNA PolII binding.  Furthermore, histone 
modifications and RNA Pol II binding peak at cis-NAT TSS, and the levels of histone 
modifications and RNA Pol II binding are correlated with the activity of the cis-NAT 
promoters.  These data suggest that the expression of human cis-NATs is driven by RNA 
Pol II and at least partially regulated by the modification of histone tails.  While the 
specific function of individual cis-NATs remains anopen question, the fact that the cis-
NAT promoters are bound by RNA Pol II and epigenetically modified suggests that they 
are specifically regulated.  Indeed, the presence of both cis-NAT promoters with 
activating marks and cis-NAT promoters with repressive marks is consistent with the 
high levels of differential expression observed here fo  cis-NATs and tissue-specific 
regulation of their function.  While the cis-NAT chromatin and expression features 
uncovered here are consistent with a functional role as regulators, they may also be taken 
to represent a required pre-condition of function.  Definitive confirmation of the 






ENDOGENOUS RETROVIRUSES AND THE EPIGENOME 
 
Abstract 
Endogenous retroviruses (ERVs) are the evolutionary remnants of retroviral germline 
infections, which are no longer capable of intercellular infectivity.  Despite being 
confined within the genomes of their hosts, ERVs are able to replicate and spread via 
retrotransposition.  This replicative process helps to ensure the elements’ proliferation 
and long term evolutionary success, but it also imposes a substantial mutational burden 
on their host genomes.  Accordingly, host organisms have evolved a variety of 
mechanisms to repress ERV transposition, including epi enetic mechanisms based on the 
modification of chromatin.  In particular, DNA methylation and histone modifications are 
used to silence ERV transcription thereby mitigating their ability cause mutations via 
transposition.  It has recently become apparent that epigenetic and chromatin based 
regulation of ERVs can also exert substantial regulatory effects on host genes.  In this 
chapter, we provide a number of examples illustrating how chromatin modifications of 
ERV insertions relate to host gene regulation including both deleterious cases as well as 
exapted cases whereby epigenetically activated ERV elements provide functional utility 
to their host genomes via the provisioning of novel regulatory sequences.  For example, 
we discuss ERV-derived promoter and enhancer sequences i  the human genome that are 
epigenetically modified in a cell-type specific manner to help drive differential 
expression of host genes.  The genomic abundance of ERVs, taken together with their 




this kind of phenomenon may be far more common thanpreviously imagined.  
Furthermore, the environmental responsiveness of epigenetic pathways suggests the 
possibility that ERVs, along with other classes of epigenetically modified TEs, may serve 
to coordinately modify host gene regulatory programs in response to environmental 
challenges. 
Introduction 
Endogenous retroviruses (ERVs) are the genomic remnants of retroviruses that integrated 
into a host genome and subsequently lost the ability to leave the host cell, instead 
replicating within the host genome [138].  Evolutionarily, ERVs are members of a 
broader class of mobile genetic elements known as LTR-containing retroelements; 
included in this broader set are the LTR retrotransposons.  LTR-containing retroelements 
are named for the Long Terminal Repeats (LTRs) found at their 5’ and 3’-ends.  These 
LTRs are direct repeats, identical at the time of insertion, and contain regulatory 
sequences required for element transcription.  The LTRs of ERVs and LTR 
retrotransposons are highly similar in structure and function [139].  The similarity 
between ERVs and LTR goes beyond the presence of th LTR sequences, however.  In 
fact, LTR retrotransposons have been referred to asbeing ‘retrovirus-like’ elements due 
to their similarity to both ERVs and retroviruses [1].  Both ERVs and LTR 
retrotransposons contain coding sequences necessary for their integration into the host 
genome as well as a region encoding a reverse transcriptase that catalyzes the 
polymerization of DNA from an RNA template.  Comparison of reverse transcriptase 
sequences from diverse retrotransposons and viruses ev aled that retroviruses and ERVs 




reconstructions based on reverse transcriptase sequence alignments indicate that 
retroviruses and ERVs represent a monophyletic subset of overall LTR retroelement 
diversity and show that the LTR retortransposons form a basal clade to this group with 
greater relative diversity.  These data were taken to i dicate that, at some time in the 
distant past, retroviruses emerged from within the LTR retrotransposon lineage via the 
acquisition of an envelope protein coding sequence that conferred intercellular 
infectivity, i.e. the ability to escape the confines of the host cell [139].  Thus, ERVs, 
which are a group of retrovirus-derived sequences that are no longer capable of 
intercellular infectivity, represent a reversion to the ancestral state of LTR 
retortransposons as non-infectious genomic elements.  
As with other classes of retrotransposable elements, LTR-containing 
retroelements, including ERVs, are able to increase their copy number in the genome via 
retrotransposition.  Through retrotransposition, LTR-containing retroelements can 
achieve high copy number within genomes, .g.~700,000 insertions in the human 
genome, comprising 8% of the total genomic sequence [1].  The retrotransposition of 
ERVs and other LTR retroelements can cause deleterious mutations in the host.  In 
mouse, where ERVs are highly active, it has been estimated that 10% of de novo 
mutations result from novel ERV insertions [7, 142].  ERV insertions can cause 
deleterious mutations via a number of mechanisms including the induction of 
transcriptional aberrations in host genes.  For example, integration of the Ten mouse 
ERV into the second intron of the Fas (tumor necrosis factor receptor superfamily, 
member 6) gene has been shown to lead to aberrant splicing of Fas transcripts via the 




the nascent host gene transcript [143].  This leads to mutant mice with an autoimmune 
phenotype.  More recently, it has been shown that insertion of a mouse ERV into to an 
intron of the Slc15a2 (solute carrier family 15, member 2) gene can cause pre-mature 
transcriptional termination at distance via a distinct mechanism that does not involve 
changes in the splicing of the gene [144].  This same work revealed that similar pre-
maturely terminated transcripts occur in ~5% of mouse genes with intronic 
polymorphisms of ERVs. 
In order to prevent deleterious insertions of ERVs and other LTR-containing 
retroelements, host genomes have evolved a variety of mechanisms to suppress element 
transposition [145].  Among these mechanisms, epigenetic and chromatin based silencing 
of insertions by the host limit the ability of the elements to produce mRNA, thereby 
greatly reducing the likelihood that they will be transposed [146, 147].  A number of 
recent studies on mammalian chromatin have demonstrated the extent to which ERV 
element sequences are marked with repressive histone m difications, which presumably 
limit their transcription.  For example, using ChIP-PCR (Chromatin Immunoprecipitation 
followed by PCR amplification), Martens et al. demonstrated that Intracesternal A 
particle (IAP) insertions, a family of ERVs, are subject to the repressive H4K20Me3 
(trimethylation of Histone 4 K20) histone modification, while at the same time showing 
very low levels of the activating mark H3K4Me3 for these same elements [148].    
Similarly, using ChIP-seq (Chromatin Immune-Precipitation followed by massively 
parallel sequencing) [149], Mikkelsen et al. found that mouse ERVs are enriched for the 




ChIP-seq data from CD4+ T-cells, Huda et  al. also found that human LTR-containing 
retroelement insertions were enriched for silencing histone modifications [151]. 
 While most chromatin studies of ERVs to date have focused on the epigenetic 
silencing of these elements for the purpose of genome defense, it has become 
increasingly clear that epigenetic modifications of ERVs and other LTR-containing 
retroelements can also have profound effects on the regulation of host genes.  In other 
words, epigenetic modifications of ERV sequences ar not only used to repress element 
transcription, but can also be exapted [94, 152] for the purposes of controlling host gene 
expression.  For example, epigenetic silencing of an ERV insertion near the promoter of a 
host gene could possibly reduce the transcriptional activity of that gene.  Alternatively, 
ERV or LTR-containing retroelement insertions could be actively modified and regulated 
in a way that benefits the host, e.g. as an alternative promoter for a host gene or an 
enhancer that regulates gene expression at distance.  Such exapted insertions could help 
to diversify the host transcriptome as has been seefor an ERV-derived promoter driving 
the expression of the IL-2 receptor beta gene in human placenta [18].  In this chapter, we 
focus on these kinds of chromatin mediated regulatory exaptations of ERVs and other 
LTR-containing retroelements.  We provide several ex mples of recent studies showing 
how epigenetic modifications of these kinds of elements can affect the regulation of host 
genes in a variety of eukaryotic species.  First, we explore host gene regulatory effects 
exerted by the epigenetic silencing of LTR retroelements (sections 2-4), and then we 
focus on how activating chromatin modification of these kinds of elements can also effect 




Epigenetic silencing of LTR retroelement insertions in Arabidopsis thaliana 
In an early study on the effect of transposable elem nt (TE) insertions on the local 
chromatin environment, Lippman et al. characterized th  chromatin environment of a 
genomic region in Arabidopsis thaliana which arose from an ancient segmental 
duplication [146].  This duplicated chromosomal region is a so-called ‘knob’, i.e. an 
interstitial heterochromatic region, which was found to contain many LTR 
retrotransposon and other TE insertions that are not present in its duplicated counterpart.  
These TE insertions are evolutionarily young indicating that they were inserted into the 
knob region after the ancient duplication by which it was generated (Figure 6.1).  The 
coincidence of heterochromatin and novel TE insertions in the knob region was taken to 
suggest that these insertions led to the formation of i terstitial heterochromatin after 
duplication, presumably as a result of host chromatin based silencing mechanisms that 
were targeted to these TEs.  Using tiling arrays, Lippman et al. demonstrated that the TE 
insertions in the knob were in fact marked with DNA methylation and the repressive 
H3K9Me3 histone modification, with elements of the gypsy family being particularly 
heavily modified.  Knockdown of the DNA methyltransferase ddm1 resulted in the 
decrease of the levels these repressive marks in the knob region and an increase in LTR 





Figure 6.1. Generation of an interstitial heterochromatic region driven by 
transposable element (TE) insertions.  (a) An ancient segmental duplication in A. 
thaliana led to two paralogous regions.  (b) One of the duplicated regions is subject to 
multiple TE insertions (left), including numerous LTR retroelements, while the other 
duplicated region remains largely free of such insertions (right).  (c) The region with TE 
insertions (left) is subject to repressive epigenetic modifications (red) and depletion of 
activating modifications (green), while the reverse is seen for the region without the 




This study demonstrated that insertion of LTR-containing retroelements could 
lead to the in situ formation of heterochromatin in one particular region of a eukaryotic 
genome in response to host defense mechanisms that silence element expression.  These 
findings suggested that the novel insertions of LTR-containing retroelements could have 
genome-wide effects via the generation of local heterochromatic regions that can silence 





Epigenetic silencing of LTR retroelement insertions and the effect on nearby genes in 
A. thaliana  
The results from Lippman et al. demonstrated that LTR insertions generate novel 
heterochromatic regions in A. thaliana, and they also showed that genes co-located with 
TEs in the heterochromatic knob-region were expressed at lower levels than their 
paralogs located in euchromatin.  Indeed, if an LTR-containing retroelement insertion 
near or within a transcribed locus is epigenetically silenced, then it may be possible for 
the element silencing to affect expression of the gene as well.  Based on this line of 
thinking, Hollister and Gaut sought to characterize the effect of methylated TE insertions, 
including ERVs and other LTR-containing retroelement insertions, on the expression of 
nearby genes A. thaliana [153].  Initially, they observed a globally lower xpression of 
genes near TE insertions; however, this did not take into account the epigenetic state of 
the insertion.  Using genome-wide bisulfite sequencing data, they went on to demonstrate 
a genome-wide depletion of methylated TE insertions near genes, suggesting that such 
insertions are selected against, perhaps by virtue of their silencing effects on nearby gene 
expression.  In fact, the authors demonstrated that genes proximal to such methylated 
insertions were expressed at lower levels, indicating that the methylation of TE insertions 
near genes reduces their expression.  In line with the role of selection in removing 
methylated TEs from the proximity of genes, Hollister and Gaut demonstrated that 
methylated polymorphic TE insertions near genes were skewed towards rare variants.  
Furthermore, this effect was observed only for insertions <1.5 kb from genic loci, 
pointing to locally confined spreading of methylation from TE insertions into nearby or 




suggesting that selection has not acted on them as it h on younger methylated TEs near 
genes. 
The depletion of LTR-retroelement and other TE insertions within and near genes 
has been observed for a number of eukaryotic species and itself strongly suggests that 
such insertions are selected against.  The study by Hollister and Gaut provided a specific 
mechanistic basis for this selection, i.e. the fact that methylated insertions within and near 
genes are deleterious by virtue of their silencing effects on gene expression.  Given what 
these authors observed, it seemed possible that the reduction of neighboring gene 
expression by the insertion of a TE could also occur in other species that epigenetically 
silence TE insertions and could perhaps be even more pr found in genomes that are 
denser in repetitive elements. 
Heterochromatin spreading from polymorphic IAP insertions in the mouse genome 
The mouse IAP family of ERVs is a highly active, with ~26,000 annotated insertions [7].  
While Mikkelsen et al. previously showed that IAP insertions in mouse were 
epigenetically silenced [150], the effect that such silencing would have on nearby genes 
remained largely unexplored.  Recently, Rebollo et al. investigated the possibility that 
novel IAP insertions in mouse could lead to the formation of local heterochromatin and 
the spreading of heterochromatin away from the insertion into nearby sequences [154].  
To do this, Rebollo et al. characterized IAP insertions which were polymorphic between 
two mouse cell lines, allowing them to observe the epigenetic state of the IAP insertion 
site with and without the insertion.  It was found that the borders of IAP insertions, both 
those which were polymorphic between the two cell types and common IAP insertions, 




H3K9Me3 was found to spread from the borders of the IAP insertion up to a maximum of 
5kb.  Importantly, for polymorphic IAP insertions, Rebollo et al. showed that the pre-
insertion site in the cell type without the IAP insertion was not enriched for H3K9Me3, 
indicating that the novel IAP insertion was the source of the repressive modification.  
The spreading of repressive modifications from an IAP insertion raised the 
question as to whether or not such spreading could lead from the insertion to a nearby 
promoter (Figure 6.2).  Indeed, Rebollo et al. were able to find an example of a 
polymorphic IAP insertion proximal to a mouse gene.  There is an IAP insertion 
upstream of the B3galtl promoter which is present only in the J1 cell type.  In the J1 cell 
type, DNA methylation and the repressive histone modification H3K9Me3 extend from 
the IAP insertion into the promoter of the B3galtl gene, which is accordingly down-
regulated in J1 compared to the TT2 cell line that lacks the gene proximal IAP insertion.  
Such a spreading of heterochromatin from LTR insertions into nearby genes, and the 
negative regulatory effects caused by such spreading, could explain the apparent negative 
selection against LTR insertions near promoters previously observed for the mouse and 






Figure 6.2. Spreading of heterochromatin from a novel IAP insertion.  (a) An active 
mouse gene promoter region prior to an IAP insertion.  (b) Cell-type specific 
insertion of an IAP element near the active mouse gene promoter.  (c) The IAP insertion 
is silenced with the repressive histone modification H3K9Me3 (red circles) and this 
repressive mark spreads to the nearby gene promoter resulting in silencing of the gene.  




It is worth noting that when looking for instances where the insertion of an IAP 
element led to heterochromatin spreading and alteration of gene expression, Rebollo et al. 
looked only at those IAP insertions proximal to promoters.  In addition to promoters, 
there are many thousands of enhancers scattered within and between mammalian genes.  




which were active in only one of the cell types analyzed [155].  Similarly, Ernst et al. 
characterized many thousands of likely human enhances based on their profile of active 
histone modifications [156].  Such active histone modifications are likely important in the 
function of the enhancers, and it stands to reason that an IAP inserted near an enhancer 
could reduce its function via the spreading of repressive epigenetic histone modifications.  
Indeed, the insertion of an IAP element near an enhancer could conceivably affect the 
expression of a gene in a more specific manor than promoter proximal insertions since 
enhancers tend to be more cell-type specific than promoters.  
Demethylation of an IAP insertion leads to ectopic expression of the agouti gene in 
mouse  
While many ERVs are epigenetically silenced, it is likely, given the large number of 
insertions present in many genomes, that some will escape such silencing, or even 
become actively modified.  Indeed, Hollister and Gaut showed that not all LTR 
retroelement insertions are repressed in A. thaliana, a large number are demethylated 
[153], and it would not be surprising to find that LTR retroelements in other species 
could also be demethylated.  Given that ERVs contain their own promoters and 
regulatory sequences, it is conceivable that when demethylated their promoters could 
potentially transcribe through or away from their inserted sites into nearby genes.  Given 
the genomic abundance of ERVs and other LTR-containi g retroelements, it would seem 
probable that a number of demethylated insertions are likely to transcribe nearby host 
gene sequences.  One such example of this phenomenon occurs at the agouti locus in 




  The agouti gene in mouse controls the pigmentation of mouse coats and hair 
follicle development.  There exist mouse strains which show ectopic expression of the 
agouti gene, predisposing the mice to tumors and obesity [157].  Interestingly, the ectopic 
expression of the agouti gene is widely variable: the expression ranges from mice which 
express it widely, to those which show variegation in expression and those which show 
no ectopic expression and are otherwise phenotypically normal.  It was demonstrated that 
the ectopic expression was not driven by the canonical promoter of the agouti gene, but 
an IAP insertion upstream of the agouti coding exons and that the level of expression 







Figure 6.3.  Demethylation of an IAP leads to ectopic expression of the agouti gene.  
(a) In phenotypically normal mice, the agouti proximal IAP insertion is subject to DNA 
methylation (5mC, red circles) and is inactive.  Accordingly, agouti gene expression is 
driven by its canonical promoter in the appropriate tissues.  (b) In mice where the IAP 
insertion is demethylated, it can drive ectopic expr ssion of the nearby agouti gene from 




This agouti locus represents a departure from the usual reasoning behind the 
epigenetic silencing of LTR-containing retroelements and other TE insertions: rather than 
preventing retrotransposition per se, epigenetic silencing of the IAP insertion serves to 
prevent deleterious transcription from the IAP insertion into the neighboring agouti gene.  
While the agouti case was a single example of an ERV altering genomic function when 
demethylated, the large number of insertions within eukaryotic genomes, ~700,000 and 
~850,000 in the human and mouse genomes [1, 7], virtually guarantees that other such 
de-repressed LTR retroelement  insertions can and do act as promoters.  Further, while 




insertions could prove adaptive and become exapted for function in the host genome.  
Indeed, several hundred promoters derived from LTR-containing retorelement insertions 
have been characterized in the human genome [98], the epigenetic characterization of 
which we discuss in the next section.    
Actively modified ERVs and human gene promoters 
The initial phases of the ENCODE project [25, 28] have allowed for the unprecedented 
characterization of the epigenetic state of the large majority of sites in the human 
genome, including many repetitive elements which could not previously be characterized 
using array based techniques.  Of equal importance, the ENCODE project has allowed for 
the comparison of the epigenetics state between cell typ s.  Such comparisons allow for 
the detection of sites with differential modification which could in turn contribute to cell-
type specific patterns of gene expression.  In sections 6 and 7, we review studies of host 
gene promoters and enhancers respectively, based on ENCODE data from human cell 
lines, which demonstrate activating epigenetic modifications of ERVs and other LTR-
containing retroelements and show how these reactivated insertions may drive cell-type 
specific patterns of gene expression. 
 The agouti locus in mouse demonstrates that the insertion of an ERV insertion 
near a gene can lead to the use of the insertion as a lternative promoter for the gene.  
Indeed, ERV and other LTR-containing retroelement-derived promoters, in both mouse 
and human, have been characterized in several studie .  A 2004 study identified 81 genes 
expressed in early mouse embryos for which the 5’-end, and thus the promoter, was 
derived from an LTR retorelement insertion [159].  A later study used Paired-End diTag 




genome [98], and a study by Faulkner et al. analyzed a large set of CAGE (Cap Analysis 
of Gene Expression) [31] libraries to investigate th  potential promoter activity of LTR-
containing retroelement insertions in diverse human and mouse tissues [32].  While these 
studies characterized a breadth of LTR-containing retroelement-derived promoters, the 
epigenetic status and/or chromatin modifications of these insertions was not investigated.      
Huda et al. investigated the epigenetic regulation of TE-derived promoters in the 
human genome, including those promoters derived from ERV and other LTR-containing 
retroelement insertions [160].  The authors identified 1,520 distinct promoters derived 
from TE insertions, among them over 300 promoters dived from LTR-containing 
retroelement insertions (Figure  6.4).  Using ChIP-seq data from the GM12878 and K562 
cell lines, Huda et al. characterized the epigenetic environment of the TE-derived 
promoters, finding an enrichment of activating modifications for active promoters along 
with a concomitant depletion of the sole repressive mark used, H3K27Me3.  Of note, 
promoters derived from LTR-containing retroelements showed the greatest divergence of 
histone modification and activity between the GM12878 and K562 cell types.  Such a 
divergence suggests that LTR-containing retroelement insertions have helped to diversify 







Figure 6.4. Cell-type specific epigenetic activation of human ERV-derived 
promoters.  (a) In one cell type, a human ERV insertion is subject to repressive histone 
modifications and accordingly is not used as a promoter for the adjacent host gene.  (b) In 
a different cell type, the same ERV insertion is marked with activating histone 
modifications, e.g. H3K9Ac (green circles), leading to active transcription of the adjacent 




This study by Huda et al. demonstrated on a genome wid  scale that the 
epigenetic activation of LTR-containing retroelement insertions can lead to the alteration 
of host gene expression via the use of the insertions as alternative promoters.  This leads 
to interesting, and still largely open, questions regarding the origin and evolution of such 
LTR-containing retroelement-derived promoters.  In the case of the agouti locus in 
mouse, ectopic transcription driven by the IAP insertion is deleterious to the mouse 
[157].  Given the intricate control of gene expression, one would expect that such ectopic 
expression would generally be deleterious.  Most would therefore likely be selected 




the cell-type specific usage and epigenetic modification of the ERV and other LTR 
retroelement-derived promoters characterized by Huda et al. is suggestive of their 
adaptive nature and potential functional utility. 
Actively modified ERVs and human gene enhancers 
DNaseI hypersensitive sites are regions of the genom  that are unusually ‘open’ in terms 
of their chromatin environment and thus susceptible o degradation by DNaseI.  Such 
sites are often important for gene regulation, e.g. active promoters and enhancers.  It was 
previously shown that a large number of DNaseI-hypersensitive sites are derived from 
ERVs and other LTR-containing retroelement insertions in the human genome [69], 
suggesting that these insertions could play roles in gene regulation apart from that of 
promoters, e.g. enhancers.  Indeed, functional enhancers derived from other families of 
TEs are known, such as the AmnSINE1 element derived enhancers that help to drive 
brain specific expression [23].  Active enhancers are epigenetically modified with 
activating histone modifications [156, 161], and while LTR-containing retroelement 
insertions are typically epigenetically silenced [151], insertions acting as enhancers 





Figure 6.5. Epigenetic activation of a human ERV-derived enhancer.  An ERV 
insertion located distal to a host gene is subject to enhancer-characteristic activating 
histone modifications, e.g. H3K27Ac (green circles).  When activated, it acts as an 
enhancer for the distal gene promoter, leading to transcription from the gene promoter.  
Figure adopted from [162]. 
 
 
In a recent study, Huda et al. used the epigenetic modification patterns of 
enhancers to predict TE-derived enhancers on a genom -wide scale [162].  Using known 
p300 binding sites as a training set, the authors used ChIP-seq data from the ENCODE 
project in the GM12878 and K562 cell types to screen DNaseI HS sites for histone 
modifications similar to those of known enhancers.   Nearly 20,000 such sites were 
identified, several thousand of which were co-located with TE insertions.  Of those, over 
700 sites were derived from LTR insertions.  Importantly, the presence of TE enhancers 
correlated with the expression of nearby genes, strongly suggesting that the TE-derived 
enhancers characterized were active and influenced gene expression.   
As in the study of TE-derived promoters by Huda et l. [160], the work on 




retroelement insertions [162], which is in contrast with general the genome-wide 
enrichment of repressive modifications on such insertions [151].  Also as in the TE-
promoter study, the authors used only two cell types for the analysis of TE-derived 
enhancers.  The large majority of enhancers characterized, however, both those derived 
from TE insertions and other, were detected in only e of the two cell types.  This is in 
line with what others have observed regarding the cell type specificity of enhancers.  For 
instance, in the large scale analysis of ENCODE ChIP-seq data, Ernst et al. found that 
while many promoters are active across a number of cell types, the large majority of 
putative enhancers were active in only one of the cell types investigated [156].  This 
opens the possibility that there are thousands of human enhancers derived from ERVs 
and other LTR-containing retroelement insertions, many of which would remain 
unidentified in a study of only two cell-types, and underscores the potential impacting on 
cell-type expression of thousands of human genes that these ERV-enhancers may exert. 
Conclusions and prospects 
In this chapter, we reviewed some of the ways in which ERV effects on host gene 
regulation are mediated by epigenetic and chromatin modifications.  ERVs are of course 
just one class of TEs, and TEs were originally discovered by Barbara McClintock by 
virtue of the regulatory effects they exert on maize host genes [163].  In light of these 
effects, McClintock referred to TEs as controlling elements, and she ultimately came to 
believe that TEs could actually re-organize genomes in response to environmental 
challenges [164].  For McClintock, this genome reorganize process was related to the 
genome dynamics of TEs per se, i. . their ability to transpose and cause genomic 




environmental responsiveness of eukaryotic genomes may also be attributed the 
epigenetic and chromatin based regulatory effects that they exert on host genes.  This 
notion is based in part on observations that epigenetic changes can in fact occur in 
response to environmental stimuli [165].  In the case of ERVs, environmentally 
programmed ERV-mediated chromatin based regulatory changes have been observed for 
the agouti locus where environmental exposure to methyl donors leads to increased 
repression of the upstream IAP thereby mitigating the mutation ectopic expression 
phenotype [166].  Given the abundance of ERVs, their widespread genomic distribution 
and proximity to genes along with their propensity to be epigenetically modified, these 
elements may provide a means for host genomes to mount dynamic epigenetically 






CELL TYPE-SPECIFIC TRANSCRIPTION TERMINATION BY 




Transposable elements (TEs) encode sequences necessary for their own transposition, 
including signals required for the termination of transcription.  TE sequences within the 
introns of human genes show an antisense orientatio bias, which has been proposed to 
reflect selection against TE sequences in the sense orientation owing to their ability to 
terminate the transcription of host gene transcripts.  While there is evidence in support of 
this model for some elements, the extent to which TE sequences actually terminate 
transcription of human gene across the genome remains an open question. 
Results 
Using high-through sequencing data, we have characterized over 9,000 distinct TE-
derived sequences that provide transcription terminatio  sites for 5,747 human genes 
across eight different cell types.  Rarefaction curve analysis suggests that there may be 
twice as many TE-derived termination sites (TE-TTS) genome-wide among all human 
cell types.  The local chromatin environment for these TE-TTS is similar to that seen for 
3’ UTR annotated (canonical) TTS and distinct from the chromatin environment of other 
intragenic TE sequences.  However, those TE-TTS located within the introns of human 
genes were found to be far more cell type-specific than the canonical TTS.  TE-TTS were 




of the same TE family, and TE-TTS in the sense orientation terminate transcription more 
efficiently than those found in the antisense orientation.  Alu sequences were found to 
provide a large number of relatively weak TTS, whereas LTR elements provided a 
smaller number of much stronger TTS.  
Conclusions 
TE sequences provide numerous termination sites to human genes, and TE-derived TTS 
are particularly cell type-specific.  Thus, TE sequnces provide a powerful mechanism 
for the diversification of transcriptional profiles between cell types and among 
evolutionary lineages, since most TE-TTS are evolutionarily young.  The extent of 
transcription termination by TEs seen here, along with the preference for sense oriented 
TE insertions to provide TTS, provide an explanation for the observed antisense 
orientation bias of human TEs.   
Background 
Different kinds of somatic cells in within an individual human contain the same genome, 
but are obviously functionally distinct.  Thus, the cell type-specific regulation of the 
genome, rather than the genome itself, defines the characteristics of a cell type.  The 
importance of cell type-specific activity of promoters in the function of different cell 
types has long been appreciated; however, the role of c ll type-specific termination of 
transcription has not been as well studied.  Nevertheless, cell type-specific variation in 
transcription termination, primarily via 3’UTR shortening, has been shown to be 
important in cancer and in other proliferating cells [39, 41, 167].  For this study, we 




transcription, may play important roles in the cell type-specific termination of 
transcription.  
There are numerous transposable element (TE) derive sequences in the human 
genome, comprising more than two-thirds of the total sequence [1] and many of these 
TEs are located within the introns of human genes.  TEs contain their own regulatory 
sequences, including specific signals which lead to the termination of transcripts initiated 
from element promoters; human endogenous retroviral elements (HERVs), for example, 
have polyadenylation signals in their long terminal repeat (LTR) regions that terminate 
transcription [168]. Thus, numerous TE sequences located within, or nearby, human gene 
sequences may contribute substantially to the termination of gene transcription via the 
provisioning of termination signals.   
There are several known examples whereby TE sequences lo ated within, or 
nearby, human genes have been shown to terminate transcription of genic mRNAs.  An 
early study of HERVs provided the first direct evidence that TE-derived sequences can 
terminate the transcription of non-TE human mRNAs and further suggested that different 
subfamilies of these elements may serve to terminate tr nscription in a cell type-specific 
manner [20].  Later, the same family of ERVs was demonstrated to terminate 
transcription of a novel alternatively spliced version of the human NAAA gene [169].  
There is also experimental evidence showing that L1 (LINE) retrotransposon sequences 
can terminate the transcription of human genes, and in this same study the intronic 
content of L1 sequences in human genes was found to be negatively correlated with their 




polymorphic L1 insertions in human genes was correlated with a decrease in their 
expression in a tissue-specific manner [170].  
 Despite the evidence cited above indicating that TE sequences can terminate 
transcription of human genes in a cell type-specific manner in some cases, the extent of 
this phenomenon and its overall effect on the human genome sequence and cell type-
specific transcriptomes have not been fully explored.  Interestingly, there is a strong 
antisense orientation bias for TE sequences within human genes [167, 171], and this 
observation has been attributed to the propensity of TEs to terminate transcription when 
inserted in the same (sense) orientation as gene tra scription [70].  Presumably, many 
such sense-oriented insertions would be selected against, owing to their termination of 
human gene transcripts, leaving a relative bias of antisense TE insertions.  Consistent 
with this implied genome-wide effect of TE sequences on the termination of human gene 
transcripts, a pair of recent genome-scale surveys of transcription termination by TEs 
revealed ~3,000 cases of human transcripts that terminate with TEs [172, 173].  These 
studies, while intriguing, relied on relatively low throughput transcriptomic technologies 
and were not able to address cell type-specificity of TE transcription termination.  Thus, 
the full extent of TE transcription termination within the human genome, and equally as 
important the cell type-specificity of this phenomenon, remains unknown. 
Here, we deeply interrogated the contribution of TE sequences to human gene 
transcription termination via the integrated analysis of high-throughput transcriptomic 
data and TE-gene annotations.  Since TE sequences hav  been shown to contribute 
disproportionately to cell type-specific regulation [160], we also evaluated the extent to 




this, we have characterized the space of transcription termination sites (TTS) derived 
from TE insertions in eight different ENCODE cell types.  For these TE-TTS, we 
characterized the contributions from different TE families, as well as their relative 
insertion orientations.  We found 9,287 TE-derived sequences that terminate the 
transcription of 5,747 human genes.  Our results also show that TEs terminate transcript 
much more efficiently when inserted in the sense ori ntation relative to gene transcription 
and thus lend credence to the previously articulated notion that TE orientation biases 
result from selection against TE termination of gene transcription.  We also show that TE 
termination of gene transcription is highly cell-type specific and thus may contribute to 
the specialization of cellular function through differential gene regulation. 
Methods 
Characterization of transcription termination sites (TTS) 
Mappings of ENCODE PET data from the GM12878, H1HESC , HepG2, 
HeLaS3, HUVEC, K562, NHEK and prostate cell types were downloaded from the 
ENCODE repository on the UCSC genome browser for the hg18 version of the human 
genome [28, 80].  PET data from nucleus (GM12878, HepG2, HeLaS3, HUVEC, K562 
and NHEK) or whole-cell (H1HESC and prostate) were us d to characterize TTS.  PET 
3’-ends from the same data set that overlapped or were separated by 20 or fewer bases 
were taken as putative TTS clusters.  Only those TTS clusters that had a normalized PET 
tag count of at least 20 per ten million tags mapped in at least one cell type were 
considered for further analysis.  For these clusters, the specific locations of the TTS for 




TTS clusters across different cell types that overlapped by at least 80% were taken to be 
the same TTS.   
UCSC gene model annotations [174] were used to associate TTS defined in this 
way with known human genes.  A TTS was considered to be associated with a gene if the 
linked 5’ ends of the PET tags were mapped to the annotated promoter of the gene and 
the linked 3’ end TTS cluster was found within the annotated transcriptional united or up 
to 5kb downstream of the canonical annotated TTS.  Human gene TTS characterized in 
this way were then co-located with TE sequences using the RepeatMasker annotations 
[60].  As it has been previously shown that transcription termination occurs within 50bp 
of the polyadenylation signal [175], TE-TTS were defin d as those TTS clusters for 
which the peak base was at least 50bp downstream fro  the start of a TE insertion and 
less than 15bp downstream of the end of the insertion.   
Histone modification enrichment analysis 
The chromatin environment of PET-characterized TTS was characterized using 
ENCODE ChIP-seq data [156].  Where available for the same cell types as the PET data, 
ChIP-seq reads for the H3K9Ac, H3K27Me3 and H3K36Me3 modifications were 
downloaded from the ENCODE repository on the UCSC genome browser [28, 29] were 
mapped to the human genome reference sequence (UCSC hg18; NCBI build 36.1) using 
the Bowtie short read alignment utility [110].  Tags which mapped to multiple locations 
were resolved using the GibbsAM utility [134].  The average numbers of ChIP-seq tags 
were found in 5 base-pair windows +/- 5kb of (1) TE-derived TTS (2) intragenic TE 





Utilization of PET-characterized TTS 
TTS for which the region including the TTS had a normalized PET tag count of at 
least 20 were designated transcribed.  From each cell typ , those regions which were in 
the top 75% most transcribed, as calculated using PET tag counts, in that cell type were 
designated as actively transcribed.  For both TE-TTS and non TE-TTS, the utilization of 
actively transcribed TTS in a cell type was determined by first determining the number of 
PET tags which begin upstream of the TTS, and which terminate in the TTS or 








Cell type-specificity of TE-derived TTS 
A TTS was considered for differential utilization if the TTS (1) had a strength of 
utilization of at least 20% in at least one cell type and the region was (2) actively 
transcribed (as described above) in at least 3 cell types.  The cell type specificity of a 
given TE-TTS was calculated using the following formula:    
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Estimation of the total number of TE-TTS and genes with TE-TTS 
To estimate the upper bound for the number of TE-derived TTS in the human 
genome, we found, for all possible combinations of the eight cell types used here, the 
number of TE-derived TTS found with each combination.  A logarithmic trend line was 




numbers of cell types.  The same analysis was applied for the total number of human 




Results and Discussion 
Characterization of transposable element-derived termination sites 
We characterized TE sequences that provide transcription termination sites (TE-
TTS) to human genes using Paired-end diTag (PET) data.  PET is a technique for the 
high-throughput characterization of the 5’ and 3’ ends of mature full-length mRNAs [80], 
which allows for deep annotation of paired transcription start (TSS) and termination sites 
(TTS) including the discovery of many novel alternative sites.  TE-TTS were 
characterized by co-locating TE sequences with 3’ PET tag clusters that are paired with 
5’ PET tag clusters mapped to known human gene promoters (see Methods, Table C.1).  
Using PET data from eight different ENCODE cell types (GM12878, H1HESC, HeLaS3, 
HepG2, HUVEC, K562, NHEK and Prostate) [28, 29 ], we discovered 9,287 distinct TE-
TTS that terminate the transcription of human genes.  PET data from these cells revealed 
a total of 89,345 non TE-derived TTS, including canonical previously annotated TTS.  
Overall, 9.4% of human gene TTS are provided by TE-derived sequences, and 28% of 
human gene loci have at least one TE-TTS.   
The breakdown of TSS contributed by different TE families and the locations of 
these TE-TTS within human gene loci are shown in Table 7.1.  While many TE-TTS 
correspond to the 3’UTRs and canonical TTS of human genes (21%), the majority of TE-
TTS represents alternative TTS found within gene boundaries (70%) and yield creating 
truncated transcripts.  A small minority of these alt rnate TE-TTS (8%) is found within 
upstream of coding sequences, representing messages that are severely truncated or 
aborted albeit in a site-specific and reproducible manner.  TE-sequences also provide 
TTS downstream of the canonical TTS of human genes (8%) providing longer alternative 




compared to 81% for non TE-TTS, indicating that TE sequences are utilized as 
alternative terminators at a slightly higher frequency than non TE-sequences.   
 
 
Table 7.1.  Locations of human gene transcription termination sites (TTS) 




Non TE All TE Alu ERV hAT L1 L2 MaLR MIR TcMar 
5'UTR 3,677 704 351 52 34 114 57 17 55 22 
Internal 46,716 5,404 2,975 162 334 844 377 110 381 159 
3'UTR 15,491 733 267 25 69 120 62 29 102 44 
Canonicalc 16,031 1,152 293 109 102 231 124 67 151 59 
Downstreamd 2,806 673 224 70 51 142 49 45 54 33 
Sum 84,721 8,666 4,110 418 590 1,451 669 268 743 317 
a The locations of TTS characterized using PET data from eight ENCODE cell types 
were characterized relative to known human gene models 
b TTS genic locations are shown for non TE-TTS and for the top eight TTS contributing 
TE families.  
c TTS located within 250bp of canonical TTS 
d TTS located up to 5kb downstream of previously canonical TTS   
 
 
Several examples of human genes with TE-TTS are show in Figure 7.1.  
Transcription initiated from the GALNT2 promoter can terminate within an ERVL 
insertion in the first intron of the locus or in two canonical TTS in the 3’ UTR (Figure 
7.1a).  TE-derived termination of GALNT2 occurs in a cell type-specific manor; most 
GALNT2 transcripts (78%) utilize the ERVL-derived TTS in the GM12878 cell type, 
whereas virtually all GALNT2 transcripts read through the ERVL insertion in the NHEK 




utilization of the ERVL-derived TTS is severely truncated and therefore highly unlikely 
to produce a functional protein.  Thus, while this gene is transcribed at high levels in both 
cell types, the ERVL-derived terminator serves to effectively reduce GALNT2 
expression in GM12878 compared to NHEK.  Similarly, EPHX2 transcription can 
terminate within an AluJb insertion in the sixth intron, resulting in a truncated transcript 
(Figure 7.1b).  This termination is also cell type-specific, with the majority of transcripts 
(66%) utilizing the AluJb-derived TTS in the K562 cell type and a minority (24%) 






Figure 7.1.  TE insertions terminate transcription in a cell type-specific manor.  
Clusters of linked paired-end ditag (PET) sequences that indicate the locations of the 5’ 
(green) and 3’ (red) ends of full-length transcripts expressed in different cell-types are 
shown above gene models indicating the locations of ex ns, introns and TEs that 
terminate transcription.  For each example, the cell-type specific fractions of TTS usage 
for TE-TTS and non TE-TTS are shown.  (a) An ERVL insertion within the first intron of 
the GALNT2 gene terminates the majority of transcripts n the GM12878 cell type, with 
a small number terminating in the two canonical TTS.  No transcripts terminate within 
the ERVL in the NHEK cell type.  (b) An AluJb insertion within the seventh intron of the 
EPHX2 gene terminates the majority of transcripts in the K562 cell type, while the 
majority of transcripts read through this sequence i  the GM12878 cell type.  (c) 
Termination of transcription within a FLAM_C insertion in the 3’UTR of the BSDC1 
gene results in a shortened 3’UTR.  The FLAM_C-derived TTS is utilized extensively in 
the K562 cell type while the majority of transcripts read through this sequence in the 





Though many alternative TE-derived TTS occur within an intron of a coding 
locus as seen for GALNT2 and EPHX2, a substantial fraction (8.5%) occurs within a 
3’UTR.  For example, a TTS derived from a FLAM_C TEsequence in the BSDC1 gene 
is found at an alternative upstream position in the 3’ UTR (Figure 7.1c).  The canonical 
BSDC1 TTS is found several kb downstream of the TE-T S and results in an unusually 
long (3.2 kb) 3’UTR.  Transcripts with these kinds of long 3’UTRs are more likely to be 
degraded via nonsense-mediated decay [176, 177], and the annotated 3’UTR of BSDC1 
also contains 10 miRNA binding sites which could be us d to degrade the mRNA or 
reduce its translation.  Thus, utilization of the FLAM_C-derived TTS, which would 
generate a transcript with a full-length ORF but a dr stically shortened 3’UTR (~300 bp) 
lacking miRNA binding sites, could effectively increase expression of BSDC1 by 
evading post-transcriptional degradation via nonsense-mediated decay and/or miRNA 
binding.  As is the case for the GALNT2 and EPHX2 genes, the utilization of this TE-
TTS is cell type-specific, with the majority of transcripts in K562 utilizing the FLAM_C 
derived TTS and the majority reading through the TE-TTS in NHEK cells (Figure 7.1c).  
The contribution of TE sequences to alternative transcription termination is further 
explored later in the manuscript. 
In an effort to further characterize the TE-TTS discovered here, we used 
ENCODE ChIP-seq data for the locations of histone modifications [28, 29, 150] to 
evaluate their local chromatin environment.  We found that the histone modification 
signatures of TE-TTS are generally similar to those f non TE-TTS and distinct from 
intragenic TE insertions that do not provide a TTS.  Different histone modifications 




of TTS histone modification signatures for an active transcriptional mark (H3K9Ac), a 
mark of transcriptional elongation and gene boundaries (H3K36Me) and a repressive 
mark (H3K27Me3) in the K562 cell type.  H3K9Ac shows a marked peak of enrichment 
upstream of both TE-TTS and non TE-TTS and then the lev ls fall off precipitously after 
the TSS (Figure 7.2a-c).  H3K27Me3 shows a slight increase downstream of the TTS for 
non TE-TTS, however the enrichment level was generally very low (~.1 tags per million 
mapped).  This downstream increase in H3K27Me3 was not een for the TE-TTS (Figure 
7.2d-f), though this could be due to the comparatively low number of TE-TTS compared 
to non TE-TTS together with the relatively low number of H3K27Me3 marks seen within 
actively transcribed genes.  The H3K36Me3 modification shows a more symmetrical 
distribution around TTS with peaks for both TE-TTS and non TE-TTS compared to 
intragenic TEs that do not show TSS related peaks (Figure 7.2g-i).  Qualitatively similar 
results were seen in the GM12878 and NHEK cell types (Figures C.1-C.2).  Overall, the 
similar local chromatin environments seen for TE-TTS and non TE-TTS suggest that the 




Figure 7.2. The chromatin environment of TE-TTS is similar to that of non-TE-TTS 
and distinct from intragenic TE sequences that do not terminate transcription.  The 
locations of TTS and the ChIP-seq tag counts corresponding to H3K9Ac (a-c), 
H3K27Me3 (d-f) and H3K36Me3 (g-i) are shown for the K562 cell type.  Enrichment 
curves, showing the average normalized numbers of ChIP-seq tags in 10 base-pair 
windows +/-5kb of TE-TTS (orange), non TE-TTS (gray) nd intragenic TE sequences 
that do not show a TTS (red), are shown for three TE families, Alu (a,d,g), ERV (b,e,h) 
and L1 (,c,f,i).  




TE transcriptional termination and insertion orient ation bias 
The vast majority of TE sequences within human genes ar  found in the antisense 
orientation relative to the direction of transcription of the gene [171].  The genic 
orientation bias of human TEs is thought to reflect differential selective elimination of 
sense TE insertions over time rather than a preferenc  in the introduction of antisense 
insertions at the moment of transposition.  The ability of TEs to cause premature 
termination of gene transcripts, thereby reducing levels of transcription, has been 
proposed as a mechanism to explain the selective elmination of sense oriented L1 
sequences from human gene loci [14].  In order to investigate the role of TE-TTS in the 
selection against sense oriented TE insertions genom -wide, we compared the insertion 
orientations of intragenic TEs that do not provide TTS versus the orientations of TE-TTS 
for the eight largest families of human TEs (Alu, ERV, hAT, L1, L2, MaLR, MIR, and 
TcMar).   
 Seven out of eight TE families show the expected antisense orientation bias for 
intragenic TE insertions for which there is no evidnce of TTS activity (Figure 7.3).  In 
other words, since these antisense TE insertions do not terminate transcription, their 
presence within human genes is tolerated by selection.  The LTR element families, the 
ERVs and MaLRs, show the strongest antisense orientat o  bias with intragenic 
insertions being found in the antisense orientation twice as often as the sense orientation.  
Conversely, Alu insertions show a much weaker antise se orientation bias.  The 
relatively stronger bias seen for LTR element insertions suggests the possibility that there 









Figure 7.3.  TE sequences providing transcription termination sites show a strong 
sense bias.  For each TE family, the sense/anti-sense ratio was determined for all 
intragenic insertion (red) and only for those TEs that provide a TE-TTS (blue).  For each 
TE family, statistical significance levels for the differences in the sense/anti-sense rations 




 For those genic TE sequences that provide a TTS, the majority of TE families 
show a significant enrichment of insertions in the sense orientation versus the other 
insertions.  Alus have one of the weaker antisense orientation biases for genic elements, 
but Alu-derived TTS show far and away the strongest s nse bias; an Alu insertion 
providing a TTS is approximately 20x more likely to be in the sense orientation than the 
antisense orientation.  While LTR element genic insertions show the strongest overall 
antisense bias, insertions providing a TTS are also much more likely to be in the sense 




orientation than the average genic LTR element insertion.  The strong sense orientation 
enrichment seen for TE-TTS indicates that genic TEsoriented in the same direction as 
transcription are much more effective transcription erminators, consistent with the notion 
that sense oriented TE insertions are selected against owing to their disruptive effects on 
gene expression.  
The only exception to this pattern is seen for the relatively ancient family of MIR 
TEs.  MIRs have previously been implicated as providing gene regulatory sequences in a 
number of studies, and the MIR sequences that remain int ct and recognizable in the 
human genome are likely to have been conserved by purifying selection [162].  Thus, the 
lack of orientation bias for MIRs, irrespective of their status as TTS, may reflect their 
general utility as gene regulators, rather than an ephemeral presence as neutral sequences 
that will be eventually lost by mutational decay. 
Contributions of Alus to transcriptional terminatio n 
Given the diversity of TE insertions found in-and-around human genes, we sought 
to characterize the relative TE-TTS contributions of the eight largest families of human 
TEs (Alu, ERV, hAT, L1, L2, MaLR, MIR, and TcMar).  To do this, we compared the 
observed numbers of TE-TTS for the different families to the expected numbers based on 
their genic frequencies (Figure 7.4).  While L1s contribute the most TE sequence 
genome-wide, Alus are the most abundant genic TE family (31% of all genic TE 
insertions) (RepeatMasker).  Thus, Alu insertions would be expected to provide a large 
number of TE-derived TTS.  However, previous studies have characterized ~400 Alu 
insertions providing TTS, a substantially smaller than expected fraction [172, 173].  In 




from other TE families, providing 43% percent (4,551) of all TE-TTS, far more than 
would be expected based on the frequency of Alu genic insertions.  Other TE families 
generally contributed fewer TTS than expected based on their genic frequencies, with 
MIR-derived TTS being far less common than expected; ERV was the only other TE 
family to provide significantly more TTS than expected.  
 
  
Figure 7.4.  Alu family sequences provide a greater than expected number of TTS.  
Expected (red) versus observed (blue) counts of TTS derived from different TE families.  
Expected counts of TTS derived from each TE family were calculated based on the 
fraction of intragenic sequences.  For each TE family, statistical significance levels for 
the differences between the expected versus observed counts (* indicates P<10-5) were 
determined using a Chi-squared distribution with df=1. 
 
 
The over-abundance of Alu-TTS could be attributed to their functional utility as 
expression regulators, or it could simply reflect the fact that Alu-TTS are not as 
disruptive and therefore more tolerated by selection.  Consistent with the latter neutral 
scenario, the over-abundance of Alu-TTS may reflect their relatively young age, 




evaluate these possibilities, we evaluated the TTS contributions of Alu subfamilies of 
different ages (FLAM, AluJ, AluS and AluY).  Relatively older Alu subfamilies (FLAM 
& AluJ) contribute more TTS than expected, whereas the younger subfamilies (AluS & 
AluY) contribute fewer than expected (Figure 7.5a).  For instance, even though FLAM 
elements are found in less than half the genic frequency of AluY insertions, they 
contribute more TTS to human genes.  These observations argue against the neutral 
explanation for the abundance of Alu-TTS.  To explore this further, we evaluated the 
strength of utilization for TTS derived from the different Alu subfamilies.  The strength 
of utilization for any TTS is measured as the relative frequency with which it terminates 
transcription versus the frequency that it is read through (see Methods).  Consistent with 
what is seen for the relative levels of TTS donation by the different Alu subfamilies, 
older families show higher levels of TTS utilization than do younger families (Figure 
7.5b), suggesting the possibility that many of these Alu-TTS are preserved via selection 







































































































































































































































































































































































































































































































































































 In light of the exceptional ability of Alus to provide TTS to human genes, we 
explored the specific sequence context by which these elements terminate transcription.  
To do this, we mapped the locations of Alu-derived TTS to their positions in the Alu 
subfamily consensus sequences [60].  Previously, when a few hundred Alu-TTS were 
considered as an ensemble, they were found to terminate human gene transcription non-
randomly at two specific locations along their sequence [172, 173].  For this study, by 
considering thousands of Alu-TTS among individual Alu subfamilies of different relative 
ages, we were able to tease apart this apparently bimodal pattern of termination and 
discern its origins.  The modern Alu element is a dimeric sequence composed of two 
related precursor sequences: a Free Left Alu Monomer (FLAM) and Free Right Alu 
Monomer (FRAM) [9, 10].  These sequences themselves descended from the Fossil Alu 
Monomer (FAM), which in turn descended from a 7SL RNA [10].  Elements from all 
three families of Alu precursors terminate transcription at single site near their 3’-end 
(Figure 7.5c).  However, when the FLAM and FRAM monomers are considered with 
respect to their homologous locations in the descendent Alu dimer sequences, these 
individual termination sites yield a pair a corresponding termination sites; one internal 
termination site corresponding to the FLAM 3’ site and a 3’ termination site 
corresponding to the FRAM 3’site.  In modern Alus, the 3’ termination site predominates 
over the internal site and the use of the internal site markedly decreases among younger 
element sequences (Figure 7.5c).  The attenuation in the strength of this TTS donating 
site from the internal region of the element may reflect the need of the elements 
themselves to produce full-length transcripts in order to be transposed.  In this case, 




at the level of the host.  Thus, the steady migration over time of the Alu-TTS donating 
site to the 3’ end of the element reflects a complex dynamic between inter-element 
selection and the effects that the elements can in turn exert on their host genome. 
Relative levels of utilization for TE-derived TTS 
The eight human TE families evaluated here have divrse evolutionary origins, 
methods of transposition and sequence composition.  Given these differences, it would be 
reasonable to expect that TTS derived from the different TE families would behave 
differently.  To assess whether this is the case, we compared the strength of utilization 
(see Methods) for TTS derived from members of the diff rent TE families along with the 
utilization levels seen for non TE-TTS.  Individual TTS derived from Alu insertions, 
while being by far the most abundant TE-derived TTS in the genome (Table 7.1 and 
Figure 7.4) are utilized far less frequently than TE- TS derived from other families or 
non TE-TTS (Figure 7.6).  This finding is in accordance with the weak transcription 
termination previously seen for Alus [178].  On theopposite extreme, TTS derived from 
sense LTR element insertions, including both the ERV and MaLR families, are utilized 
significantly more frequently than TTS from any other TE family or alternative non TE-
TTS.  Indeed, 25% of TTS derived from LTR element insertions have a maximum 
utilization of over 90% in at least one of the ENCODE cell types.  The only group of TTS 
which shows higher maximum utilization is the group of previously annotated canonical 
non TE-TTS.  The large differences in the relative str ngths of Alu and LTR element-
derived TTS may explain the differences seen for in the orientation biases between these 
families (Figure 3).  The idea being that Alu insertions provide weaker TTS, and thus 




strong TTS and thus sense oriented LTRs are strongly selected against.  Overall, the Alu, 
ERV and MaLR TE families all exert substantial effects on the expression of human 
genes via the termination of transcription, but they do so using distinct genome-wide 
metastrategies.  The Alu family, by providing many relatively weak TTS, can affect a 
large number of genes albeit in a subtle way on a gene-by-gene basis, whereas LTR 





Figure 7.6.  LTR-TTS are more strongly utilized than TE-TTS provided by other 
families.  Distributions of maximum utilization values (see M thods) are shown for TE-
TTS from different families along with alternative (green) and canonical annotated 
(yellow) TTS.  TE-TTS maximum utilization values are shown separately for sense (red) 
and antisense (blue) insertions.  Statistical significance levels for the differences between 
the maximum utilization insertion orientations for each TE family (* indicates P<.005) 




The L1 family is curious, being the only TE family to show a strong antisense 
bias for those insertions providing a TTS (Figure 7.3), yet at the same time showing no 
difference in TTS strength of utilization between sen e and antisense insertions (Figure 
7.6).  Han et al. showed that L1 insertions are capable of terminating transcription in 
either the sense or antisense orientation, with several polyadenylation signals occurring in 
the antisense orientation [14].  The same study also showed that sense L1 insertions can 
cause transcriptional disruption when in the sense orientation, independent of 
polyadenylation.  As the PET technique requires that transcripts be polyadenylated, the 
data used here cannot take into account non-polyaden lat d transcriptional disruption by 




orientation bias and strength of utilization may reflect the relative usage of 
polyadenylation in L1-TTS from the different strands. 
In light the results on the orientation bias of TE-TS (Figure 7.3), we also 
compared the strength of utilization for TE-TTS found in sense versus antisense 
orientations relative to the direction of transcription.  Five out of eight of the TE families 
(Alu, ERV, L2, MaLR and MIR) showed a significant difference (P< 0.01, Wilcoxon 
rank-sum test) in TTS strength of utilization depending on the orientation of the insertion.  
In all five of these families, TTS derived from sen insertions are more likely to be 
utilized than those derived from antisense insertions (Figure 7.6).  These results are 
consistent with the findings from the overall TE orientation bias in human genes 
suggesting that selection acts to remove TE-derived terminators that disrupt gene 
expression. 
Cell type-specific regulatory potential of TE-TTS 
Several features of TE-TTS already described in this report raise the possibility 
that TE-TTS can provide for cell type-specific regulation of gene expression.  For 
example, the individual cases seen in Figure 7.1 clearly demonstrate cell type-specific 
termination of transcription by TEs.  TEs also provide relatively more alternative TTS 
than non TE-TTS.  Finally, individual TE-TTS are utilized less frequently than canonical 
known TTS from annotated gene models.  In order to further investigate the potential 
genome-wide role of TE-TTS in the cell type-specific termination of transcription, we 
calculated cell type-specificity levels of all TTS found in genes that are actively 
transcribed in at least three cell types.  The cell type-specificity metric we use measures 




Methods).  TE-TTS show far greater levels of cell type-specificity in the termination of 
transcription than seen for canonical TTS (Figure 7.7a).  In addition, TE-TTS differ in 
their cell type-specific utilization based on their locations within human genes.  Internal 
TE-TTS, which yield transcripts with truncated ORFs, show significantly more cell type-
specific utilization than TE-TTS located in 3’ UTRs or downstream of canonical TTS.  
The relatively highly cell type-specific utilization of internal TE-TTS suggests that they 
provide a mechanism for dynamic post-transcriptional regulation of human genes via the 
production of truncated transcripts.  TE-TTS within 3’UTRs and downstream of 
canonical TTS are also generally more cell type-specific than canonical TTS, though to a 
lesser extent, and these TTS may be functional in producing longer or shorter 3’UTRs.  
As discussed previously, variation in 3’ UTR length provides for yet another level of 





Figure 7.7 TE-TTS terminate transcription in a cell type-specific manor.  (a) Cell 
type-specificity value distributions are shown separately for TE-TTS (red) located within 
introns, 3’ UTRs and downstream of annotated TTS.  Cell-type specificity values are also 
shown for canonical annotated TTS (yellow).  (b) Raref ction curves showing the 
average numbers (+/- sad) of TE-TTS (dark blue) and genes with at least one TE-TSS 
(light blue) detected when all possible combinations f 1-8 cell types are used.  Observed 





The apparent cell type-specificity of many TE-TTS suggests the possibility that 
the TE-TTS discovered in this study via the analysis of eight ENCODE cell types 
represent only a fraction of the total complement of TE-TTS that exist in the human 
genome.  To address this possibility, we computed a rarefaction curve for TE-TTS by 
calculating the number of unique TE-TTS found using all possible combinations of 1-8 of 
the cell types analyzed here (Figure 7.7b).  We then fit this rarefaction curve with a 
logarithmic trend line (y=31.34lnx+33.61; r=0.99) to evaluate the extent to which the 
percent of detected TE-TTS is expected to change with increasing numbers of cell types.  
Based on the observed trend, we estimated that doubling the number of cell types 
included in a study of this kind would result in only a 20% increase in the number of TE-
TTS found, suggesting a substantially diminishing rate of returns, with respect with 
respect to the discovery of novel TE-TTS, as more cell types are added.  Similarly, the 
number of genes found to contain a TE-TTS leveled off as more cell types were included.  
Nevertheless, taking 210 as the total number of human cell types indicates that the TE-
TTS discovered here represent half of the total number of human gene TE-TTS.  Thus, 
TEs may provide close to 20,000 TE-TTS for ~11,000 human genes. 
Conclusions 
Transcription termination as the origin of TE antisense orientation bias 
It has been appreciated for some time that TE sequences within the introns of 
human genes show a strong antisense orientation bias [167].  It was proposed that this 
bias is due to the propensity of the TE sequences to terminate transcription of host genes 
when inserted in the sense orientation, resulting in selection against such sense oriented 




transcription have not revealed evidence in support of this hypothesis [172, 173].  Here, 
for the first time, we provide genome-scale evidence i  support of the notion that the 
antisense orientation bias of TEs can be attributed to their ability to preferentially 
terminate host gene transcription when inserted in the sense orientation.  We have shown 
that TE sequences which provide a TTS are significatly more likely to be found in the 
sense orientation than other intragenic TE sequences (Figure 7.3), and that TE-TTS in the 
sense orientation terminate transcription much more efficiently than those found in the 
antisense orientation (Figure 7.6).   
Among the eight TE families studied here, the Alu, ERV and MaLR families are 
distinct from the other 5 families.  TTS from derived from Alu sequences are generally 
weakly utilized compared to other TE families, while at the same time having a weak 
antisense orientation bias.  The weaker orientation b as of Alu sequences suggests that 
there is weaker selection against Alu sequences insrted in sense.  We suggest that this 
weaker selection is due to the generally weak utiliza ion of Alu-TTS.   Conversely, LTR 
elements, the ERV and MaLR families, show a very strong antisense bias and a strong 
utilization; such strong utilization may account for the strong antisense orientation of 
LTR elements. 
Cell type and lineage-specific termination of transcription by TEs 
Evidence reported here points to the contribution of TE sequences to the cell type-
specific termination of transcription; we have shown that internal TTS derived from TE 
sequences are significantly more cell type-specific ompared to canonical TTS (Figure 
7a).  In this way, TE sequences have contributed substantially to the generation of cell-




transcription.  In addition to providing for cell type-specific termination of transcription, 
data reported here indicate that TE sequences are also likely to have contributed 
substantially to evolutionary lineage-specific transcription termination.  Numerous TE 
insertions can be generated in a short evolutionary time, and accordingly the majority of 
human TE subfamilies are lineage-specific specific [101].  This means that the regulatory 
effects that these TEs exert on their host genomes, including termination of transcription 
as shown here, will also be lineage-specific and account for regulatory differences 
between evolutionary lineages.   
The Alu family, for example, is a relatively young family of TEs, which is 
confined to the primate evolutionary lineage.  The Alu family has been active throughout 
primate evolution [1], and has likely been altering primate gene expression via TTS 
donation since the origin of the primate lineage, as c n be seen from the results on the 
more ancient Alu antecedents from the FAM-related subfamilies (Figure 7.5).  This 
process appears to have accelerated, leading to even more species-specific differences in 
transcription termination, with the amplification of the more modern Alu dimers (Figure 
5). 
Transcription termination via TE sequences as a comon phenomenon 
The abundance of TE insertions across eukaryotic lineages suggests that the effect 
of TE insertions on gene expression via the terminatio  of transcription is not limited to 
humans [7].  In this study, we characterized the involvement of eight evolutionary diverse 
families of TEs in the termination of transcription.  TEs related to these eight families are 
present in present in the genomes of many other eukaryotes.  For instance, while LTR 




highly active in and other species, .g. the Intracisternal A particle (IAP) family of 
mouse.  Indeed, it has been estimated that 10% of mutations in mouse are caused by the 
novel retrotransposition of an LTR element.  As a consequence of this, mice presumably 
have to contend with a great deal of deleterious transcription termination via novel LTR 
element insertions.  However, these novel insertions also provide the opportunity for 












Studies here to date 
Through this dissertation, six studies regarding the effect of non-coding sequences, most 
notably sequences derived from TE insertions, are shown.  These studies revealed novel 
sources of transcription variation in the human genome derived from non-coding 
sequences.  The initial two studies deal with transcription initiation by human TE 
sequences; the first (Chapter 2) characterized thousands of novel cis-NAT promoters 
derived from TE sequences and associated with human genes, while the second (Chapter 
3) characterized endogenous retroviral sequences which function as promoters for human 
genes.  In the third study (Chapter 4), techniques for characterizing transcription factor 
binding sites derived from TE sequences using data generated from the massively high-
throughput ChIP-seq technique were reviewed.  Such techniques allow for the 
characterization of lineage-specific transcription factor binding sites derived from TE 
sequences.  The fourth study (Chapter 5) characterized the chromatin environment of cis-
NAT promoters associated with human genes, and shows that the cis-NAT promoters 
bear activating histone modifications in accordance with their activity.  Further it is 
shown that high cis-NAT and gene promoter expression co-occurs far more often than 
expected, suggesting some form of co-regulation.  Also examining the local chromatin 
environment of non-coding sequences, the fifth study (Chapter 6) reviewed ways in 
which the epigenetic modification of TE sequences have been shown to effect the 




on the promoter activity of non-coding sequences, the sixth study (Chapter 7) 
characterized the cell-type specific termination of human gene transcription by TE 
sequences. 
In order to replicate and spread within the host genome, TEs must first be 
transcribed into mRNA.  This means that they need th ir own promoters and TFBS, i.e. 
the internal promoter of the L1 family [13].  It would not be surprising then, given the 
number of TE sequences in the human genome, if some were TE sequences were able to 
promote transcription of not just their own sequence, but of neighboring host sequences 
as well.  In the first two studies shown here (Chapter 2, Chapter 3), we have characterized 
such phenomena. Antisense transcription in the human genome has been appreciated for 
some time, though the role of these antisense transc ipt , remains largely unknown [33, 
34, 42].  In Chapter 2 we showed that a substantial fraction of human antisense 
transcription is initiated from TE-derived promoters.  Indeed, we showed that the large 
majority of human genes have some level of antisense transcription initiated by a TE 
sequence.  In the second study, instances where members of the ERV family provided 
promoters to human protein coding gene were characterized; over 100 cases where an 
ERV sequence could be shown to transcribe a human gene were identified.  In both of 
these studies, the vast majority of the sequences involved can no longer transpose, but 
they have nevertheless altered the human transcriptome via their promoter activity.   
 The ChIP-seq technique has revolutionized the understanding of DNA-protein 
interactions, allowing for the genome-wide characterization of transcription factor 
binding and histone modifications [27].  Where traditional Sanger sequencing produced 




much shorter, due to (1) the technology used and (2) the need for resolution in measuring 
the DNA-protein interaction.  However, a shorter sequence greatly increases the number 
of locations in a genome to which the sequence could map.  Thus, given the highly 
repetitive nature of the human genome, DNA-protein interactions involving repeated 
sequences are more difficult to characterize.  However, such characterization is important 
given that TE sequences can spread TFBS through the genome [2, 24, 100].  The methods 
presented in Chapter 4 allow for the characterization of TFBS derived from TE 
sequences.  Such TFBS could alter the transcriptome of the host in a lineage-specific 
manor.  Similar techniques using data from different cell types could also be used to 
identify DNA-protein interactions involving TE sequences that appear in a cell type-
specific or condition-specific manor. 
In chapter 5 the chromatin environment of cis-NAT promoters as it relates the cis-
NAT promoter activity was investigated.  The study presented in Chapter 2 and other 
previous studies have identified many cis-NATs for human genes [34, 42], however the 
regulation of cis-NAT expression remained largely unexplored.  Chapter 5 showed that 
cis-NAT promoters in the human genome bear chromatin modifications similar to those 
seen on the promoters of human protein coding genes, a d that cis-NAT promoter 
activity is correlated with the level of activating histone modifications, e.g. H3K9Ac.  
The presence of activating epigenetic marks on these cis-NAT promoters strongly 
suggests that the activity of these cis-NAT promoters is regulated, and such regulation is 
indicative of function.  Indeed it was shown in Chapter 5 that there is an association 
between highly expressed genes and highly expressed ci -NATs, suggesting that the two 




transcriptome first through the transcription of cis-NATs, but also possibly through 
activation of the associated gene. 
The transposition of TE sequences within the host organism will likely be neutral 
at best and very possibly deleterious.  It would not be surprising then if host genomes 
employ mechanisms for reducing transposition.  One such mechanism is the deposition of 
repressive chromatin modifications onto the TE sequences, preventing transcription of 
the TE and therefore also preventing transposition.  While preventing transposition would 
be a benefit to the host, the silencing of the TE sequence could conceivably also effect 
the expression of nearby genes via the generation of heterochromatin.  In Chapter 6, we 
reviewed studies which have shown that the deposition of silencing epigenetic 
modifications on ERV sequences does in fact have such an effect.  Additionally, we 
reviewed instances of epigenetic activation of ERV insertions which lead to the activation 
of nearby genes. 
While the mechanisms of transcription termination and polyadenylation in 
eukaryotes have been known for some time, the use of c ll type-specific transcription 
termination as a possible layer of gene regulation has not been appreciated for nearly as 
long.  Two recent studies have shown that alternative TTS are utilized in induced 
pluripotent stem cells and cancer cells, resulting in the generation of transcripts with 
intact ORFs, but truncated 3’UTRs [39].  Conversely, it was shown that mouse cells 
undergoing differentiation utilized alternative TTS which resulted in longer 3’UTRs [41].  
Such differential 3’UTR generation could affect thecellular lifespan of the mRNA via 
the loss or gain of miRNA binding sites and nonsense mediated decay, and thus function 




knowledge of alternative termination of transcription in humans by characterizing 
alternative and cell type specific TTS derived from TE sequences. While many of these 
TE-TTS resulted in alternative 3’UTRs, many more were located within introns of human 
genes, resulting in transcripts missing part of the ORF.  These TE-TTS were highly cell 
type-specific, suggesting that producing truncated transcripts may serve as a common 
method of gene regulation.  Interestingly, it was recently shown that such internal 
termination sites could lead to production of truncated messages which when translated 
lacked C-terminal domains.  These truncated proteins have been suggested to act as 
molecular decoys, reducing the availability of ligands for full-length proteins [180].  The 
work shown here demonstrates that TE sequences have dr matically altered human 
transcription via the alternative termination of transcription in a cell type-specific manor. 
Future prospects of genome-wide bioinformatics studies 
The bioinformatics studies presented here yielded interesting results, but the level at 
which they studied the function human genome was quite high, i.e. from a bird’s eye 
view; many potentially interesting non-coding elements, which have many potential 
effects on human gene transcription, were shown, but the biological effects uncovered 
computationally were not experimentally demonstrated.  The field of bioinformatics 
should be, at this point, mature enough to move beyond such high-level studies and probe 
more deeply for specific biological effects and biological meaning.  For example, the 
FLAM_C-derived TTS in the BSDC1 3’UTR (Figure 7.1) is very intriguing and has 
significant potential to affect the cell type-specific regulation of BSDC1 protein 
production via 3’UTR shortening and miRNA binding site loss.  Further, such effects 




resulting regulation would occur only in primates.  This raises the possibility that this 
insertion has helped to shape primate-specific gene expression.  However, there exists at 
this point no evidence that 3’UTR shortening at the BSDC1 locus has any such effect on 
the amount of BSDC1 protein produced.  A relatively simple set of experiments could be 
conducted in order to quantify the affect that the BSDC1 3’UTR has on protein levels, 
similar to what was done by Jenal et al. [181]; though the study by Jenal et al. had very 
different goals, a similar set of constructs would be useful.  
Here, I provide an example of the kind of experimental studies that could be used 
to validate the bioinformatic predictions I made in my Ph.D. dissertation research via the 
analysis of using genome-wide data sets.  Several constructs for expressing Renilla 
luciferase with different segments of the BSDC1 3’UTR could characterize the ability of 
the different segments to lower mRNA and protein leve s (Figure 8.1).  The 
polyadenylation signals of the FLAM_C-derived TTS and BSDC1 canonical TTS would 
be mutated and a very strong polyadenylation signal added to the 3’-end of the construct 
(black) to ensure that only a singly mRNA form is produced from the construct.  The 
FUTR (FLAM_C-UTR, red) is the truncated 3’UTR that the BSDC1 transcript would 
contain if the FLAM_C-derived TTS were utilized.  The mUTR (miRNA-UTR, yellow) 
is the portion of the BSDC1 3’-UTR downstream of the FLAM_C-derived TTS 
containing the miRNA binding sites.  Cells would be transfected with these constructs 









Figure 8.1.  Constructs for characterizing the effect of the BSDC1 3’UTR on protein 
levels.  The Renilla luciferase gene (blue) is paired with different combinations of the 
BSDC1 3’UTR:  the 3’UTR generated when the FLAM_C-derived TTS is utilized 
(FUTR, red) and the remainder of the canonical 3’UTR containing miRNA binding sites 




Such experiments would be carried out in two cell types: one in which some or all 
of the miRNAs which have target sites in the BSDC1 3’UTR are expressed, and one in 
which they are not.  One or more of the miRNAs would be artificially expressed in the 
cell type lacking miRNA expression in order to demonstrate that the effects of 3’UTR 
shortening on protein levels are a result of miRNA binding.  Alternatively, a highly 
expressed miRNA sponge, in this case the mUTR, could be introduced into the cell type 
expressing the miRNAs in order to reduce the effectiv  miRNA expression [182, 183].  
Hypothetical Renilla/Firefly luciferase ratios relative to the construct lacking a BSDC1 
3’UTR fragment (PAS, Figure 8.1) are shown in Figure 8.2.  For all three conditions, it 
would be expected that the relative R nilla/Firefly ratio for the FUTR construct, being 
short and lacking any known miRNA binding sites, would be close to 1, i.e. the same as 
the PAS construct.  In the cell type lacking relevant miRNA expression, the levels 




expected to be similar as well, possibly slightly lower due to the unusually long BSDC1 
3’UTR.  However, for a cell type naturally expressing miRNAs targeting the BSDC1 
3’UTR, or for the cell type artificially expressing them, the relative Renilla/Firefly 
luciferase ratio would be expected to be much lower.   The cell type expression the 
mUTR miRNA sponge would be expected to show a higher relative Renilla/Firefly 
luciferase the mUTR containing constructs due to the ‘sponging’ of the relevant 
miRNAs.  A similar analysis via qRT-PCR would need be done to characterize the 
mRNA levels of Renilla and Firefly luciferase produced.  Similar experiments could be 
conducted for other genes in which a 3’UTR TE-TTS results in the loss of miRNA 
binding sites or otherwise dramatically altered 3’UTRs. 
   
 
 
Figure 8.2.  Hypothetical relative Renilla/Firefly luciferase activity levels.  The 
expected relative ratios of Renilla/Firefly luciferase with the Renilla construct containing 






Such additional experimental investigation may become the norm for 
bioinformatics studies of functional genomics; the genome-wide analysis of non-coding 
functional elements, while academically interesting, could be made even more relevant 
vie the experimental elucidation of specific, verifi d, effects.  Returning to the BSDC1 
locus, the differential utilization of the FLAM_C-derived TTS would be of little 
consequence if it had no overall effect on the exprssion or translation of the BSDC1 
gene; it would be in effect a molecular curio.  The ne d to attach experimentally validated 
biological meanings to bioinformatics results will likely increase as the field matures and 
standards for publication rise.  Indeed, it may become, or perhaps already has become, 
the main role of bioinformatics to uncover those prviously unnoticed yet interesting 
functional elements that can later be characterized via classic molecular experimental 







SUPPLEMENTARY INFORMATION FO CHAPTER 3 
 
Supplementary Methods 
Paired end ditags (PETs) 
Gene identification signature (GIS) analysis is a sequencing and mapping strategy 
that allows for the high-throughput demarcation of gene transcription boundaries, i.e. the 
5’ and 3’ gene termini [80].  The GIS analysis procedure that produced the data we 
analyzed started with the isolation of polyA+ RNA from cells lines subject to different 
treatments: 1) the log phase of MCF7 cells, 2) MCF7 cells treated with estrogen (10nM 
beta-estradiol) for 12 hours, 3) HCT116 cells treated with 5FU (5-fluorouracil) for 6 
hours, 4) the log phase of embryonic stem cell hES3 in feeder free culture condition.  
Full-length cDNAs (flcDNA) were generated from RNA and selected using the 
biotynlated CAP trapper method [184].  The CAP trapper method relies on the 
introduction of a biotin group to the cap structure found at the 5’ end of full length 
mRNAs followed by first strand cDNA synthesis.  Biotin residues are selected using 
streptavidin-coated magnetic beads, which results in he retention of only flcDNAs.  
BamHI and MmeI restriction sites are ligated to the 5’ and 3’ termini of the flcDNAs, 
which are then cloned to produce the GIS-flcDNA library.  This library is digested with 
MmeI to yielding 18bp sequence fragments (signatures) f om the 5’ and 3’ ends of 




5’ and 3’ flcDNA signatures are covalently ligated to form 36bp paired-end ditags 
(PETs), each of which represents an individual transcript.  PETs are exised using BamHI 
digestion and then concatenated and cloned for high-t roughput sequencing.  A single 
sequencing read of ~700bp leads, on average, to the characterization of 15 distinct PETs. 
The GIS cloning and sequence analysis resulted in 584,624 PETs for the log 
phase MCF7 cells, 153,179 PETs for the estrogen-treated MCF7 cells, 280,340 PETs for 
the HCT116 cells, and 1,799,970 PETs for the hES3 cells.  These PETs were then 
mapped to the human genome using the following criteria: paired 5’ and 3’ ends must be 
on the same chromosome, they must be in the correct 5’-to-3’ order and orientation, they 
must be within 1 million base pairs, there must be a 16bp contiguous sequence match (out 
of 18bp) for the 5’ end of the PET and a 14bp contiguous match (out of 16bp) for the 3’ 
end of the PET.  Using these criteria, most of the PET sequences (>90%) mapped to 
single locations in the human genome, but PETs mapping to 2-10 locations were also 
included in the analysis. 
The quality and mapping specificity of PETs has been confirmed in a number of 
different ways [80].  For instance, >95% of PETs map to known human gene transcripts 
and the vast majority fell within 10bp of the transcription start and termination sites.  
Most relevant to our study is the fact that the GIS analysis has been shown to be 30 times 
more efficient than standard cDNA methods for characterizing transcript and has resulted 
in the discovery of numerous previously uncharacterized transcripts.  Thus, GIS is 
particularly suited to the discovery of alternative transcripts in the human genome of the 
kind initiated by ERV sequences.   




The CAGE technique was developed for the high-throughp t characterization of 
transcription start sites (TSS) [30].  CAGE uses a similar technology to that described 
above for the generation of PETs in GIS.  The main difference is that CAGE only 
characterizes the 5’ ends, as opposed to both 5’ and 3’ PET ends, of flcDNAs.  CAGE 
also employs the isolation of flcDNAs using biotinylated mRNA caps as described for 
GIS.  Once flcDNAs are isolated, linkers with MmeI r striction sites are ligated to the 5’ 
ends of the flcDNAs, and the first 20 bp of the cDNAs is cleaved with a MmeI restriction 
digest. The resulting 5’ end cDNA fragments (so-called CAGE tags) are amplified, 
concatenated and sequenced.  This procedure allows for the high-throughput 
characterization of the 5’ ends of mRNAs, and mapping of the resulting sequence 
fragments to the genome identifies transcriptional st rt sites (TSS).  CAGE tags are 
mapped to the human genome mandating a contiguous match of 18 out of 20bp.  
Approximately 60% of CAGE tags can be unambiguously mapped to the genome in this 
way.  Only CAGE tags that mapped to one location in the genome were used in our 
study.   
CAGE is a slightly more mature technology than GIS and it has been extensively 
validated [31, 54].  In addition to the ability of CAGE tags to converge on known TSS in 
the human genome, CAGE also identifies thousands of previously unknown TSS.  This is 
consistent with our discovery that numerous ERV-derived TSS correspond to alternative 
transcripts.  
Gene expression analysis 
Human and mouse gene expression data were taken from the Novartis 




Affymetrix microarray experiments conducted in replicate on 79 human and 61 mouse 
tissues.  For each Affymetrix probe, signal intensity values (i.e. expression levels) were 
median and log2 normalized across tissues.  Affymetrix probes were mapped to GenBank 
RefSeq gene accessions using the UCSC Table Browser utility [81].  Human-mouse 
orthologous gene pairs and 28 corresponding tissue pairs were identified as described 
previously [185].  Similarity between human-mouse orth logous gene pair tissue-specific 
expression profiles was measured using the Pearson correlation co-efficient (r) as 
described previously [186].  An adjusted r-value threshold of 0.5789, above which 
human-mouse orthologous gene pairs can be considered to have correlated expression 
patterns across n=28 tissues, was computed using the formula t=r*sqrt((n- 2) /(1–r2)), 
where t follows the Student- distribution with n-2 degrees of freedom.  The r-value 
threshold was based on a P-value of 0.00125 computed using a Bonferroni correction 
with the number of comparisons (40) performed (i.e. P=0.05/40).     
The GNF2 data were also used to compare the values of a number of gene 
expression parameters for human genes that have ERV-TSS that yield chimeric 
transcripts (ERV+) versus all other human genes (ERV-) with Novartis expression data.  
Average values for the following gene expression parameters across the two sets were 
compared: 1) average expression, 2) maximum expression, 3) breadth of expression and 
4) tissue-specificity of expression.  Average, maximum and breadth of expression were 
computed as described previously in [186].  Tissue-p cificity was computed using the τ 
parameter described in [187].  The values of τ range between 0 and 1 with more tissue-
specific genes having higher values.  Human gene tissue-specific expression profiles 




K-means clustering using the program Genesis [188].  The observed counts of ERV+ 
genes in each of these clusters were compared to the expected counts based on the whole 
genome distribution using a chi-square test.  
Human ESTs were mapped to ERV-derived TSS and associ ted genes and the 
tissues (or cell lines) from which they were characterized were determined using the 
Human ESTs track of the UCSC Genome Browser [55].  The distribution of EST tissue 
types across alternative versus primary promoters was compared using a joint chi-square 
test.  Observed EST tissues counts for the alternative versus the primary TSS were 
compared with expected counts based on the pooled tissue counts to compute a chi-
square value for each promoter and the joint chi-square probability for the two promoters 
was computed.  
Gene ontology (GO) analysis 
The set of human genes with ERV-TSS that yield chimeric ERV-gene transcripts 
(ERV+) were evaluated for enrichment of biological process and molecular function GO 
terms using the program using the program GOTree Machine (GOTM) [189].  The 
GOTM program was used to implement a hypergeometric test comparing GO term 
frequencies in the ERV+ human gene set against a background set made up of all human 
genes with corresponding Affymetrix probes.  GOTM produces a list of enriched GO 
terms along with a view of the GO directed acyclic graph (DAG) showing the parent-
child relationships among enriched GO terms.    
ERV age analysis 
ERVs accumulate mutations after inserting into the genome.  Thus, the relative 




divergence levels between ERVs and their consensus sequences [1].  ERV-to-consensus 
divergence levels were taken from the RepeatMasker output.  Average levels of ERV-to-
consensus divergence were compared for all ERVs, ERVs that overlap with ESTs, ERVs 





Table A.1.  List of ERVs that initiate ERV-gene chimerical transcripts along with 
their associated genes.   







LTR41 chr1 17954613 17954613 NM_030812 chr1 17954430 18026143 
MER4A chr10 106004209 106004209 NM_004832 chr10 106004 67 106017199 
LTR12D chr14 23175701 23175701 NM_005794 chr14 23175421 23184686 
LTR12D chr14 23175701 23175701 NM_182908 chr14 23175421 23184686 
MER54B chr16 751307 751307 NM_005823 chr16 751133 758866 
MER54B chr16 751307 751307 NM_013404 chr16 751133 758866 
MER39 chr17 7392869 7392869 NM_003809 chr17 7393098 7401930 
MER39 chr17 7392869 7392869 NM_172089 chr17 7393139 7405649 
MLT2E chr19 9112101 9112101 NM_020933 chr19 9112072 9135082 
LTR12B chr3 129354764 129354764 NM_021937 chr3 129355002 129610178 
LTR54 chr4 84425703 84425703 NM_015697 chr4 84404001 84424988 
MER41D-int chr4 191144734 191144734 NM_020040 chr4 191140672 191143018 
MER51A chr7 10979661 10979661 NM_014660 chr7 10980040 11109807 
MER51A chr7 10979661 10979661 NM_001007157 chr7 10980 40 11175766 
LTR43 chr8 143778578 143778578 NM_017527 chr8 143778532 143782611 







LTR41 chr1 17954234 17954613 NM_030812 chr1 17954430 18026143 
LTR41 chr1 17958237 17958696 NM_030812 chr1 17954430 18026143 
HERVH48 chr1 181939402 181944093 NM_015149 chr1 181871830 182164288 
HERV4_I chr11 117598355 117598585 NM_001098526 chr11 117569651 117601019 
HERVL40 chr12 31766377 31766997 NM_207337 chr12 31715338 31773251 
LTR40a chr13 29764513 29764758 NM_001014380 chr13 29674767 29779163 
LTR40a chr13 29764513 29764758 NM_032116 chr13 296747  29779584 
LTR12D chr14 23176754 23177445 NM_005794 chr14 23175421 23184686 
LTR12D chr14 23176754 23177445 NM_182908 chr14 23175421 23184686 
MLT2E chr19 9111991 9112101 NM_020933 chr19 9112072 9135082 
MER67D chr19 42033104 42033171 NM_003419 chr19 420331 6 42062310 
MER52D chr2 109729279 109729386 NM_023016 chr2 109729199 109733852 
Harlequin chr2 188083923 188088834 NM_001032281 chr2 188051551 188127464 
LTR16C chr20 4666836 4667196 NM_177549 chr20 4659928 4669314 
LTR7 chr4 89292502 89292904 NM_004827 chr4 89230440 89299035 
LTR1D chr4 178965922 178966704 NM_001085490 chr4 178886900 179148663 
HERV9 chr5 146361399 146364490 NM_181674 chr5 145949260 146415783 
HERV9 chr5 146361399 146364490 NM_181678 chr5 145949260 146441207 
LTR5B chr5 177414929 177415182 NM_001080544 chr5 1774 4995 177415888 
LTR50 chr8 12873949 12874595 NM_020844 chr8 12847553 12931655 
LTR43 chr8 143778243 143778578 NM_017527 chr8 143778532 143782611 




LTR41 chrX 134693953 134694178 NM_152582 chrX 134693879 134701914 
LTR41 chrX 134693953 134694178 NM_001017436 chrX 134693879 134719184 
LTR41 chrX 134781361 134781586 NM_001007551 chrX 134773630 134781660 






MER54B chr16 725416 725902 NM_022493 chr16 719771 730998 
LTR9 chrX 2729224 2729740 NM_175569 chrX 2680114 2743960 
MER51A chr2 3339561 3340106 NM_003310 chr2 3171749 3360605 
MER21C chr7 5933542 5933818 NM_001099697 chr7 5932302 5976840 
MER21C chr7 5933542 5933818 NM_173565 chr7 5932302 5976840 
MER31B chr8 11702728 11703173 NM_004462 chr8 11697598 11734226 
LTR36 chr22 17028682 17028800 NM_017414 chr22 1701257 17040162 
MER41A-int chr12 26797075 26797151 NM_002223 chr12 26379553 26877398 
LTR12 chr12 29480709 29481473 NM_183378 chr12 29471755 29541886 
HERVE chr12 31165336 31165939 NM_001080502 chr12 31158726 31250355 
LTR27B chr7 33358011 33358250 NM_001033604 chr7 33135676 33612205 
LTR27B chr7 33358011 33358250 NM_001033605 chr7 33135676 33612205 
LTR27B chr7 33358011 33358250 NM_014451 chr7 33135676 33612205 
LTR27B chr7 33358011 33358250 NM_198428 chr7 33135676 33612205 
MLT2B2 chr17 34767819 34768179 NM_032875 chr17 346703 6 34811402 
MER41G chr22 34984494 34985070 NM_003661 chr22 34979069 34993522 
MER41G chr22 34984494 34985070 NM_145343 chr22 34979069 34993522 
LTR7 chr18 38577764 38578263 NM_002930 chr18 38577189 38949655 
MER68 chr4 38951204 38951750 NM_025132 chr4 38860418 38963824 
LTR19C chr13 42526886 42527709 NM_013238 chr13 42495361 42581304 
MER61F-int chr15 43131729 43132168 NM_003104 chr15 43102632 43154331 
MER92C chr4 46920855 46921054 NM_000812 chr4 46728335 47123202 
LTR12C chr13 50224579 50226004 NM_198989 chr13 50184759 50315886 
MER4C-int chr7 50525903 50526498 NM_000790 chr7 50493627 50596262 
MER4C-int chr7 50525903 50526498 NM_001082971 chr7 50493627 50600648 
MER4D chr3 54650117 54651004 NM_018398 chr3 54131732 55083622 
MER21C chr5 54816203 54816867 NM_003711 chr5 54756441 54866630 
MER21C chr5 54816203 54816867 NM_176895 chr5 54756441 54866630 
MER34B chr4 62321975 62322273 NM_015236 chr4 62045433 62620762 
HERV4_I chr19 63452392 63453769 NM_014480 chr19 63431881 63466820 
MER57A-int chr6 64070948 64072854 NM_016571 chr6 64047518 64087841 
MER52A chr4 64888385 64889631 NM_001010874 chr4 6482 015 64957773 
LTR12 chr7 68888991 68889595 NM_015570 chr7 68702254 69895790 
MER52A chr13 69395827 69397313 NM_020866 chr13 69172726 69580460 
MER4B-int chr12 74045504 74047192 NM_152779 chr12 74014729 74050436 
MER34B chr9 74532752 74533337 NM_138691 chr9 7432656 74641087 




MLT2B2 chr12 79840894 79841339 NM_004664 chr12 7971530  79855825 
HERV17 chr8 81814505 81817335 NM_001033723 chr8 81713323 81949571 
LTR54 chr1 85637738 85638265 NM_012137 chr1 85556756 85703411 
HERVH chr10 92557476 92561145 NM_000872 chr10 92490557 92607651 
HERVH chr10 92557476 92561145 NM_019859 chr10 92490557 92607651 
HERVH chr10 92557476 92561145 NM_019860 chr10 92490557 92607651 
HERVH chr4 93581454 93584375 NM_001510 chr4 93444572 94912672 
LTR9 chr7 98858058 98858575 NM_015545 chr7 98854689 98874355 
MER34D chr13 99168644 99168812 NM_206808 chr13 99056 36 99342824 
HERVH chr14 101779943 101781050 NM_014226 chr14 101764930 101841284 
MLT2D chr7 110096425 110096839 NM_032549 chr7 110090345 110989583 
LTR12C chr4 110124142 110125521 NM_198721 chr4 109954420 110443248 
LTR12C chr4 110124142 110125521 NM_032518 chr4 109964489 110443248 
HERVH chr8 110382902 110385440 NM_032869 chr8 110322324 110415491 
LTR16C chr12 116670959 116671316 NM_173598 chr12 116375221 116777724 
LTR22B chr10 117136681 117136898 NM_207303 chr10 116843113 117698484 
LTR7Y chr3 117306893 117307327 NM_002338 chr3 11701839 117647068 
HERVH chr3 117309183 117312335 NM_002338 chr3 11701839 117647068 
LTR7Y chr3 117312335 117312765 NM_002338 chr3 11701839 117647068 
LTR16B chr9 118368734 118369128 NM_198188 chr9 1182273 7 118489334 
LTR16B chr9 118368734 118369128 NM_014010 chr9 1182273 7 119217138 
LTR16B chr9 118368734 118369128 NM_198186 chr9 1182273 7 119217138 
LTR16B chr9 118368734 118369128 NM_198187 chr9 1182273 7 119217138 
HUERS-P3 chr6 119008185 119016806 NM_001042475 chr6 118892931 119079713 
HUERS-P3 chr6 119008185 119016806 NM_206921 chr6 1189 9289 119079713 
MER41B chr8 119012088 119012717 NM_000127 chr8 1188807 2 119193239 
MLT2B4 chr8 119444631 119445182 NM_001101676 chr8 119270875 119703365 
LTR38B chr6 119666263 119666850 NM_005907 chr6 119540 67 119712625 
LTR12C chr3 120273950 120275501 NM_152538 chr3 12010 170 120347588 
LTR7 chr6 123945179 123945578 NM_006073 chr6 123579181 123999641 
MER52A chr4 124247306 124248778 NM_145207 chr4 124063674 124460054 
MER21A chr6 124675036 124675939 NM_001040214 chr6 124166767 125188483 
LTR22C chr7 126086080 126086529 NM_000845 chr7 125865892 126670546 
LTR40a chr8 126207807 126207882 NM_173685 chr8 126173276 126448543 
MLT2A2 chr3 126756469 126756970 NM_022776 chr3 126730393 126796624 
LTR10C chr5 133976397 133976985 NM_001033503 chr5 133970018 133996426 
LTR10C chr5 133976397 133976985 NM_016103 chr5 133970018 133996426 
PABL_A chr9 135137645 135138270 NM_020469 chr9 135120383 135140451 
MER21C chr2 137646118 137646928 NM_001080427 chr2 137464931 138151757 
HERV9 chr5 146361399 146364490 NM_181676 chr5 145949260 146415671 




LTR1B chr7 146429315 146430028 NM_014141 chr7 14544385 147749019 
LTR8A chr7 147352928 147353621 NM_014141 chr7 14544385 147749019 
MER21A-int chr4 147875445 147878401 NM_031956 chr4 147847628 148086484 
MER4A1-int chr3 151891622 151892158 NM_152394 chr3 151860366 151904432 
HERV30 chr3 155568283 155571737 NM_001038705 chr3 155538155 155630198 
MER41B chr6 160579903 160580541 NM_003058 chr6 160557783 160599949 
HUERS-P2 chr3 168448261 168451231 NM_024687 chr3 168440778 168580765 
LTR10G chr3 168474996 168475504 NM_024687 chr3 168440778 168580765 
LTR7 chr4 187400103 187400470 NM_000892 chr4 187385665 187416618 
HERVH chr4 187402139 187405364 NM_000892 chr4 187385665 187416618 
HERVL40 chr2 202090151 202090443 NM_152525 chr2 20206 401 202192146 
MER21C chr1 223825852 223826508 NM_001008493 chr1 223741156 223907468 
MER21C chr1 223825852 223826508 NM_018212 chr1 223741156 223907468 
LTR49-int chr2 231087179 231087883 NM_003113 chr2 230989114 231089486 






Figure A.1. ERV-derived promoter of the LY6K gene. A) The LTR43 (red) ERV 
sequence is located in the proximal promoter region and overlaps the LY6K 5’ UTR.  
The locations of PET sequences (green) and spliced ESTs (black) are shown.  B) The 
LTR43 (red) sequence region is enlarged and the individual PET sequences (green) and 
spliced ESTs (black) that support the existence of this promoter are shown.  C) 








Figure A.2.  Gene expression profiles and correlations for human and mouse 
GSTO1 and GSTO2.  A) Relative expression values resulting from median and log2 
normalization of Affymetrix signal intensity values across tissues.  B) Pearson correlation 
coefficient values (r) showing the correlation, or lack thereof, for tissue-specific 





Figure A.3. Ranked list of r-values showing the correlation between human-mouse 
orthologous gene tissue-specific expression profiles for all human genes that have a 
lineage-specific ERV-derived TSS that generates a chimeric ERV-gene transcript.  












































Table A.2.  Human gene expression values for genes with ERV-TSS versus all other 
genes. 
Expressiona ERV+b ERV-c Td Pd 
Average 378.3 ± 52.9 600.6 ± 10.0 3.97 7.3e-5 
Maximum 1920.1 ± 309.9 3143.5 ± 50.33 3.76 1.7e-4 
Breadth 23.9 ± 2.6 27.0 ± 0.1 1.18 2.4e-1 
Tissue-specificity 0.75 ± 0.01 0.71 ± 0.00 2.88 4.0e-3 
aExpression parameters measured using the Novartis GNF2 data as described 
bAverage and standard error for human genes possessing an ERV that promotes an ERV-
gene chimeric transcript 
bAverage and standard error for all other human genes 








Figure A.4.  Co-expressed clusters of human genes.  Average tissue-specific 
expression profiles across 79 tissues are shown for each cluster.  Clusters enriched for 
genes with ERV-TSS that generate chimeric transcripts are boxed in red.  Chi-square 
statistical analysis indicating enrichment in cluster 1 (brain) and cluster 20 (testis) is 
shown below the clusters. 
 
cluster #probe Observed Expected chi-square
1 1753 12 3.87598 17.02787535 brain
2 2926 4 6.469548 0.9426727
3 1936 1 4.280603 2.514214961
4 1852 4 4.094874 0.00219815
5 452 2 0.999397 1.001810501
6 550 2 1.21608 0.5053366
7 1016 4 2.246432 1.368837315
8 1499 1 3.314372 1.616088155
9 1837 3 4.061709 0.277524844
10 3799 6 8.399799 0.685615837
11 1725 1 3.81407 2.07625744
12 4167 4 9.213467 2.950055682
13 534 1 1.180704 0.02765619
14 4268 7 9.436784 0.629230882
15 4169 14 9.217889 2.480891257
16 2005 7 4.433166 1.486215024
17 2639 7 5.834975 0.23261172
18 3828 5 8.46392 1.417633857
19 3040 6 6.721608 0.077469284
20 780 8 1.724623 22.83418023 testis






Figure A.5.  Human gene co-expression cluster 1 (brain) and cluster 20 (testis) are 
shown.  Average relative expression levels are indicated on the y-axis and the tissue-









Figure A.6.  Tissue distribution of ERV CAGE tags.  Observed counts for ERV CAGE 
tags are compared to expected counts based on all CAGE tags for brain, testis and the 


























Table A.3.  Statistically over-represented (enriched) GO biological process terms for 
human genes with an ERV-derived TSS generating a chimeric ERV-gene transcript. 
AffyID a ERV-geneb GOc P-valued 
201563_at NM_003104 GO:0019751 polyol metabolic process 0.0015 
205311_at NM_000790, 
NM_001082971 
GO:0006066 alcohol metabolic process 0.0034 
206463_s_at NM_005794, 
NM_182908 
GO:0008202 steroid metabolic process 0.0030 
208647_at NM_004462 




GO:0008202 steroid metabolic process 0.0030 
210946_at NM_003711, 
NM_176895 
GO:0044255 cellular lipid metabolic process 
0.0089 
213379_at NM_015697 
GO:0008299 isoprenoid biosynthetic process 
0.0013 
218304_s_at NM_022776 GO:0008202 steroid metabolic process 0.0030 
aAffyID mapped to ERV-related gene  
bERV-related gene  
cOver-represented biological process GO term and description 






Figure A.7.  GO directed acyclic graph showing the parent-child relationships of 
statistically over-represented (enriched) GO biological process and molecular 
function terms for human genes with an ERV-derived TSS generating a chimeric 






Figure A.8.  Relative frequency of ERV-derived TSS detected by PET versus all 
















































































SUPPLEMENTARY INFORMATION FOR CHAPTER 5 
 
 
Table B.1. Number of CAGE tags mapped from each cell line, sub-cellular location 
and poly-adenylation state. CAGE tag mappings from the GM12878, H1HESC, 
HEPG2, HUVEC and K562 and NHEK cell lines were downloaded from the ENCODE 
repository on the UCSC genome browser. 
  
Cell Line Sub-cellular location Poly-A- Poly-A+ Total 
GM12878 
Cytosolic 18,211,686 --- --- 
Nucleolar --- --- 26,792,181 
Nuclear 27,652,635 --- --- 
H1HESC Whole Cell 28,801,912 --- --- 
HEPG2 
Cytosolic 19,645,027 --- --- 
Nucleolar --- --- 35,803,226 
Nuclear 16,792,966 --- --- 
HUVEC Cytosolic 19,837,471 --- --- 
K562 
Cytosolic 20,273,886 18,769,778 --- 
Nucleolar --- --- 9,527,032 
Nucleoplasmic --- --- 14,826,128 
Nuclear 25,989,950 20,648,810 --- 
NHEK 
Cytosolic 23,312,041 --- --- 




Table B.2. CAGE clusters identified in each cell line, sub-cellular location and poly-
adenylation state.  Overlapping CAGE tag mappings (Table S1) from the ENCODE cell 
lines and in the same sub-cellular locations and poly-adenylation states were grouped 
together and designated as clusters 
Cell Line Sub-cellular location Poly-A- Poly-A+ Total 
GM12878 
Cytosolic 407,021 --- --- 
Nucleolar --- --- 2,458,566 
Nuclear 1,087,671 --- --- 
H1HESC Whole Cell 903,838 --- --- 
HEPG2 
Cytosolic 668,040 --- --- 
Nucleolar --- --- 2,888,807 
Nuclear 4,188,848 --- --- 
HUVEC Cytosolic 857,093 --- --- 
K562 
Cytosolic 4,096,071 525,177 --- 
Nucleolar --- --- 3,503,588 
Nucleoplasmic --- --- 4,617,119 
Nuclear 6,829,025 2,244,742 --- 
NHEK 
Cytosolic 1,730,893 --- --- 
Nuclear 3,082,557 --- --- 





Table B.3. ChIP-seq reads mapped for each histone modification and cell types. 
ChIP-seq data from the GM12878, H1HESC, HEPG2, HUVEC, K562 and NHEK cell 
types cell ties were downloaded from the ENCODE repository on the UCSC genome 
browser.  Reads were mapped using bowtie, keeping the best hits with ties broken by 
quality.  Ambiguously mapped reads were resolved using GibbsAM. 
Modification  
Tags Mapped 
GM12878 H1HESC HEPG2 HUVEC K562 NHEK 
Control 7,436,431 11,908,617 11,039,784 16,836,245 13,240,739 10,666,985 
H3K4Me1 14,069,086 9,713,507 --- 14,524,897 --- 11,260,426 
H3K4Me2 9,163,434 14,479,372 17,293,347 12,005,596 12,454,360 11,031,009 
H3K4me3 10,218,953 7,072,374 10,289,145 12,497,262 15,989,323 10,296,574 
H3K9Ac 12,022,891 16,477,468 7,351,567 8,670,429 17,281,199 12,454,536 
H3K9Me1 --- --- --- 10,658,052 15,905,405 10,731,385 
H3K27Ac 10,770,731 --- 8,856,877 16,833,005 15,871,535 12,788,055 
H3K27Me3 14,430,662 7,160,479 --- 11,652,289 12,412,831 9,141,036 
H3K36Me3 15,195,406 14,680,520 13,579,529 9,818,236 14,950,529 9,182,104 
H4K20Me1 12,224,195 16,605,685 10,356,633 16,664,745 13,685,630 12,380,840 







Figure B.1.  Enrichment of chromatin modifications and RNA PolII at cis-NAT 
promoters in K562 cells using CAGE data from nucleus polyadenylated isolates Cis-
NAT promoters were divided into 4 bins based on activity, and the normalized average 
numbers of ChIP-seq reads from each histone modification +/-5kb of the cis-NAT TSS 
were calculated for each bin.  A ‘+’ or ‘–’ above a b r indicates that the number of ChIP-
seq reads for that bin and modification is significantly higher or lower than the control, 
respectively (P < 0.001).   A ‘+’ or ‘-‘ within the bar indicates that a bin is significantly 
enriched or depleted, respectively, for the histone modification compared to the next 






Figure B.2.  Enrichment of chromatin modifications and RNA PolII at cis-NAT 
promoters in NHEK cells using CAGE data from non-polyadenylated nucleus 
isolates.  Cis-NAT promoters were divided into 4 bins based on activity, and the 
normalized average numbers of ChIP-seq reads from each histone modification +/-5kb of 
the cis-NAT TSS were calculated for each bin.  A ‘+’ or ‘–’ above a bar indicates that the 
number of ChIP-seq reads for that bin and modificaton is significantly higher or lower 
than the control, respectively (P < 0.001).   A ‘+’ or ‘-‘ within the bar indicates that a bin 
is significantly enriched or depleted, respectively, for the histone modification compared 








Figure B.3. Spearman Rank correlation between cis-NAT promoter activity and 
histone modification for K562 nucleus polyadenylated isolates.  Cis-NAT promoters 
were divided into 100 bins based on activity, and the normalized average number of 
ChIP-seq reads +/-5kb of the cis-NAT TSS were calcul ted.  A Spearman rank 
correlation was used to determine the relationship between local histone modifications or 






Figure B.4. Spearman Rank correlation between cis-NAT promoter activity and 
histone modification for NHEK nucleus non-polyadenylated isolates.  Cis-NAT 
promoters were divided into 100 bins based on activity, and the normalized average 
number of ChIP-seq reads +/-5kb of the cis-NAT TSS were calculated.  A Spearman rank 
correlation was used to determine the relationship between local histone modifications or 






Figure B.5. ChIP-seq read density near cis-NAT TSS in K562 cells using CAGE 
data from polyadenylated RNA from nuclear isolates. Cis-NAT promoters were 
divided into 4 bins based on activity, and the normalized average numbers of ChIP-seq 







Figure B.6. ChIP-seq read density near cis-NAT TSS in NHEK cells using CAGE 
data from non-polyadenylated RNA from nuclear isolates. Cis-NAT promoters were 
divided into 4 bins based on activity, and the normalized average numbers of ChIP-seq 










Figure B.7.  Chromatin modification environment around genic promoters in K562.  
Genic promoters were taken from the UCSC genes set, and their activity measured using 
CAGE data from polyadenylated RNA from nucleus isolates from K562 cells. Genic 
promoters were divided into the same for bins as cis-NAT promoters for the same data 
set, and the normalized average numbers of ChIP-seq reads in 10 base-pair windows +/- 







Figure B.8.  Chromatin modification environment around genic promoters in 
NHEK.  Genic promoters were taken from the UCSC genes set, and their activity 
measured using CAGE data from non-polyadenylated RNA from nucleus isolates from 
NHEK cells. Genic promoters were divided into the same for bins as cis-NAT promoters 
for the same data set, and the normalized average numbers of ChIP-seq reads in 10 base-






Figure B.9. Correlation between genic and cis-NAT promoter activity in K562.  Cis-
NAT promoters in the K562 cell type were identified using CAGE data from non-
polyadenylated RNA form nucleus isolates.  Activity of genic promoters and the sum of 
corresponding cis-NAT promoter activity was measured by CAGE tag counts. A 
Spearman rank correlation was used to determine the relationship between total cis-NAT 









Figure B.10. Correlation between genic and cis-NAT promoter activity in NHEK.   
Cis-NAT promoters in the NHEK cell type were identified using CAGE data from non-
polyadenylated RNA form nucleus isolates.  Activity of genic promoters and the sum of 
corresponding cis-NAT promoter activity was measured by CAGE tag counts. A 
Spearman rank correlation was used to determine the relationship between total cis-NAT 








SUPPLEMENTARY INFORMATION FOR CHAPTER 7   
 
Table C.1.  Number of PET tags within TTS clusters, and number of TTS clusters 
found fore each cell type. PET tag mappings from ENCODE cell types were used to 
find TTS.  Co-locating PET 3’ ends were clustered to characterized TTS.  Those TTS 
overlapping TE sequences were found to be TE-TTS. 
Cell Type Sub-Cellular Location PET Tags in TTS Non-TE TTS TE-TTS 
GM12878 Nucleus 18,475,428 16,672 2,296 
H1HESC Whole Cell 13,793,627 17,671 1,242 
HeLaS3 Nucleus 1,863,548 5,728 407 
HepG2 Nucleus 8,934,435 15,883 3,919 
HUVEC Nucleus 3,305,792 18,253 1,247 
K562 Nucleus 7,619,273 13,947 2,557 
NHEK Nucleus 17,517,569 15,142 1,126 




Table C.2. ChIP-seq reads mapped for each histone modification and cell line. ChIP-
seq data from the GM12878 and K562 cell lines were downloaded from the ENCODE 
repository on the UCSC genome browser.  Reads were mapped using bowtie, keeping the 





GM12878 K562 NHEK 
H3K9Ac 12,022,891 17,281,199 12,454,536 
H3K27Me3 14,430,662 12,412,831 9,141,036 






Figure C.1. Enrichment of chromatin modifications at Transcription Termination 
sites in GM12878.  TE-TTS and non TE-TTS were characterized using ENCODE PET 
data from the GM12878 cell type.  Other intragenic TE insertions were defined as those 
intragenic insertions that do not show a TTS.  The av rage normalized numbers of ChIP-







Figure C.2. Enrichment of chromatin modifications at Transcription Termination 
sites in NHEK.  TE-TTS and non TE-TTS were characterized using ENCODE PET data 
from the NHEK cell type.  Other intragenic TE insertions were defined as those 
intragenic insertions that do not show a TTS.  The av rage normalized numbers of ChIP-
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